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RÉSUMÉ 
La neurogenèse est présente, dans le cerveau adulte, dans la zone sous-ventriculaire 
(ZSV) encadrant les ventricules latéraux et dans le gyrus dentelé (GD) de l’hippocampe, 
permettant l’apprentissage, la mémoire et la fonction olfactive. Ces micro-environnements 
possèdent des signaux contrôlant l’auto-renouvellement des cellules souches neurales (CSN), 
leur prolifération, leur destin et leur différenciation. Or, lors du vieillissement, les capacités 
régénératives et homéostatiques et la neurogenèse déclinent. Les patients atteints de la maladie 
d’Alzheimer (MA), comme le modèle animal reproduisant cette maladie (3xTg-AD), montrent 
une accélération des phénotypes liés au vieillissement dont une diminution de la neurogenèse. 
Notre hypothèse est que la découverte des mécanismes affectant la neurogenèse, lors du 
vieillissement et de la MA, pourrait fournir de nouvelles cibles thérapeutiques pour prévenir le 
déclin cognitif. Les études sur l’âge d’apparition et les mécanismes altérant la neurogenèse dans 
la MA sont contrastées et nous ont guidé vers deux études. L’examen des changements dans les 
étapes de la neurogenèse lors du vieillissement et du développement de la neuropathologie. Nous 
avons étudié la ZSV, les bulbes olfactifs et le GD de souris femelles de 11 et 18 mois, et 
l’apparition des deux pathologies associées à la MA : les plaques amyloïdes et les 
enchevêtrements neurofibrillaires. Nous avons découvert que les souris 3xTg-AD possèdent 
moins de cellules en prolifération, de progéniteurs et de neuroblastes, induisant une diminution 
de l’intégration de nouvelles cellules dans le GD et les bulbes olfactifs. Notons que le taux de 
neurogenèse chez ces souris de 11 mois est similaire à celui des souris de phénotype sauvage de 
18 mois, indiquant une accélération des changements liés au vieillissement dans la MA. Dans la 
ZSV, nous avons aussi démontré une accumulation de gouttelettes lipidiques, suggérant des 
changements dans l’organisation et le métabolisme de la niche. Enfin, nous avons démontré que 
 
 
 
 
iv 
le déficit de la neurogenèse apparait lors des premières étapes de la MA, avant l’apparition des 
plaques amyloïdes et des enchevêtrements neurofibrillaires. A l’examen des mécanismes 
inhibant la neurogenèse lors de la MA, nous voyons que chez des souris de 5 mois, le déficit de 
la neurogenèse dans la ZSV et le GD est corrélé avec l’accumulation de lipides, qui coïncide 
avec l’apparition du déclin cognitif. Nous avons aussi découvert que dans le cerveau humain de 
patients atteints de la MA et dans les 3xTg-AD, des gouttelettes lipidiques s’accumulaient dans 
les cellules épendymaires, représentant le principal soutien des CSN de la niche. Ces lipides sont 
des triglycérides enrichis en acide oléique qui proviennent de la niche et pas d’une défaillance du 
système périphérique. De plus, l’infusion locale d’acide oléique chez des souris de phénotype 
sauvage permet de reproduire l’accumulation de triglycérides dans les cellules épendymaires, 
comme dans la MA. Ces gouttelettes induisent un dérèglement de la voie de signalisation Akt-
FoxO3 dans les CSN, menant à l’inhibition de leur activation in vitro et in vivo. Ces résultats 
permettent une meilleure compréhension de la régulation de la neurogenèse par le métabolisme 
lipidique. Nous avons démontré un nouveau mécanisme par lequel l’accumulation des lipides 
dans la ZSV induit une inhibition des capacités de prolifération et de régénération des CSN lors 
de la MA. Les travaux futurs permettront de comprendre comment et pourquoi le métabolisme 
lipidique du cerveau est altéré dans la MA, ce qui pourrait offrir de nouvelles voies 
thérapeutiques pour la prévention et la régénération. 
 
Mots clefs : Maladie d’Alzheimer, vieillissement, cellules souches, neurogenèse, zone sous-
ventriculaire, hippocampe, gyrus dentelé, lipide, acide gras, acide oléique. 
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SUMMARY 
In the adult brain, neurogenesis continues in the subventricular zone (SVZ) surrounding 
the lateral ventricles and the dentate gyrus (DG) of the hippocampus where it plays a critical role 
in learning, memory, and olfactory function. Within these microenvironments, combinatorial 
signals control neural stem cell (NSC) self-renewal, proliferation, fate determination and 
differentiation. Unfortunately, during aging, neurogenesis declines along with many other 
homeostatic and regenerative capabilities. Furthermore, Alzheimer’s disease (AD) patients and 
many AD models show an acceleration of several aging related phenotypes including 
neurogenesis. We hypothesize that uncovering how neurogenesis is affected during aging and in 
AD will provide novel targets for prevention of cognitive decline. However, conflicting findings 
including the age of onset and the mechanisms altering neurogenesis in AD propelled us to 
perform the two following studies. First, we examined the various steps of neurogenesis and how 
they change as a result of aging, neuropathology development, and neurogenic niches. We 
studied neurogenesis in the SVZ, olfactory bulb, and DG of 11- and 18-month-old female mice 
and simultaneously measured the stages of the two major AD-associated pathologies, amyloid 
plaques and neurofibrillary tangles. We found that, 3xTg-AD mice had fewer proliferating cells, 
neural progenitors and neuroblasts, resulting in decreased numbers of adult-born cells added to 
the dentate granule cell layer and the olfactory bulbs. Interestingly, the levels of neurogenesis in 
11-month-old 3xTg mice were similar to those in 18-month-old WT mice, indicating an 
acceleration of aging-related changes in neurogenesis. Interestingly, we found that the deficits in 
neurogenesis appear at early stages of AD-associated pathologies, before the appearance of the 
hallmark Aβ plaques and neurofibrillary tangles. Instead, we found a pronounced accumulation 
of large lipid droplets, suggestive of significant organizational and metabolic changes (Chapter 
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2). Second, we examined the mechanisms inhibiting neurogenesis in AD. Studying young 5-
month-old mice, we found that deficits in SVZ and DG neurogenesis still correlated with 
extensive lipid accumulation coinciding with the onset of cognitive decline. Importantly, we 
found that postmortem AD brains and 3xTg-AD mice accumulate neutral lipids within 
ependymal cells, the main support cell of the SVZ niche. Using novel mass spectrometry 
techniques, we identified these lipids as oleic acid-enriched triglycerides. Moreover, analysis of 
plasma, cerebrospinal fluid, and microdissected SVZs showed that these lipids originate from 
niche-derived rather than peripheral lipid metabolism defects. Remarkably, locally increasing 
oleic acid in wild-type mice was sufficient to recapitulate the AD-associated ependymal 
triglyceride phenotype and led to a de-regulation of the Akt-FoxO3 NSC preservation pathway, 
and inhibition of NSC activation in vitro and in vivo (Chapter 3). Together, this work suggests a 
novel mechanism of cognitive defects. Specifically, lipid accumulation within SVZ niche cells 
during early adulthood inhibits the proliferative and regenerative capacity of NSCs in AD.  
Future work aimed at understanding how and why brain lipid metabolism is altered in AD could 
provide therapeutic targets for preventative and regenerative strategies for those suffering from 
AD.  
 
Keywords: Alzheimer’s disease, aging, stem cell, neurogenesis, subventricular zone, 
hippocampus, dentate gyrus, lipid, fatty acid, oleic acid. 
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I. GENERAL INTRODUCTION 
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I.1 NEUROGENESIS  
 
Early neuroscientists believed the nervous system to be fixed and incapable of plasticity. 
However, the discovery of dividing cells in adult mammalian brains in the mid 1960’s changed 
the way we look at the brain and importantly revealed potential for regeneration and plasticity 
that was thought to be impossible. It is now accepted that post-natal proliferation persists within 
the brains of virtually all species studied including rodents (Altman & Das, 1965), primates 
(Gould et al., 1999; Kornack & Rakic, 1999) and humans (Eriksson et al., 1998; Kukekov et al., 
1999), in two main brain regions, the subventricular zone (SVZ) of the lateral ventricles and the 
dentate gyrus (DG) of the hippocampus. In these locations, resident pools of slowly dividing 
glial neural stem cells (NSC) generate highly proliferative transit amplifying progenitors (TAP)s 
that give rise to fate-committed neuronal or glial precursors. These progenitors migrate to their 
final destinations and differentiate into functional post-mitotic neurons and glia important for 
various aspects of cerebral function and plasticity (Doetsch et al., 1999a; Doetsch et al., 1999b; 
Seri et al., 2001; Imura et al., 2003; Alvarez-Buylla & Lim, 2004).  
 In adulthood, neurogenesis is maintained by permissive microenvironments that provide 
key intrinsic and extrinsic factors that conserve pools of stem cells throughout life. The 
identification of adult NSCS and what regulates them has been a complex task, nevertheless 
important progress has been made in understanding what controls where, how, and why adult 
neurogenesis occurs.  
Stem cells are functionally defined by their two cardinal properties: the ability to 1) self-
renew by symmetric or asymmetric cell division and 2) differentiate into multiple cellular 
lineages. In mammals, there are two main types of stem cells: pluripotent embryonic stem cells 
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and lineage-restricted somatic stem cells. Embryonic stem cells are isolated from the inner cell 
mass of a blastocysts and give rise to all three germ lines: ectoderm, mesoderm and endoderm. 
Adult stem cells persist in various tissues including, for example, skin (epidermal) and brain 
(neural). These cells only give rise to cell types of the specific tissue in which they reside. 
 
I.1.1 Development of neural stem cells 
 
Prior to adopting their mature adult phenotype, NSCs evolve through several distinct 
developmental stages during which they possess different properties and perform different 
biological functions (Figure 1) (Alvarez-Buylla et al., 2001). Throughout development of the 
central nervous system (CNS), the main biological function of the early NSCs precursors is 
tissue growth. In their first phase, the precursors of NSCs correspond to primitive neuroepithelial 
cells (NEPs). NEPs span the one cell-layer thick neural tube, contacting both the inner 
ventricular surface and the outer pial surface, and they divide symmetrically in order to rapidly 
expand their population.  The onset of asymmetric cell divisions initiates a second phase, when 
the accumulation of differentiated progeny and consequent thickening of the neural tube cause 
NEPs to transition into radial glial cells (RGCs). Once thought to mainly serve a scaffolding 
function, it is now known that RGCs generate the neurons, astrocytes, and oligodendrocytes of 
the developing CNS, either directly or indirectly via intermediate progenitor cells (Noctor et al., 
2004; Kriegstein & Alvarez-Buylla, 2009; Hansen et al., 2010). In the final stages of 
development, a subpopulation of RGCs begins assembling the SVZ niche that will maintain 
NSCs during adulthood. They do so by retracting their apical processes while maintaining 
ventricular contact at their basal surface, subsequently converting into either ventricle-lining  
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Figure 1. Development of adult neural stem cells.  
Prior to adulthood, neural stem cells (NSCs) pass through three morphologically and functionally 
distinct phases. 1) Initially, neuroepithelial stem cells divide symmetrically to expand their 
numbers. As the neuroepithelium (NE) thickens, neuroepithelial cells elongate and convert into 
radial glial cells (RGC). 2) RGCs divide asymmetrically to generate neurons or intermediate 
progenitors (nIPCs). Oligodendrocytes are also derived from RGCs through oligodendrocyte 
progenitors (oIPCs). As the progeny from the RGCs and IPCs move into the mantel (MA) for 
differentiation, the brain thickens. RGCs have apical-basal polarity as they contact the ventricle 
via a single primary cilium and project basally to contact blood vessels, meninges and the basal 
lamina. A subpopulation of RGCs retain apical contact and function as NSCs in the neonate. As 
formation of the main populations of differentiated neural cell types nears completion, forebrain 
radial glial cells retract their peripheral radial process and differentiate into either ventricle-
contacting subventricular zone (SVZ) astrocytes or ventricle-lining ependymal cells, setting up 
the SVZ niche. A subpopulation of SVZ astrocytes retains NSC characteristics postnatally and 
1) 2)
3)
 
 
 
 
5 
into adulthood. 3) During adulthood, NSC function shifts to forebrain maintenance; aNSCs 
primarily divide asymmetrically, maintaining the size of the stem cell pool while generating new 
neuroblasts and glioblasts. Image originally from (Kreigsten and Alvarez-Buylla et al., 2009, 
Annual Review of Neuroscience), reproduced with permission from Annual Reviews © 2009. 
MZ, marginal zone, VZ, ventricular zone. 
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ependymal cells or ventricle-contacting SVZ astrocytes (Merkle et al., 2004; Spassky et al., 
2005). 
The biological function of NSCs undergoes a major change when they begin shifting into 
a mode dedicated to tissue maintenance. This maintenance phase begins in the postnatal period 
and continues throughout adulthood.  In the forebrain, a subpopulation of SVZ astrocytes 
continues functioning as postnatal and adult NSCs (Doetsch et al., 1999a; Imura et al., 2003; 
Morshead et al., 2003).  
 
I.1.2 Identification of adult neural stem cells 
Subventricular zone 
Although new dividing cells were labelled in the brains of adult mammals in the 1960’s 
(Altman & Das, 1965) this finding was met with significant scepticism, delaying the 
identification of adult NSCs for decades. In 1992, Reynolds and Weiss placed dissected adult 
striatum in culture in the presence of growth factors and discovered that a sub-population of cells 
grew into free-floating clonal colonies comprised of neural stem cells and progenitors, termed 
neurospheres (Reynolds & Weiss, 1992). Individual neurospheres were capable of serial self-
renewal and multi-potency, as they differentiated into neurons, astrocytes and oligodendrocytes 
upon removal of growth factors (Vescovi et al., 1993; Reynolds & Weiss, 1996). Elucidation of 
the appropriate culture conditions to isolate and propagate NSCs provided the first explicit 
demonstration of adult NSCs. Soon after, the van der Kooy lab showed that lateral ventricle 
subependymal cells were a necessary and sufficient source of neurospheres (Morshead et al., 
1994). Subsequently, neurospheres were isolated all along the ventricular system, including the 
spinal cord (Weiss et al., 1996). Although this technique did not allow for the purification of 
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NSCs, the neurosphere assay did confirm their presence in the adult CNS and provided a much-
needed tool for studying their properties.  
Ablation techniques and lineage tracing experiments allowed for the identification of 
NSCs in vivo, their cellular lineage, and division kinetics under physiological and regenerative 
conditions. Morshead et al. used high doses of 3H-thymidine to induce cell death in constitutively 
proliferating SVZ cells, depopulating the lateral ventricle sub-ependymal zone. Interestingly, a 
sub-population of cells persisted and displayed NSC characteristics both in vitro and in vivo 
(Morshead et al., 1994). Clonal retroviral infection of SVZ cells demonstrated that NSCs mainly 
divide asymmetrically, allowing them to simultaneously maintain the stem cell pool and generate 
rapidly dividing TAPs. Newly generated cells remain in the SVZ for approximately 15 days 
before migrating to the olfactory bulb (25%) or dying (60%) (Morshead et al., 1998). A related 
study used glial fibrillary acid protein (GFAP)-Tva mice that express the receptor for avian 
leukosis virus under the GFAP promoter to trace the fate of GFAP-expressing cells after infusion 
of fibroblastic growth factor (FGF). Injection of the avian leukosis virus encoding alkaline 
phosphatase (AP) into the SVZ resulted in specific labeling of GFAP-expressing cells and their 
progeny. After 1 day AP expression was limited to the SVZ. AP-positive migrating neuroblasts 
and olfactory bulb interneurons began to appear at 3.5 and 14 days after infection, respectively 
(Holland & Varmus, 1998). Similar findings were seen after SVZ ablation using the anti-mitotic 
chemotherapy drug cytosine arabinoside (AraC). After 6 days, all SVZ cells are depleted with 
exception of post-mitotic ependymal cells and GFAP-expressing putative NSCs. GFAP+ cells 
with a radial morphology resumed proliferation to first give rise to TAPs and neuroblasts, which 
migrate through the rostral migratory stream (RMS) to repopulate olfactory interneurons over a 
14 day period (Doetsch et al., 1999b). Furthermore, genetic ablation of GFAP-expressing cells 
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specifically, eliminated adult neurogenesis and neurosphere formation completely (Imura et al., 
2003; Morshead et al., 2003; Garcia et al., 2004). Together, these and other studies led to the 
conclusion that glial cells with NSC properties reside within the subependyma of the adult lateral 
ventricle and are the source of neurospheres in rodents. The development of whole mounts of the 
lateral ventricle walls aided the further characterization and localization of GFAP+ NSCs within 
the SVZ. NSCs were shown to send out two processes, one that projects apically through a 
pinwheel-like cluster of ependymal cells to contact the ventricle and the other reaching basally to 
touch niche blood vessels. These cells possess NSC properties, making new neurons in vivo and 
differentiating into neurons, astrocytes, and oligodendrocytes in vitro (Mirzadeh et al., 2008). 
Further work by Ponti et al., revealed the proliferation dynamics of GFAP+ NSCs, achaete-scute 
homolog-1 (Ascl)+ TAPs, and doublecortin (DCX)+ neuroblasts in vivo. This study 
demonstrated that, following the initial division of NSCs, TAPs divide three times before turning 
into neuroblasts (which divided once or twice before leaving the SVZ (Ponti et al., 2013). 
Together, these data established that glia NSCs are mainly quiescent, dividing only once every 2-
3 weeks to generate TAPs that give rise to migratory, fate-committed neuroblasts and glioblasts 
in vivo.  
Several succeeding studies attempted to selectively label NSCs using markers including 
(sex-determining region y)-box-2 (Sox2), GFAP, Nestin, Musashi 1 and 2, Prominin-1/CD133 
and bromodeoxyuridine (BrdU) long-term retention (reviewed in (Basak & Taylor, 2009)). 
However, since NSCs are virtually identical to niche astrocytes, no specific combination of 
markers could definitively distinguish the two (reviewed by (Mamber et al., 2013)). Many 
groups used flow cytometry to enrich for NSCs, using markers including Prominin-1/CD133 
(Uchida et al., 2000; Corti et al., 2007; Obermair et al., 2010), Lewis X (LeX) (Capela & 
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Temple, 2002), Aldehyde dehydrogenase (ALDH) (Obermair et al., 2010) and peanut agglutinin 
(Rietze et al., 2001). For example, Corti et al. showed that Prominin-1 is co-expressed with 
known NSC markers Sox1/2, Musashi, and Nestin and that the Prominin-1+ SVZ cells makeup 
the neurosphere-forming population. Moreover, transplantation experiments showed that 
Prominin-1-positive cells give rise to neurons and glial cells in vivo (Corti et al., 2007). In a 
second study, Obermair et al. compared SVZ cells that expressed Prominin-1, ALDH, and LeX 
on both genetic and functional properties. They found that rarely dividing cells are LeX-positive, 
Prominin-1-positive, and express high levels of ALDH, while rapidly dividing cells are 
Prominin-1-negative, LeX-negative, and express low levels of ALDH. This suggested that 
expression of Prominin-1, Lewis X, and high levels of ALDH could be used to distinguish 
between quiescent, slowly dividing and active, rapidly dividing neural precursor populations. In 
addition, cells expressing Prominin-1, LeX, and high levels of ALDH also co-expressed high 
levels of the classic stem cell markers, Notch and Nestin, and expressed low levels of TAP 
markers such as PAX6 and Mash-1 and formed multi-potent neurospheres in vitro (Obermair et 
al., 2010). Together, these and other studies uncovered NSCs in the adult CNS that are capable 
of multi-potent differentiation in vitro. The next step was to identify their properties and 
neurogenic lineage in vivo. 
Using genetic markers and lineage tracing several sub-types of NSCs have been 
categorized (Figure 2). For example, three distinct Notch/Hes5-expressing NSC populations 
were identified in the SVZ 1) GFAP+/brain lipid binding protein (BLBP)-, 2) GFAP+/BLBP+, 
and 3) GFAP-/BLBP+. BLBP+ NSCs comprised a proliferating, epidermal growth factor 
receptor (EGFR)+, component of pinwheel structures, made up the majority of neurosphere-
forming cells and persistently generated neurons in the adult (Giachino et al., 2014). Using a 
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different set of markers, Codega et al. isolated a quiescent NSC population (qNSC) that were 
CD24-/GFAP+/CD133+, and an active NSC population (aNSC) that were CD24-
/GFAP+/CD133+/EGFR+/Nestin+. They demonstrated that after transplantation both 
populations generated new neurons in vivo, however aNSCs generated significantly more new 
neurons than quiescent NSCs due to shorter cell cycles. Similarly, both qNSCs and aNSCs 
formed neurospheres, however aNSCs made up the vast majority of neurosphere colonies. 
Importantly, qNSCs could become activated in culture and upregulated Nestin and EGFR 
expression, suggesting that these cell types are interconvertible cell populations (Codega et al., 
2014). Intriguingly, the Morshead group has recently identified a novel NSC sub-population that 
is upstream of the classical adult GFAP-expressing NSCs. This population of NSCs is activated 
by leukemia inhibitor factor (LIF) and displays primitive NSC properties, such as octamer-
binding transcription factor 4 (Oct4) expression and the ability to integrate into the inner cell 
mass of blastocysts. Moreover, these cells generate self-renewing, multi-potent neurosphere 
colonies that give rise to GFAP+ NSCs in vitro. In addition, when GFAP+ NSCs are eliminated 
in vivo, the remaining Oct4+ NSCs can fully repopulate the SVZ (Sachewsky et al., 2014). 
Collectively, these experiments demonstrated up to four possible sub-types of adult NSCs reside 
within the SVZ and give rise to progenitors and neuroblasts during adulthood (Figure 2).  
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Figure 2. Summary of the neurogenic stem cell lineage and markers. 
Primitive neural stem cells (NSCs) express Oct4 and respond to LIF but not EGF or FGF 
(Sachewsky. et al., 2014). Quiescent NSCs (qNSCs) express GFAP/CD133 but not EGFR or 
Nestin, while active NSCs (aNSCs) express GFAP/CD133/EGFR/Nestin (Codega et al., 2014) 
and Hes5/BLBP (Giachino et al., 2014). aNSCs divide to give rise to transit amplifying cells 
(TAPs) that begin to lose expression of immature NSC markers and become lineage specified to 
produce doublecortin (DCX)-expressing neuroblasts in the SVZ. (Image generated by Laura 
Hamilton and Loic Cochard). 
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Dentate gyrus 
Hippocampal neurogenesis occurs in the subgranular zone located at the interface 
between the granule cell layer and the hilus of the DG (Altman & Das, 1965). In the prevailing 
model of adult hippocampal neurogenesis, similarly to the SVZ, quiescent radial glia-like (RGL) 
cells within the subgranular zone generate proliferative precursors known as intermediate 
progenitors, which give rise to neuroblasts. Within days, newborn neurons extend dendrites 
toward the molecular layer and project axons through the hilus toward the CA3 (Zhao et al., 
2006). In the following weeks and months new neurons continue maturing and synaptic 
integration into the existing circuitry (reviewed by (Ge et al., 2008)).  
The identification and characterization of NSCs in the dentate gyrus has not been without 
controversy and questions still remains as to whether definitive NSCs exist in the DG. The first 
study to characterize RGCs as the putative stem cells in the DG ablated dividing neural precursor 
cells in vivo by infusing the anti-mitotic drug AraC (Seri et al., 2001). The authors followed up 
these initial results using viral transduction strategies to track the fate of nestin or GFAP+ cells 
and found that both populations give rise to adult-born hippocampal neurons (Seri et al., 2004). 
Genetic ablation (Garcia et al., 2004; DeCarolis et al., 2013) and transgenic fate-mapping 
(Garcia et al., 2004; Seri et al., 2004; Ahn & Joyner, 2005; Lagace et al., 2007; Dranovsky et al., 
2011; DeCarolis et al., 2013) further confirmed that RGC have stem cell properties. Based on 
these studies, it was presumed that the RGC was the stem cell that supported adult neurogenesis. 
In the following years, two keys studies aimed to untangling the self-renewal capacity and fate of 
RGCs.  Importantly, one study proposed a self-renewing RGL, while the other found RGCs to 
have only short-term self-renewal. Two groups used in vivo clonal analysis to reveal that a single 
RGL undergoes several rounds of self-renewal and differentiation to produce both neurons and 
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astrocytes over a long duration, demonstrating characteristic stem cell properties by individual 
RGLs (Bonaguidi et al., 2011; Dranovsky et al., 2011). On the other hand, Encinas et al. 
proposed that RGLs do not possess long-term self-renewal. Instead, RGLs repeatedly entered the 
cell cycle once activated and generated only neurons before terminally differentiating into 
astrocytes (Encinas et al., 2011). A unifying theory can be reached if multiple subpopulations of 
NSCs are present within the DG and that these studies have looked at slightly different 
populations and thus found differing NSC properties. 
 
I.1.3 Niche structure, cell types, and location  
 
Adult NSCs reside in specialized niches that tightly regulate their behaviour to maintain a 
life-long pool. Within these niches, combinatorial extrinsic signals arising from adjacent NSCs, 
TAPs, neuroblasts, ependymal cells, microglia, extracellular matrix molecules, the cerebrospinal 
fluid (CSF), and the vasculature interact with cell-intrinsic mechanisms to control proliferation, 
self-renewal capacity, fate determination, migration, differentiation, and survival (Fuchs et al., 
2004; Morrison & Spradling, 2008; Suh et al., 2009; Walker et al., 2009). Insights into how the 
NSC niches are organized and the key regulators that promote or hinder neurogenesis are 
continually being uncovered. 
Subventricular zone 
In the lateral ventricle SVZ, NSCs are ideally positioned to be regulated by 
environmental signals. Systemic factors reach NSCs via their contacts with the CSF and SVZ 
blood vessels (Figure 3) (Mirzadeh et al., 2008; Tavazoie et al., 2008; Codega et al., 2014). A 
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major source of local signals are the adjacent ependymal cells, which constitute approximately 
25% of cells within this NSC niche (Doetsch et al., 1997) and surround NSCs in pinwheel 
structures within the walls of the lateral ventricles (Mirzadeh et al., 2008). Ependymal cells 
provide a critical barrier mediating the exchange of ions, macromolecules and immune cells 
between the brain and the circulating CSF, and also secrete a variety of molecules that regulate 
NSC activity. NSC cilia act as a mechanosensory (Singla & Reiter, 2006) and sensory organelle 
involved in the integration of multiple signalling pathways including sonic hedgehog (Shh), 
wingless-integrin (Wnt), and platelet-derived growth factor (PDGF) signalling (Corbit et al., 
2005; Jackson et al., 2006; Rohatgi et al., 2007; Corbit et al., 2008). TAP cells are found closely 
apposed to their precursors and often in close proximity to blood vessels (Doetsch et al., 1999a; 
Shen et al., 2008; Tavazoie et al., 2008). The motile cilia of ependymal cells contribute to CSF 
flow and are required to create gradients of Slit chemorepellents that guide neuroblast migration 
from the SVZ toward the olfactory bulb (Nguyen-Ba-Charvet et al., 2004; Sawamoto et al., 
2006). Microglia, the resident immune cells of the brain, are also found scattered throughout the 
SVZ and although their exact role has not been identified, it is proposed that they secrete soluble 
factors within the niche.  
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Figure 3. Cellular composition of the adult lateral ventricle niche.  
Quiescent (qNSC) and active (aNSC) adult neural stem cells extend an apical extension to 
directly contact the ventricle cerebrospinal fluid and a long basal process ending on blood 
vessels. NSCs form the core of a pinwheel-like structure comprised of multi-ciliated ependymal 
cells. When activated, NSCs divide to produce transit-amplifying progenitors (TAPs) that 
differentiate into chains of migrating neuroblasts destined for the olfactory bulb. (Image 
originally from Mirzadeh et al., 2008, Cell Stem cell), modified and reproduced with permission 
from Elsevier © 2008.  
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Dentate gyrus 
DG neurogenesis is tightly regulated by many of the same factors as the SVZ including 
adjacent cells, extracellular matrix molecules and the vasculature. However, unlike the SVZ 
ependymal and CSF factors do not border the DG. Instead, local innervations from cortical and 
hippocampal inputs are sources of key regulation that in addition to pre-programmed intrinsic 
mechanisms alter DG neurogenesis (Fuchs et al., 2004; Morrison & Spradling, 2008; Suh et al., 
2009; Walker et al., 2009; Hsieh, 2012; Aimone et al., 2014). 
 
I.1.4 Regulation of adult neural stem cells 
 
Since adult NSCs are thought to be remnant radial glia cells from development, it is no 
surprise that major developmental signalling pathways including bone morphogenic protein 
(BMP), Shh, Notch and Wnt, continue to regulate the maintenance, activation, and fate choice of 
adult neural precursors.  
 
I.1.4.1 Bone morphogenetic proteins 
 
BMPs are a group of cytokines from the transforming growth factor (TGF)-β family, 
originally discovered for their ability to induce the formation of cartilage and bone (Urist, 1965). 
BMPs have since been shown to be essential for orchestrating tissue architecture throughout the 
nervous system (reviewed in (Bond et al., 2012)). BMP2 and BMP4 and their downstream 
effectors Smad1/5/8 are present in the adult brain and NSCs and TAPs in the adult SVZ express 
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both these ligands and their receptors (Lim et al., 2000; Peretto et al., 2004). BMPs control a vast 
range of cellular behaviours largely due to the differential levels of BMP signalling within the 
niche. One explanation for this stems from the proximity of each cell type to the BMP inhibitor 
Noggin, expressed by ependymal cells. BMP signalling in neural progenitor cells leads to an 
inhibition of neural specification and promotion of glia differentiation (Lim et al., 2000; Colak et 
al., 2008). While, exogenous infusion of Noggin decreases neuroblast production in the SVZ and 
increases oligodendrogenesis (Colak et al., 2008). It has also been suggested that NSCs express 
Noggin, implying additional cell autonomous regulation within the NSC population (Peretto et 
al., 2004). Similarly, within the DG, BMP regulates NSC quiescence and activation (Bonaguidi 
et al., 2008; Mira et al., 2010). Taken together, these results suggest that the levels of BMP 
signalling within the adult neurogenic niches are tightly regulated to allow the production of 
differentiated progeny while preserving the stem cell population.  
 
I.1.4.2 Sonic hedgehog 
 
Shh was first identified in drosophila during a genetic screen looking for genes that 
regulate the patterning of embryonic segmentation. They discovered that one of their mutant 
embryos displayed a phenotype resembling a hedgehog and named the gene hedgehog (Nusslein-
Volhard & Wieschaus, 1980). Shh signalling in the adult SVZ has been implicated in fate 
specification and NSCs proliferation (recently reviewed by (Alvarez-Buylla & Ihrie, 2014)). Shh 
has been detected in the CSF but is not prevalent in the SVZ, however, its downstream effectors 
are expressed throughout this region (Petrova et al., 2013). Injection of Shh in the lateral 
ventricle in rodents, results in elevated BrdU+ proliferating cells and downstream transcription, 
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suggesting that Shh-responsive cells are indeed present in this region (Traiffort et al., 1998). 
Moreover, exogenous administration of Shh has been shown to increase the number of multi-
potent cells and enhance self-renewal capacity of neurospheres, indicating that this protein can 
activate proliferation and inhibit differentiation of NSCs (Palma et al., 2005). Anti-mitotic AraC 
treatment revealed that it is the sub-population of remaining slow-dividing cells that display 
active Shh signalling (Ahn & Joyner, 2005) and this signalling is required for the establishment 
and maintenance of the adult SVZ (Balordi & Fishell, 2007b; a; Han et al., 2008; Ihrie et al., 
2011). Indeed, recent studies have shown that Shh inhibits neurogenesis and leads to a decrease 
of proliferation and neurogenesis, and a gradual loss of NSCs, suggesting a role for Shh in NSC 
maintenance (Petrova et al., 2013). Shh also regulates DG NSCs. Overexpression of Shh near the 
dentate gyrus increases proliferation and neurogenesis of SGZ cells. Additionally, in culture, Shh 
maintains proliferation of adult hippocampal neuronal progenitors (Lai et al., 2003). Although 
the sources of Shh have not been clearly identified, there is evidence suggesting a role of 
lipophilic modification in Shh distribution. When bound to cholesterol, Shh is distributed over 
hundreds of micrometers. In contrast, when cholesterol is unbound, its distribution is greatly 
restricted, though it retained similar biological activity. Thus, lipid-modification may be one way 
of targeting secreted factors within the niche (Lewis et al., 2001) 
 
I.1.4.3 Notch-delta 
 
The Notch signalling pathway is a critical regulator of lateral inhibition, a process 
involving cell-cell communication to control cell fate during embryonic and adult life. Several 
gain and loss of function experiments have shown that like Shh, Notch plays an essential role in 
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the preservation of the NSC pool. Indeed, Notch ligands Notch1,2,3, Jagged1 and Delta1 are 
expressed by GFAP-expressing NSCs and astrocytes within the SVZ as well as in neuroblasts 
within the RMS (Givogri et al., 2006; Basak et al., 2012). Jagged1 treatments in vitro and in vivo 
have demonstrated that Notch signalling is required for NSC proliferation and self-renewal 
(Nyfeler et al., 2005). Similarly, it has been shown that EGF signalling in TAP cells inhibited 
proliferation and self-renewal of NSCs by suppressing Notch signalling within NSCs (Aguirre et 
al., 2010). Another study showed that when recombining binding protein suppressor of hairless 
(Rbpj) was deleted in the adult brain, all NSCs differentiated into TAPs and neurons. As a result, 
neurogenesis increased transiently, but 3 months later all neural stem cells were depleted and 
neurogenesis was extinguished (Imayoshi et al., 2010). Moreover, Nestin promoter driven 
Notch-1 deletion results in a selective loss of active NSCs. In contrast, quiescent NSCs were 
unaffected after Notch1 ablation until induced to proliferate during regeneration or aging 
conditions, whereupon they became Notch1-dependent and failed to maintain neurogenesis 
(Basak et al., 2012). However, since this study only inhibited Notch signalling in Nestin+ cells, 
which have since been shown to be the active NSCs (Codega et al., 2014), it is not surprising 
that only active NSCs were affected. In another study, Notch-1 deletion in vivo resulted in 
increased NSCs leaving the SVZ niche toward the OB, while over-expression of Notch-1 in vitro 
led to the transformation of TAPs to NSCs (Piccin et al., 2013). Lineage tracing experiments 
with Hes5::CreER transgenic mice demonstrated that NSCs with active canonical Notch 
signalling generate multiple neuron subtypes in the OB (Giachino et al., 2014), implying that all 
adult NSC lineages need Notch signalling. Interestingly, Notch signalling also appears to 
regulate niche components through Ephrins to keep ependymal cells from differentiating into 
niche astrocytes in the adult SVZ (Nomura et al., 2010). Indeed, many Ephrins and Ephrin 
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receptors regulate cell proliferation in the adult SVZ (Conover et al., 2000; Holmberg et al., 
2005; Ricard et al., 2006; Genander & Frisen, 2010). Neural precursors in the DG are also 
regulated by Notch. Briefly, Notch1 and Jagged, are expressed in the SGZ where they participate 
in many developmental cell fate decisions and in certain contexts promotes an undifferentiated, 
precursor cell state (Stump et al., 2002). Moreover, two Notch ligands, Jag1 and Dll4, are 
prominently expressed in the vasculature, and it is possible that these vasculature-derived Notch-
ligands might regulate Notch signalling activity in NSCs (High et al., 2008). Overall, Notch 
balances NSC proliferation while keeping them in an undifferentiated state.  
 
I.1.4.4 Wnt 
 
The Wnt signalling pathway regulates crucial aspects of cell fate determination and 
proliferation. Using axin-reporter mice, Adachi et al. found active Wnt signalling in GFAP+ and 
Mash1+ cells, but not in DCX+ neuroblasts. Retroviral stabilization of downstream effectors of 
canonical Wnt signalling increased the number of Mash-1+ TAPs, while chemical inhibition of 
Wnt signalling led to increased proliferation and enhanced neurogenesis in the OB (Adachi et al., 
2007). SVZ regeneration studies suggest a role for Wnt in asymmetric NSC division.  They 
observed an upregulation of Wnt signalling after antimitotic treatment, when NSCs are biased 
towards asymmetric division to repopulate the SVZ (Piccin & Morshead, 2011). Continuous live 
imaging in culture showed that NSCs produce either neurons and astrocytes or oligodendrocytes, 
but never all three. Importantly, only the oligodendrocytes lineage NSCs responded to canonical 
Wnt signalling. In vitro and in vivo increased or decreased Wnt3 altered the number of Olig2+ 
cells and platelet derived growth factor receptor (PDGFR)-α positive cells, but did not affect 
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neurogenesis and astrogliogenesis. This suggests that Wnt contributes to the fine-tuning of 
oligodendrogliogenesis in the adult SVZ (Ortega et al., 2013). Wnt signalling is implicated in 
proliferation and differentiation during development and in adult DG NSCs (Lie et al., 2005; 
Adachi et al., 2007). In particular, two Wnt target genes NeuroD1 and Prox1 play important 
roles in neuronal differentiation (Gao et al., 2009; Karalay et al., 2011). Similarly to Shh, Wnt 
signalling can be regulated by lipidation (reviewed by (Steinhauer & Treisman, 2009)). Wnt3 has 
two lipid modification sites, specifically a palmitic acid (Willert et al., 2003) and a palmitoleic 
acid (Takada et al., 2006) that regulate the affinity of Wnt to bind to its receptor (Komekado et 
al., 2007; Kurayoshi et al., 2007; Franch-Marro et al., 2008) and its secretion (Willert et al., 
2003; Takada et al., 2006; Komekado et al., 2007; Kurayoshi et al., 2007).  
 
I.1.4.5 Epidermal and fibroblast growth factor 
 
Growth factors are major regulators of adult neurogenesis. In 1992, Reynolds and Weiss 
first isolated adult NSCs when they placed dissected striatum in culture with EGF (Reynolds et 
al., 1992). Other groups performed similar culture studies using FGF (Richards et al., 1992; 
Gritti et al., 1996; Johe et al., 1996). Further analyses indicated that FGF- and EGF-responsive 
cells corresponded to the same populations within the SVZ. SVZ cells where shown to co-
express EGF and FGF receptors in vivo, and when placed in vitro the number of neurospheres 
isolated in the presence of FGF2 and/or EGF was the same (Gritti et al., 1999). It is now 
accepted that EGFR is primarily expressed on a sub-population of activated NSCs and their 
immediate progeny, TAP cells (Vescovi et al., 1993; Doetsch et al., 2002; Pastrana et al., 2009; 
Codega et al., 2014). Exogenous stimulation of the EGFR by ventricular infusion of EGF 
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increases the number of NSCs contacting the ventricle (Doetsch et al., 2002), the rate of 
proliferating oligodendrocyte progenitors, and the number of migrating cells into the surrounding 
parenchyma (Craig et al., 1996; Doetsch et al., 2002; Aguirre et al., 2005; Aguirre & Gallo, 
2007; Gonzalez-Perez et al., 2009). It has been shown that the endogenous ligand for the EGF 
pathway is transforming growth factor (TGF)-α. TGF-α-deficient mice exhibit decreased 
proliferation within the adult SVZ, which is rescued in vitro by administration of EGF (Tropepe 
et al., 1997). Infusion of FGF-2 similarly increases proliferation in the adult SVZ and results in 
fewer newly born neurons (Kuhn et al., 1997; Holland & Varmus, 1998), while loss of FGF-2 
decreases the slow-dividing stem cell pool (Zheng et al., 2004), suggest that FGF-2 functions to 
maintain the neural precursor population.  
 
I.1.4.6 Insulin-like Growth Factor 
 
Insulin-like growth factors (IGFs) are a group of hormones with similar structural 
features to insulin and are produced by many tissues in the body including the brain (Bondy CA 
et al., 1993, GA Werther 1990). IGFs bind to IGF receptors to activate the PI3K-AKT signalling 
pathway and its downstream effectors FoxO transcription factors and –TOR kinase. Genetic 
manipulation of IGF effectors has established their critical role in NSCs maintenance. FoxO 
family members (FoxO1, FoxO3, FoxO4) have been shown to control NSC self-renewal (Paik et 
al., 2009; Ro et al., 2013). FoxO1/3/4 deficiency leads to an acute increase in NSC proliferation 
and neurogenesis, followed by premature NSC exhaustion and loss of neurogenesis (Paik et al., 
2009). Interestingly, this phenotype seems to be mainly due to loss of FoxO3, as it has been 
shown to be necessary and sufficient for NSC preservation (Renault et al., 2009; Schmidt-
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Strassburger et al., 2012). Indeed, loss of FoxO3 in FoxO3- knockout mice results in a smaller 
NSC pool in vivo and NSCs/NPs from FoxO3- knockout mice generate fewer primary and 
secondary neurospheres and these sphere were no longer multi-potent, indicating a loss of both 
cardinal properties of NSC (Renault et al., 2009). Similarly, constitutive activation of FoxO3 
leads to NSC apoptosis and depletion (Schmidt-Strassburger et al., 2012). Our group showed that 
Mammalian target of rapamycin (mTOR) signalling is central in determining proliferation versus 
quiescence in the adult forebrain NSC niche. Within the SVZ, mTOR complex-1 (mTORC1) 
activation is present in TAPs but not in GFAP+ NSCs. Inhibition of mTORC1 with Rapamycin 
depletes the TAP pool in vivo and suppresses EGF-induced proliferation in neurosphere cultures. 
Interestingly, mTORC1 inhibition reduced NSC proliferation that could be reversed with EGF 
infusion. In addition, the decrease of neural precursor proliferation seen during aging could be 
reactivated by EGF administration in an mTORC1-dependent manner (Paliouras et al., 2012). 
These findings established links between mTOR signalling, proliferation, EGF-signalling and 
aging-associated quiescence in the adult forebrain NSC niche. Taken together, IGF-1-
downstream effectors are needed for maintaining proliferation and retaining stem cell 
characteristics within SVZ niche throughout life. 
 
I.1.4.7 Hippocampal circuitry 
 
The hippocampus and DG receive and transmit signals that modify neurogenesis (Veena 
et al., 2011). GABA-mediated excitation promotes neuronal differentiation of type 2, nonradial 
NSCs, and synaptic integration of immature neurons (Ge et al., 2006; Ge et al., 2007). Song et 
al. demonstrated that nestin-expressing RGCs in the SGZ were responsive to GABA through ɣ2 
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receptors (Song et al., 2012). GABA, presumably from spill over from GABAergic synapses, 
suppressed the symmetric proliferation of RGLs, instead biasing them to quiescence (Song et al., 
2012). Glutamate also regulates proliferation within the DG (Cameron et al., 1995) and is 
important for neuronal development and integration (Tashiro et al., 2006). A lesion in the dorsal 
nuclei of raphe or inhibition of serotonin production like-wise decreases proliferation in the DG 
(Brezun & Daszuta, 1999; 2000) (Radley & Jacobs, 2002). In addition, denervation of 
dopaminergic neurons also decreases proliferation of NSCs in the SGZ (Hoglinger et al., 2004). 
Consistent with this, neurogenesis is required for the benefits of antidepressant treatments 
(Gould et al., 1999; Santarelli et al., 2003). 
 
I.1.4.8 Brain barriers 
 
The brain is arguably the most critical organ in the body and thus is especially well 
protected from both physical and metabolic stress. These barriers additionally provide regulatory 
and instructive roles especially within the SVZ niche. The two barriers regulating the exchange 
of molecules between the CNS and the blood are the blood-brain and blood-CSF barriers. As 
another line of defense, the brain has elaborate clearance mechanisms provided by the blood, 
CSF, and billions of glial cells.  
 
The blood-brain barrier 
 
The blood-brain barrier is a selectively permeable interface comprised of astrocytes, 
endothelial cells, smooth muscle pericytes, and fibroblasts. Together, these cells provide physical 
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and chemical obstacles to the movement of macromolecules from the periphery into the central 
nervous system, controlling neuronal function and protecting the brain from injury and disease 
(Zlokovic, 2008). Blood vessel endothelial cells restrict the diffusion of microscopic substances 
and large or hydrophilic molecules, while allowing the diffusion of small hydrophobic molecules 
such as oxygen, carbon dioxide, hormones and lipids. However, the role of vessels in the CNS 
extends beyond restricting the influx of molecules into the brain. In both the SVZ and DG,  
endothelial cells release soluble factors that stimulate the self-renewal of NSCs, inhibit their 
differentiation, and stimulate neurogenesis (Shen et al., 2004; Shen et al., 2008; Tavazoie et al., 
2008). Indeed, 80% of proliferating cells in the SVZ are found within 10 mm of blood vessels, 
and 70% of NSCs lie within 5 mm (Tavazoie et al., 2008). In addition, sources of vascular 
endothelial growth factor (VEGF), Notch, pigment epithelium-derived factor (PEDF) secreted by 
endothelial cells regulate the proliferation and commitment of NSCs to a neurogenic fate 
(Andreu-Agullo et al., 2009; Pierfelice et al., 2011), suggesting a tight association between 
blood-borne factors and neurogenesis. Astrocytes are an essential component of the 
neurovascular unit and directly regulate the properties of the blood-brain barrier. There are more 
than a billion astrocytes throughout the brain and SVZ niche that provide crucial structural and 
regulatory functions. Through endfeet surrounding blood vessels, astrocytes form gap junctions 
and are closely associated with the vasculature and its basal lamina. In addition, astrocytes play a 
major role in brain metabolism by controlling the concentrations of ions and nutrients of the 
interstitial fluid that surrounds neurons. At this level, astrocytes can regulate the neurogenic 
niche indirectly by determining the accessibility of endothelial and circulation-derived factors as 
well as the availability of cytokines and growth factors in the basal lamina (Barres, 2008; 
Saunders et al., 2013; Siegenthaler et al., 2013). Astroglial-derived soluble and membrane bound 
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factors promote proliferation and neuronal fate. Astrocytes regulate neurogenesis by the 
secretion of factors such as Wnt3 (Lie et al., 2005), Shh (Jiao & Chen, 2008), interleukin-1b, 
interleukin-6, and IGF-binding protein 6 (Barkho et al., 2006). Indeed, astrocytes derived from 
neurogenic niches (DG and SVZ), but not from non-neurogenic areas (spinal cord), promote 
proliferation and neuronal fate commitment of neural precursors in culture (Lim & Alvarez-
Buylla, 1999; Song et al., 2002a). In the adult SVZ, astrocytes express Robo receptors and 
regulate the migration of Slit1-expressing neuroblasts through the RMS (Kaneko et al., 2010). 
SVZ astrocytes also release glutamate to regulate the survival of neuroblasts and are critical for 
the maturation and synaptogenesis of newly formed neurons (Platel et al., 2010). In the DG 
resident astrocytes are critical for the maturation and synaptogenesis of newly formed neurons. 
Astroglial-derived soluble and membrane bound factors promote proliferation and neuronal fate 
for hippocampal NSCs (Song et al., 2002a; Song et al., 2002b; Nedergaard et al., 2003; Ullian et 
al., 2004; Ma et al., 2005). Wnt3 has been examined extensively as a candidate that mediates 
astrocyte signals in NSCs (Lie et al., 2005). Moreover, ATP production from astrocyte 
metabolism regulates NSC proliferation (Cao et al., 2013a; Cao et al., 2013b).  
Microglia are the resident macrophages and primary immune cells of the brain where 
they serve multiple functions, ranging from phagocytosis to neuroprotection. In the adult DG, 
microglia are found in the hilus and along the border of the GC layer (Wirenfeldt et al., 2003). 
Most newborn cells in the adult DG fail to survive past the first week (Sierra et al., 2010) and 
after 3 to 4 weeks the number of surviving newborn cells stabilizes (Kempermann & Neumann, 
2003; Sierra et al., 2010). Microglia modify neurogenesis through apoptosis-coupled 
phagocytosis of new neurons that have not integrated (Ribak et al., 2009; Sierra et al., 2010). 
The contribution of microglia to the neurogenic niche appears to depend largely on their 
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secretion of cytokines and chemokines. Depending on the mode of activation, microglia release 
proinflammatory or anti-inflammatory cytokines that can support or suppress neurogenesis 
(Monje et al., 2003; Butovsky et al., 2006). 
 
The brain-CSF interface 
 
The brain-CSF interface is the lining of epithelial-like ependymal cells between the 
cerebral ventricles and parenchyma. These cells filter CSF factors and secrete signals that aid in 
the regulation of SVZ NSCs. CSF surrounds the brain, both internally and externally, and is 
secreted by the epithelial cells of the choroid plexus in the cerebral ventricles (lateral, 3rd, and 4th 
ventricles). CSF is propelled through the ventricular system by beating motile cilia of ependymal 
cells, allowing the long-range dissemination of local and systemic signals. Growth factors and 
ligands implicated in SVZ NSC regulation are also present in the CSF, including TGFs, IGFs, 
PDGFs, Shh, Wnts, BMPs, Slits and retinoic acid (Lehtinen et al., 2011; Lee et al., 2012; 
Zappaterra & Lehtinen, 2012). Interestingly, a recent study has shown that part of the restorative 
function of sleep may be due to the brain increasing the clearance of degradation products of 
neural activity via the rapid inflow of CSF (Xie et al., 2013).  
Additionally, ependymal cells create a neurogenic microenvironment by secreting 
diffusible factors such as noggin, a selective BMP-signalling inhibitor (Lim et al., 2000). NSCs 
contact ependymal cells via adheren junctions, anchoring them within the niche and creating an 
apical domain that is directly exposed to the CSF (Mirzadeh et al., 2008). Some receptors, such 
as vascular cell adhesion protein 1 (VCAM1), are differentially distributed on NSCs. VCAM1 is 
localized to the apical surface of NSCs at the center of pinwheels, and disruption of VCAM1 
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signalling causes activation and proliferation of quiescent stem cells, and their exit from the SVZ 
niche (Kokovay et al., 2012). Although the sources of most niche signals remain to be fully 
characterized, it is clear that multiple factors and sources integrate to affect NSC activity and the 
number of new neurons and astrocytes they produce. This interplay sustains neurogenesis over a 
lifetime and allows for exquisite sensitivity to a wide-range of local and distal stimuli. 
 
The SVZ and SGZ represent neurogenic niches or local microenvironments that permit 
and support neurogenesis. Studies have identified key components and factors of the two 
neurogenic niches. It is interesting to note that there are clear similarities and important 
differences between SVZ and DG neural precursors. SVZ NSCs have been shown to fulfill the 
two cardinal stem cell properties i.e. multi-potentiality and self-renewal. They generate both 
neurons (Doetsch et al., 1999b; Gheusi et al., 2013) and glia including astrocytes, 
oligodendrocytes and ependymal cells (Menn et al., 2006; Gonzalez-Perez et al., 2009) and have 
the capacity for self-renewal (Reynolds & Weiss, 1992; Doetsch et al., 1999a). On the other 
hand, in the DG there is still much debate over whether “true” NSCs even exist in the adult. 
Evidence supporting RGLs as NSCs comes from anti-mitotic regeneration assays (Seri et al., 
2001), genetic ablation (Garcia et al., 2004), and transgenic fate-mapping (Ahn & Joyner, 2005; 
Lagace et al., 2007; Dranovsky et al., 2011). In vivo clonal analysis further revealed that a single 
RGL could go through several rounds of self-renewal and differentiation to produce both 
neurons and astrocytes over a long duration. However, oligodendrocytes were not produced from 
this process (Bonaguidi et al., 2011). In the same year, alternative RGL properties were 
postulated. Encinas et al. proposed that RGLs do not possess long-term maintenance instead 
RGLs repeatedly enter cell cycle once activated and generate only neurons before terminally 
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differentiating into astrocytes (Encinas et al., 2011). A clear similarity between putative NSCs in 
the SVZ and DG is the expression of genes such as GFAP, nestin and sox2 although lineage 
tracing suggests that these markers label slightly different but overlapping cell populations. 
Moreover, regulatory factors between these two niches share commonalities and differences. For 
example, a main difference is that the SVZ boarders the lateral ventricle that is lined with 
ependymal cells that play important regulatory roles in NSC behaviour as discussed previously 
above. While, innervations from the entorhinal cortex, raphe nuclei and hilus interneurons are 
important regulators of DG neurogenesis (Leranth & Hajszan, 2007). The types of neurons 
produced in these two areas are also different. New neurons born in the SVZ migrate the OB and 
differentiate into various types of GABAergic granule cells as well as small populations of 
glomerular cells that express GABA or TH (Merkle et al., 2007; Brill et al., 2009). In the DG, 
the majority of new neurons are glutamatergic granule neurons with a small percentage of newly 
born cells differentiating into GABAergic basket cells. 
 
I.1.5 The function of adult born neurons 
 
I.1.5.1 Rodents 
 
Subventricular zone  
 
Olfaction is a central sense for most vertebrates as it provides information about danger, 
food palatability, reproductive fitness, and innate or learned behavioural responses. With this in 
mind, the discovery of adult neurogenesis in the olfactory system is not entirely surprising. 
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However, determining the precise function of adult born OB neurons has fuelled years of 
research and still remains largely controversial in both rodents and humans.  
 
More than 30,000 neuroblasts exit the rodent SVZ each day (Alvarez-Buylla et al., 2001), 
where they migrate tangentially through the rostral migratory stream (Lois & Alvarez-Buylla, 
1994; Jankovski & Sotelo, 1996) toward the olfactory bulb (OB) to differentiate into 
periglomerular and granule olfactory interneurons (Lois & Alvarez-Buylla, 1994). Newly 
generated OB neurons are mainly GABAergic granule cells (GCs) with a small percentage of 
dopaminergic periglomerular cells (PGCs). Experiments using viral targeting or genetic lineage 
tracing have revealed that distinct interneurons subtypes are made within discrete locations along 
adult SVZ (Figure 4). Specifically, superficial granule interneurons are mainly generated by 
NSCs in the dorsal SVZ while deep granule interneurons are primarily derived from the ventral 
SVZ. Distinct populations of PGCs also arise from distinct locations within the anterior and 
medial adult SVZ, and a population of glutamatergic olfactory bulb neurons is derived from the 
dorsal SVZ (Merkle et al., 2007; Brill et al., 2009). Newborn OB neurons have been 
morphologically and electrophysiologically characterized using retroviruses. GCs become 
morphologically mature by 2 weeks of age, forming elaborate dendrites that extend into the 
external plexiform layer of the bulb (Petreanu & Alvarez-Buylla, 2002). In contrast, PGCs take 4 
weeks to fully develop their dendritic and axonal morphology (Belluzzi et al., 2003). 
Functionally, as in the adult DG, the first synapses made onto new cells are gamma-aminobutyric 
acid (GABA)ergic, followed soon after by glutamatergic inputs. In periglomerular cells, the 
maturation of the voltage-dependent sodium current, and consequently the capacity of the newly 
generated cells to fire action potentials, seems to precede the appearance of synaptic contacts 
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Figure 4. The adult SVZ is heterogeneous and produces discrete interneuron subtypes.  
Neuroblasts derived from the subventricular zone (SVZ) enter the core of the olfactory bulb and 
migrate radially to populate the granular layer (GRL) and glomerular layer (GCL). Color 
gradients correspond to the site of origin of the differently coloured newly generated olfactory 
neurons. The ventral SVZ predominantly generates GABAergic deep granule cells (purple) and 
periglomerular cells (magenta). The dorsal SVZ, by contrast, produces superficial granule cells 
(green) and dopaminergic periglomerular cells (teal). The medial face of the SVZ generates 
glutamatergic superficial granule cells (yellow) and periglomerular cells (orange). Image from 
(Ihrie and Alvarez-Buylla, Neuron 2011), reproduced with permission from Elsevier © 2011.  
 
 
 
 
32 
(Belluzzi et al., 2003; Carleton et al., 2003). In rodents, only 50% of the new neurons 
integrate and survive (Petreanu & Alvarez-Buylla, 2002; Winner et al., 2002). Their death via 
apoptosis occurs during a critical period ranging from 14 to 28 days (Yamaguchi and Mori 
2005), and is strongly influenced by sensory experience (Petreanu & Alvarez-Buylla, 2002; 
Rochefort et al., 2002). Odour enrichment and odour learning promote the rate of survival and 
the integration of newborn neurons in the OB (Rochefort et al., 2002; Miwa & Storm, 2005; 
Alonso et al., 2006; Mouret et al., 2008; Bovetti et al., 2009; Moreno et al., 2009; Veyrac et al., 
2009; Kermen et al., 2010; Sultan et al., 2010; Sultan et al., 2011).  Conversely, blocking odour 
signal transduction in  
sensory neurons, by nostril occlusion or diazepam-enhanced inhibition decreases the survival of 
newly generated neurons (Corotto et al., 1994; Petreanu & Alvarez-Buylla, 2002; Yamaguchi & 
Mori, 2005). Notably, the size of the OB does not change throughout life, even with the 
continuous arrival of newborn interneurons, suggesting that adult neurogenesis in the OB is a 
matter of replacement rather than addition (Biebl et al., 2000; Petreanu & Alvarez-Buylla, 2002). 
To this end, it appears that the death of new neurons in the OB actually plays a permissive role in 
olfactory function. When a caspase inhibitor was used to locally prevent the elimination of 
newborn OB neurons, a significant number of new neurons were rescued from apoptosis, which 
led to a deficit in odour exploration and odour discrimination (Mouret et al., 2008). 
In order to study the function of adult neurogenesis, various approaches have been 
developed to abolish the neurogenic process, including anti-mitotic drugs, focal irradiation, and 
conditional transgenic ablation. Blockade of neurogenesis by infusion of an antimitotic drug 
impaired the ability of odour detection and short-term memory, suggesting that new neurons are 
involved in odour detection and odour memory processing. Electrophysiological recordings 
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revealed that ablation of adult born neurons impairs recurrent and lateral inhibition of OB 
neurons and reduces the frequency of gamma oscillations which leads to decreased OB 
sensitivity (Breton-Provencher et al., 2009). In addition, gene deficient mice, which result in a 
decrease of new neurons in the OB, could not discriminate between dissimilar odours (Gheusi et 
al., 2000; Bath et al., 2008). Unfortunately, not all findings have supported this result. Mice 
treated with γ-ray irradiation to block neurogenesis showed normal OB sensitivity (Lazarini et 
al., 2009), suggesting that odour discrimination was not affected. In another study, genetic 
ablation of newly born neurons in the OB impaired the structure and neural circuits in the OB 
(Imayoshi et al., 2008; Sakamoto et al., 2011). It was reported that newly generated GCs exhibit 
long term synaptic plasticity that is gradually lost during neuronal maturation, indicating that 
newly born GCs play a more important role in plasticity than mature GCs (Nissant et al., 2009). 
While, Sultan et al. found newborn neurons to be responsible for processing learned odorants 
(Sultan et al., 2011). SVZ NSCs also respond to injury, migrate to the site of damage and help 
with brain repair (Zhang et al., 2004a; Zhang et al., 2004b; Zhang et al., 2014). Together, these 
findings suggest that neurogenesis has a role in olfaction, plasticity and regeneration in rodents. 
In addition to the cognitive functions discussed above, some studies have examined the role of 
adult olfactory neurogenesis in other contexts including parental behaviour, mate choice, and 
mate odour recognition. However, conflicting findings and non-specific ablation techniques have 
made it difficult to conclusively show a role of OB neurogenesis in these behaviours.  
 
Dentate gyrus 
 
Determining the role of adult born DG neurons in brain function has fuelled years of 
research. The first evidence of functional integration of adult born neurons in mammals was 
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provided by van Praag et al., when they showed that adult generated DG neurons become 
electrophysiologically functional in vivo and are integrated as granule cells (van Praag et al., 
2002). Soon after, electrophysiological characterization of individual newborn neurons showed 
that they become increasingly hyperpolarized, progress from low to high capacitance, and from 
receiving GABAergic input to glutamatergic input as they mature (Ambrogini et al., 2004; 
Esposito et al., 2005). Researchers have begun to unravel the functional role of new neurons on 
the existing neural circuitry and their contributions to brain function (Deng et al., 2009). At 
present, there are multiple roles identified for adult neurogenesis including learning (Gould et al., 
1999), spatial memory and pattern separation (Shors et al., 2001; Imayoshi et al., 2008; Clelland 
et al., 2009; Deng et al., 2009; Kitamura et al., 2009; Aimone et al., 2011; Sahay et al., 2011b). 
Consistent with this, running increases neurogenesis (van Praag et al., 1999; Kobilo et al., 2011; 
Gregoire et al., 2014) and performance on pattern separation tasks (Creer et al., 2010; Sahay et 
al., 2011a), while suppression of adult neurogenesis impairs population coding of similar 
contexts (Niibori et al., 2012). In addition, selective ablation using a tag and ablate strategy that 
selectively ablated a population of predominantly mature, adult-generated neurons either before 
or after learning, without affecting ongoing neurogenesis found that removal of these neurons 
before learning did not prevent the formation of new contextual fear or water maze memories. In 
contrast, removal of an equivalent population after learning degraded existing contextual fear 
and the spatial memory-dependent water maze memories, without affecting non-hippocampal 
memory (Arruda-Carvalho et al., 2011). Interestingly, there is evidence that new DG neurons 
preferentially integrate into spatial memory networks (Kee et al., 2007). Moreover, it appears 
that young DG neurons mediate pattern separation while old granule cells facilitate pattern 
completion (Aimone et al., 2010; 2011; Nakashiba et al., 2012). 
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Unfortunately, differences in spatial and cellular specificity provided by most ablation 
techniques have made it difficult to definitively establish whether the behavioural effects 
observed are always attributable to ablation of neurogenesis or other indirect impairments. 
Moreover, due to the diversity and complexity of behavioural tests, many discrepancies in the 
interpretation of the results have further complicated this issue.  
 
I.1.5.2 Humans 
 
Similarly to rodents, the adult human brain contains two main regions where continuous 
neurogenesis takes place, the SVZ (Sanai et al., 2004; Quinones-Hinojosa et al., 2006) and the 
subgranular zone in the hippocampal DG (Eriksson et al., 1998; Roy et al., 2000; Jessberger & 
Gage, 2014). Over the last two decades, creative strategies have been used to study neurogenesis 
in humans. The first studies, analysed hippocampal tissues from deceased cancer patients that 
had received injections of the thymidine analog BrdU before tumour-removing surgery and co-
labelled these cells with neuronal markers such as DCX and neuronal nuclei (NeuN). These 
reports demonstrated that in vivo, large numbers of newly generated neurons are produced within 
the DG (Eriksson et al., 1998; Knoth et al., 2010). Kukekov and colleagues subsequently 
isolated multi-potent neurospheres from surgical biopsy specimens containing SVZ or 
hippocampus of adult human brains, suggesting the presence of NSCs in these regions (Kukekov 
et al., 1999). The SVZ niche organization and cellular composition has also been studied. The 
organization of the human SVZ differs slightly from that of rodents, possessing a hypocellular 
gap between the ventricle-lining ependymal layer, but maintaining a sub-ependymal neurogenic 
niche containing neural precursors and neuroblasts (Sanai et al., 2004; Quinones-Hinojosa et al., 
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2006; Leonard et al., 2009). Three distinct subtypes of astrocytes have been identified along the 
lateral wall of the lateral ventricles. These astrocytes are located at different locations along the 
anterior-posterior length of the ventricle vary in size, ultrastructure, and relationship to the 
ependymal zone (Quinones-Hinojosa et al., 2006). A subpopulation of these astrocytes 
proliferate in vivo and behave as multi-potent precursor cells in vitro (Sanai et al., 2004), 
implying that SVZ astrocytes of the adult human brain indeed are NSCs. Cells expressing 
neuronal markers TuJ1 and DCX have been observed in the SVZ and the majority of these cells 
have an elongated morphology suggesting they are in migration (Bernier et al., 2000; Weickert et 
al., 2000; Sanai et al., 2004; Quinones-Hinojosa et al., 2006; Ernst et al., 2014).  
In rodents, as mentioned previously, new neurons born in the SVZ migrate through the 
RMS and integrate into the OB. However, due to major morphological differences between the 
rodent and human, similar studies conducted in the RMS and OB have led to controversial 
conclusions. Curtis et al. found a stream of proliferating cell nuclear antigen (PCNA)+ 
proliferating cells along the under surface of the caudate nucleus (caudal to the genu of the 
corpus callosum and the frontal cortical white matter of the gyrus rectus) travel ventrally and 
rostrally to enter the anterior olfactory cortex. Within this pathway, cells expressing the neuronal 
marker bIII-Tubulin and migratory marker polysialylated-neural cell adhesion molecule (PSA-
NCAM) and BrdU/NeuN-double labeled new neurons were demonstrated in the OB (Curtis et 
al., 2007b). In addition, studies of the human OB have shown striking similarities to the rodent. 
For example, staining for DCX showing newly generated neuroblasts and Ki67+ and PCNA+ 
proliferating cells in the granular and glomerular layers that coexpressed markers of immature 
neurons, such as βIII-Tubulin, DCX, and neurogenic differentiation factor-1 (NeuroD) within the 
OB (Maresh et al., 2008).  Many of these neurons colabelled with various neuronal sub-type 
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markers including GABAergic and dopaminergic (Bedard & Parent, 2004). On the other hand, 
other studies have detected neuroblasts in the anterior ventral SVZ and RMS, but not in the OB. 
The Frisen group utilised the presence of atmospheric 14C during nuclear bomb testing to carbon 
date neurons and glial cells in human tissue samples. This technique showed substantial levels of 
neurogenesis in the human DG whereas no evidence of ongoing neurogenesis was detected in the 
human SVZ or OB (Bergmann et al., 2012; Spalding et al., 2013). Recently, the same group 
found neural precursors in the human SVZ making new neurons. However, these neurons 
generated a subset of striatal interneurons, a neurogenic route that is absent in the rodent brain 
(Ernst et al., 2014). 
Together, this work suggests that the generation of neuroblasts from neural stem and 
progenitor cells in the SVZ occurs in the adult human brain. Importantly, NSCs can still be 
isolated from the SVZ of elderly subjects, including those with severe neurodegeneration, such 
as Alzheimer’s disease (Leonard et al., 2009). This gives hope that when the precise regulation 
of NSCs is understood, endogenous regeneration will be feasible. 
 
I.2 ALZHEIMER’S DISEASE 
 
Alzheimer’s disease (AD) is an aging-related degenerative neurological disease that leads 
to a premature deterioration of multiple cognitive modalities including, learning, memory, and 
personality. Brain degeneration and synaptic loss proceeds in a region-specific and temporally 
determined manner, beginning in the entorhinal cortex and advancing to the hippocampus and 
posterior temporal and parietal cortices (Braak & Braak, 1991b; a; 1995). Symptom onset is 
largely determined by genetic risk factors that separate AD into two forms: genetic/early-onset 
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familial (onset <60 years old) and sporadic/late-onset (onset >60 years old). Intriguingly, in both 
cases, patients display the same cognitive symptoms and pathological hallmarks. German 
pathologist Alois Alzheimer was the first to describe the neuropathology of AD, uncovering five 
neuropathologies including focal deposits (amyloid plaques), intraneuronal fibrils 
(neurofibrillary tangles), blood vessel abnormalities (cerebrovascular amyloidoisis), glial 
reactivity (gliosis) and lipoid deposits within non-neuronal cells (lipid accumulations) 
(Alzheimer, 1907). Importantly, over a hundred years later, these findings still drive the 
diagnostic criteria for AD, which largely relies on neuropathological detection of amyloid 
plaques and neurofibrillary tangles for a definitive AD diagnosis. In recent years, genetic and 
genome-wide association studies have solidified the importance of the five initial AD 
pathologies, showing clusters of genetic mutations related to amyloid processes and storage 
(PS1, PS2, APP, APOE, SORL1, CLU, CRI, PICALM, BIN1, ABCA7), immunity/inflammation 
(CLU, CRI, EPHA1, ABCA7, MS4A4A/MS4A6E, CD33, CD2AP) and lipid transport and 
metabolism (APOE, CLU, ABCA7, SORL1) (reviewed in (Tosto & Reitz, 2013; Karch et al., 
2014). However, while significant progress has been made towards understanding the 
metabolism and biological impact of AD-associated pathologies, AD remains the most 
prominent and costly neurodegenerative disease of our time, with no cures or disease modifying 
therapies.  
 
I.2.1 Alzheimer’s disease pathologies and neural stem cells 
 
NSCs not only provide the potential for endogenous regenerative and preventative 
strategies to combat cognitive decline, but their activity is also deregulated in AD. NSC activity 
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decreases naturally during aging and is altered in models of neurodegenerative diseases, 
suggesting an involvement in aging- and disease-associated cognitive deficits (Demars et al., 
2010; Hamilton et al., 2010; Lazarov & Marr, 2010; Lazarov et al., 2010; Bouab et al., 2011; 
Hamilton et al., 2013). In fact, this decline in neurogenesis leads to deficits in olfactory function 
and hippocampal-dependent learning and memory, the main cognitive symptoms of AD (Bizon 
et al., 2004; Enwere et al., 2004; Dupret et al., 2008). Thus, determining how AD-associated 
pathologies restrain neurogenesis could uncover new strategies for ameliorating brain function in 
AD. 
 
I.2.1.1 Amyloid 
 
Genetic linkage studies identified amyloid precursor protein (APP) and presenilins (PS) 1 
and 2 as three early onset AD causing genes, over 20 years ago (reviewed in (Tanzi et al., 1996; 
Tanzi, 2012). This enabled the development of numerous transgenic animal models and allowed 
for in depth work on the role of amyloid in AD.  The initiating factor in AD is thought to come 
from genetic, age-related, and/or environmental factors that lead to an imbalance between the 
production, clearance and aggregation of the Aβ peptide causing it to accumulate within the 
brain (known as the amyloid cascade hypothesis) (Hardy & Higgins, 1992). Amyloid has been 
linked to a wide range of biological and pathological processes including, synaptic strength 
inflammation, mitochondrial dysfunction, autophagy and apoptosis (Selkoe, 1991; Rhein & 
Eckert, 2007; Sanz-Blasco et al., 2008; Spires-Jones & Hyman, 2014). In addition, many studies 
have demonstrated roles for various amyloid species in the regulation of neural precursor 
behaviour.  
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APP is a transmembrane protein that can be metabolized by two distinct and mutually 
exclusive pathways: the secretory pathway (or non-amyloidogenic) and the amyloidogenic 
pathway. The non-amyloidogenic pathway involves proteolytic cleavage by α-secretase resulting 
in the generation of soluble N-terminal fragment (sAPP) α and a carboxyl terminal fragment 83 
(CTF)-83 that is further cleaved by γ-secretase into P3 and amyloid intracellular domain (AICD). 
The cleavage of APP by α-secretase occurs within the sequence of amino acids of the amyloid 
beta (Aβ) peptide, and therefore precludes the formation of amyloid peptides (Haass & Selkoe, 
1993). In the amyloidogenic pathway, APP is alternatively cleaved by β-secretase, releasing a 
smaller N-terminal fragment (sAPPβ) and a longer CTF99 that contains the full amyloidogenic 
sequence of amino acids. Further cleavage by γ-secretase at either position 40 or 42 of Aβ, yields 
Aβ1-40 and Aβ1-42 peptides (Aβ). AD-associated mutations affect the processing of APP, 
increasing the formation of Aβ1-42 (Selkoe & Wolfe, 2000). Aβ species are released as monomers 
that progressively aggregate into dimers, trimers, oligomers, protofibrils and fibrils, to finally 
deposit and seed the amyloid plaques. The enzymatic actions of beta-site amyloid precursor 
protein cleaving enzyme 1 (BACE-1) comes from PS1 at its catalytic core (Vassar, 2004; Haass 
& Selkoe, 2007). Consistent with this, experiments have shown that increasing β-secretase leads 
to higher CTF99 and Aβ generation and a decrease of CTF83 and AICD, while increasing α-
secretase activity increases AICD (Kume et al., 2004). Importantly, γ-secretase is responsible for 
the intramembranous proteolysis of many other membrane proteins including Notch, a critical 
NSC regulator during development and adulthood (Gaiano & Fishell, 2002). 
 
Amyloid and neural stem cells 
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The impact of APP fragments on adult SVZ neural precursors has been studied by 
increasing the concentration of specific amyloid species in 1) in vitro culture systems, 2) 
genetically mutated mice, or 3) by intracerebroventricularly (ICV) infusion.  
 
In vitro  
 
In vitro experiments on adult neural precursors have shown consistently that Aβ1–42 
upregulates neurosphere number and neurogenesis. When Heo and collegues treated 
neurospheres with three different forms of Aβ1–42 they found that the oligomeric form increased 
the number of neurospheres, their size and neural differentiation capacity, while higher 
concentrations of monomeric and fibrillar Aβ1–42 had the opposite effect on these measures (Heo 
et al., 2007). A similar study by Sotthibundhu et al. treated neural precursors with oligomeric or 
fibrillar Aβ1–42 and found a significant increase in the number of neurospheres and increased 
neurosphere size. When neurospheres were placed in differentiation conditions, Aβ1–42 
significantly increased the number of neurons per neurosphere compared with control conditions. 
Importantly, Aβ1–16 and Aβ1–40 had no effect on these parameters. Additionally, this study 
compared neurosphere formation in two Aβ-producing mouse models; C100 mice 
(overexpressing the human APP β-carboxyl-terminal 100 amino acid fragment) and 
APPswe/PS1DE9 (overexpressing human APP gene with the AD-linked Swedish mutation near the 
β-secretase cleavage site and the PS1 gene containing an exon-9 deleted variant). When SVZs 
from these mice were placed in culture they found an increase in the number of neurospheres at 5 
months but not at 12 months (Sotthibundhu et al., 2009). From these in vitro studies, it is clear 
that the APP fragments and Aβ aggregation status can regulate neural precursor activity.  
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Alzheimer’s disease transgenic mice 
 
Neurogenesis studies in AD mutant mice have mainly focused on hippocampal 
neurogenesis, however in the rare cases when the SVZ was studied in parallel, similar findings 
have been observed in the two regions. Generally, when one AD-associated mutation of APP 
and/or PS1 is expressed or in cases where only knock-in technology is used, an impairment of 
neurogenesis is detected. Conversely, in cases where APP mutations are combined (triple or 
quadruple mutations) increased proliferation and neurogenesis is observed (Chuang, 2010a; 
Crews et al., 2010b; Lazarov & Marr, 2010; Lazarov et al., 2010; Winner et al., 2011; Zhou et 
al., 2011). 
 
APP mutant mice and neural stem cells 
 
Jin and colleges are so far the only group to study both DG and SVZ neurogenesis in 
APP mutant mice. Using PDGF-APPswe(K670N/M671L),ind(V717F) (PDAPP) transgenic mice, they 
quantified neural precursor activity at a presymptomatic age (3 months), before amyloid 
depositions and neuronal loss is observed and after in 12 month-old mice. They found an 
increase in numbers of proliferating cells in both regions and at both ages (Jin et al., 2004a). In 
addition, Becker et al. found a correlation between a reduction of amyloidosis and enhanced 
neurogenesis in APP mutant mice. They showed that anti-Aβ42 immunotherapy reduced 
amyloid deposition and enhanced the numbers of BrdU+ cells in the DG of PDAPPind mice 
(Becker et al., 2007). A second study placed APPswe (APP23) mice in an enriched environment 
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that normally enhances neurogenesis and found that this reduced the ratio of Aβ42/Aβ40 and 
enhanced DG neurogenesis (Mirochnic et al., 2009). These findings provided early links 
between amyloid deposition and altered neural precursor activity. However, mechanistic insights 
into how APP mutations increase neurogenesis have yet to be performed. 
 
PSI mutant mice and neural stem cells 
 
Unfortunately, studies on AD-associated PS1 mutations have not studied neurogenesis in 
the SVZ. However, PS1/γ-secretase processing of APP into AICD has been shown to regulate 
the expression of the EGF receptor, a critical determiner of NSC activation and proliferation 
(Repetto et al., 2007).  
 
APP/PS1 mutant mice and neural stem cells 
 
A variety of mice expressing various combinations of APP and PS1 mutations have been 
created, however, SVZ neurogenesis has only been studied in the APPswe/PS1ΔE9 mouse. 
Niidome and colleagues quantified the number of PCNA-positive proliferating cells in both the 
SVZ and DG and found no change. However, strangely the number of 1-day BrdU-positive 
proliferating cells was decreased in the DG, but not in the SVZ at 9 months of age (Niidome et 
al., 2008). Demars et al., quantified the number of 1-day BrdU+ proliferating cells and newborn 
neurons in the SVZ and DG and found significant decrease in both regions that coincided with a 
drastic upregulation of tau hyper-phosphorylation already at 2 months of age. Moreover, when 
they grew neurospheres from the SVZ of APPswe/PS1ΔE9 mice, they found that these spheres 
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exhibit impaired proliferation dynamics and aberrant tau hyper-phosphorylation as well (Demars 
et al., 2010). Together, the work on APP and PS1 mutant mice, suggests that an additional 
consequence of aberrant APP processing in AD may be the dysregulation of NSCs. However, 
due to the multiple variables at play in transgenic mice and various mutations driven by various 
promoters, it is unclear how individual APP species alter neurogenesis.  
 
Intracerebroventricular amyloid infusion and neural stem cells 
 
Multiple studies have determined how specific APP fragments effect neurogenesis in 
vivo. Early studies showed reduced levels of the sAPPα fragment in AD patients (Van Nostrand 
et al., 1992; Lannfelt et al., 1995) and several AD-causing APP mutations lie in close proximity 
to the β-secretase cleavage site of APP, increasing sAPPβ production at the expense of sAPPα 
(Thinakaran et al., 1996). Interestingly, ICV infusion of sAPPα increased synaptic density and 
improved memory retention (Meziane et al., 1998). sAPPα has also been implicated in the 
enhancement of synaptogenesis, neurite outgrowth, cell survival, cell adhesion (Mattson, 1997; 
Gakhar-Koppole et al., 2008).  Interestingly, sAPPα binding sites have been detected on EGFR-
expressing neural precursors and PSA-NCAM-expressing neuroblasts within the SVZ. sAPPα 
potentiates EGF-induced neurosphere growth in vitro and infusion of sAPPα into the lateral 
ventricle of mice led to an increase in proliferation. Conversely, blocking sAPPα secretion using 
an α-secretase inhibitor or downregulating APP synthesis by antisense oligonucleotide against 
APP decreased the proliferation of EGF responsive cells, which reduced the progenitor pool 
(Caille et al., 2004). Recently, these findings have been confirmed and extended. Infusion of 
sAPPα into the lateral ventricle again increased proliferation and neural differentiation. 
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However, this led to a decrease in the number of GFAP+/Nestin+ neural precursors in both the 
SVZ and DG. Interestingly infusion of sAPPβ on the other hand, led to a significant decreased in 
these parameters, demonstrating that an imbalance of APP fragments can have significant effects 
on NSC regulation (Demars et al., 2013). Infusion of other amyloid beta fragments, Aβ1-42 or 
Aβ25-35 into the lateral ventricle decreased cell proliferation in the SVZ (Haughey et al., 
2002b). Li and Zuo, ICV infused aggregated Aβ25–35 and found inhibited neurogenesis and 
decreased numbers of 1 day BrdU-positive cells in the dentate gyrus, but no effect on the SVZ 
(Li & Zuo, 2005). These experiments suggest that select Aβ fragments can decrease neural 
precursor proliferation and differentiation. However, these findings are not unanimous, with a 
second study reporting that acute ICV injection of Aβ1–42 stimulates neurosphere number and 
neurogenesis when neural precursors are subsequently placed in vitro (Sotthibundhu et al., 
2009). Collectively, infusion experiments have shed light into the possible consequences of 
various APP fragments within the adult neurogenic niche.  
Taken together, transgenic mice and infusion experiments have demonstrated that APP 
metabolites, including sAPPα, sAPPβ, and Aβ fragments, can have unique roles that modulate 
neurogenesis differently. However, the combined effects of individual species and whether they 
are present under physiological conditions remain unknown.  
 
I.2.1.2 Tau 
 
Tau has been implicated in multiple forms of dementia including AD. In fact, the major 
component of neurofibrillary tangles is an abnormally hyper-phosphorylated and aggregated 
form of tau. Tau is a microtubule-associated protein found in most tissues and highly expressed 
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in the nervous system. In neurons, it is an important component of the cytoskeleton where it 
interacts with α- and β-tubulin to promote the assembly and stability of microtubules and vesicle 
transport (Lindwall & Cole, 1984; Kosik, 1993). The phosphorylation state of Tau is critical to 
stabilize the polymers of tubulin. Hyper-phosphorylated tau is insoluble, lacks affinity for 
microtubules, and self associates into paired helical filament structures. More than 30 mutations 
of Tau on chromosome 17 have been detected in frontotemporal dementia with Parkinsonism 
(Goedert & Jakes, 2005).  In contrast, Tau mutations do not occur in Alzheimer’s disease, and 
the extent of neuron loss is out of proportion with the number of neurofibrillary tangles (Gomez-
Isla et al., 1997). Nevertheless, increased levels of phosphorylated and total tau in the 
cerebrospinal fluid correlate with reductions in scores on cognitive examinations (Wallin et al., 
2006).  Elevated levels of phosphorylated tau and total tau in the CSF have been used as 
biomarker test with good accuracy for predicting emergent Alzheimer’s disease in patients with 
mild cognitive impairment (Mattsson et al., 2009). Experimental models have demonstrated that 
Aβ accumulation precedes and drives tau aggregation (Gotz et al., 2001; Oddo et al., 2003a).  
Moreover, Aβ-induced degeneration of cultured neurons and cognitive deficits in mice with an 
Alzheimer’s disease-like symptoms require the presence of endogenous tau (Rapoport et al., 
2002).  
 
Tau transgenic AD-mice and neurogenesis 
 
In order to study the impact of tau pathology in AD, Oddo et al., created the triple 
transgenic Alzheimer’s disease mouse model (3xTg-AD) (Oddo et al., 2003b). 3xTg-AD mice 
contain three mutations associated with familial Alzheimer’s disease and dementia (APPswe, 
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PS1M146V and tau P301L). Many of the neuropathologies initially described by Alois Alzheimer 
have been reported in these mice including amyloid deposition, neurofibrillary tangles, and 
gliosis each with distinct onset ages (Figure 5). Moreover, they show temporal and region-
specific Aβ and tau pathology, which closely resembles that seen in the human AD brain. In 
addition, 3xTg-AD mice have clear functional and cognitive impairments, including reduced 
long-term potentiation, as well as deficient spatial, long-term and contextual memory (Oddo et 
al., 2003a; Oddo et al., 2003b). The spatial and temporal deposition of AD-associated pathology 
has been characterized in detail in 3xTg-AD mice. Intraneuronal Aβ accumulates within the 
cortex and hippocampus beginning at 3-4 months in female 3xTg-AD mice (Carroll et al., 2007; 
Mastrangelo & Bowers, 2008), whereas the classical pathological changes start in the neocortex 
and expand towards the hippocampus from around 6 months for plaques and 12 months for 
NFTs (Oddo et al., 2003a; Mastrangelo & Bowers, 2008). In addition, gliosis and microglial 
activation has been observed at 6-7 months of age (Janelsins et al., 2005; Caruso et al., 2013). 
The onset of cognitive deficits in these mice is between 4-6 months of age and correlates with 
the accumulation of intraneuronal Aβ (Billings et al., 2005; Carroll et al., 2007; McKee et al., 
2008). Moreover, cognitive deficits are closely followed by decreased long-term potentiation and 
impairment in basal synaptic transmission (Oddo et al., 2003b). 
Neurogenesis experiments in 3xTg-AD animals have been performed in both the SVZ 
and DG. Rodriguez et al. quantified phosphohistone-3 (PH3)+ proliferating cells within the SVZ 
and DG of 2, 3, 4, 6, 9, and 12 month old 3xTg-AD mice (Rodriguez et al., 2008; Rodriguez et 
al., 2009). In the DG, they compared male and female mice and found early deficits in 
proliferation starting at 4 months of age in the dorsal blade of the DG in female mice, while in  
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Figure 5. 3xTg-AD mouse model: onset of neuropathology and behavioural deficits. 
The earliest neuropathogy observed in 3xTg-AD mice is intraneuronal amyloid beta deposition 
in the cortex and hippocampus at 3-4 months (Billings et al., 2005). Amyloid plaque deposition 
has been reported as early as 6 months (Oddo et al., 2003a; Billings et al., 2005) but others have 
not observed plaques until much later, around 18 months of age (Mastrangelo & Bowers, 2008). 
Gliosis and microglial activation has been reported around 6-7 months of age (Janelsins et al., 
2005; Caruso et al., 2013). Tau hyperphosphorylation has been observed at 11 months of age 
(Oddo et al., 2003a; Mastrangelo & Bowers, 2008). Cognitive symptoms including deficits in 
long-term retention begin to appear at 4-5 months of age (Billings et al., 2005; Carroll et al., 
2007; McKee et al., 2008) and by 6 months there is a decrease in long-term potentiation and an 
impairment in basal synaptic transmission (Oddo et al., 2003b). (Image generated by Laura 
Hamilton).  
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male mice, this decrease was delayed, only reaching significance at 9 months of age. Within the 
ventral blade, females showed significant deficits at 12 months, while males showed deficits at 6 
months of age (Rodriguez et al., 2008). In a follow-up study, the same group found impaired 
proliferation beginning at 3 months in the SVZ of male 3xTg-AD mice (Rodriguez et al., 2009). 
This work was the first to study how an AD-like microenvironment containing both amyloid 
plaques and neurofibrillary tangles affects neurogenesis. These studies also took into account the 
age, sex, and both neurogenic niches, providing important clues into how neurogenesis is 
impacted as pathological hallmarks of AD progress. These findings suggested that early deficits 
in proliferation coincide with cognitive decline, however, the mechanisms underlying the deficits 
in neurogenesis were not investigated. 
 
I.2.1.3 Cerebral amyloid angiopathy  
 
Cerebral amyloid angiopathy (CAA) affects more than 90% of patients with Alzheimer’s 
disease (Greenberg et al., 2004) and results from the accumulation of amyloid beta in blood 
vessels, inducing vasoconstriction and occlusion of cerebral blood flow (Smith & Greenberg, 
2009; Thal et al., 2009). Aβ is also cytotoxic to endothelial (Xu et al., 2001; Suhara et al., 2003) 
and smooth-muscle cells (Van Nostrand et al., 1998; Mok et al., 2006), conferring a 
predisposition to cerebral hemorrhages (Suter et al., 2002; Haglund et al., 2006). Vascular injury 
and parenchymal inflammation has been suggested to perpetuate the cycle of protein aggregation 
and oxidation in the brain. The clearance of Aβ through diseased blood vessels and the blood-
brain barrier is also impeded, perpetuating the deposition of amyloid throughout the brain 
(Shibata et al., 2000; Weller et al., 2008; Ito et al., 2013). Although the role of amyloid 
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angiopathy in neurogenesis has not been directly explored, as mentioned previously, blood 
vessels are a critical component of the adult NSC niche, as they mediate the flow of molecules 
that regulate the proliferation of NSCs and progenitors. Moreover, recent parabiosis experiments 
have demonstrated a role of systemic factors in the suppression of neurogenesis during aging 
(Villeda et al., 2011).  
 
I.2.1.4 Gliosis/Inflammation 
 
The presence of activated glial cells and the increase in inflammation-associated proteins 
in the AD brain has led to the consideration that chronic inflammation plays a role in the 
pathophysiology of AD (McGeer & McGeer, 1995). Astrocytes isolated from AD patients and 
reactive astrocytes from AD-transgenic mice have been shown to secrete TGFβ1 and IL10 (Apelt 
& Schliebs, 2001; Blasko et al., 2004). Activated microglia and reactive astrocytes localize to 
amyloid plaques, and their biochemical markers are elevated in the brains of patients with AD 
(Wyss-Coray & Mucke, 2002). Another study showed that initially, microglia degrade Aβ but 
that chronically activated microglia release chemokines and a cascade of damaging cytokines 
including, IL-1, IL-6, and tumour necrosis factor α that damage cells (Akiyama et al., 2000). 
Several mediators of inflammation such as IL-1β, IL-6, and tumour necrosis factor (TNF)-α have 
been extensively studied in the CSF of AD patients, but conflicting results have been observed 
(Teunissen et al., 2002). Indeed, although the majority of studies report no difference (Lanzrein 
et al., 1998; Galimberti et al., 2008), others have seen an increase (Blum-Degen et al., 1995; 
Tarkowski et al., 1999) and even a decrease (Yamada et al., 1995) in levels of these 
inflammatory markers in the CSF of AD patients compared with controls.  Thus, it will be 
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interesting to see if there is a role for AD-associated inflammatory signals on neurogenesis and 
whether NSCs could also be contributing to the gliosis by over-producing new astrocytes during 
AD. 
 
I.2.1.5 Lipoid accumulation 
 
Lipids have wide-reaching functions in the body including, insulation, protection and 
energy production and storage. Moreover, lipids provide critical signals for the dynamic 
requirements of cellular behaviour by modulating gene expression, growth and survival 
pathways, and inflammatory and metabolic responses (Saltiel & Kahn, 2001; Hotamisligil, 
2006). To execute these various tasks, the body absorbs, synthesizes and modifies all major 
classes of lipids including, fatty acids, glycerolipids (triglycerides, diglycerides, 
monoglycerides), glycerophospholipids (ex: phosphocholines. Lysophosphocholines, 
phosphatidylserines), sphingolipids, saccharolipides, polyketides, sterols (ex: cholesterol) and 
prenols (Fahy et al., 2009). However, recent biochemical, genetic, and biomarker studies have 
provided compelling evidence linking aberrant lipid metabolism to neurodegeneration in AD 
(Fraser et al., 2010; Astarita et al., 2011; Podtelezhnikov et al., 2011; Tanzi, 2012; Hussain et 
al., 2013). Moreover, peripheral metabolic conditions such as insulin resistance, obesity, and 
dyslipidemia have been identified as major AD risk factors (reviewed in (Pasinetti & Eberstein, 
2008)).  
 
Neutral lipids in Alzheimer’s disease 
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Neutral lipids comprising cholesterols, cholesterol-esters, fatty acids, and triglycerides 
are the main source of energy and membrane lipids in the body (reviewed by (Ruggles et al., 
2013)). In response to increased intracellular free fatty acid levels, fatty acids are preferentially 
converted into triglycerides and packaged into organelles called lipid droplets (Figure 6). Lipid 
droplets are made of a phospholipid monolayer that buds off the endoplasmic reticulum and 
surrounds the neutral lipid core (Martin & Parton, 2006; Ohsaki et al., 2009; Digel et al., 2010). 
The storage of lipids allows a cell to buffer the toxic impact of excess lipids and to survive 
periods of diminished nutrient availability. In times of lipid deficiency, lipases breakdown these 
stores to provides membrane building blocks, such as fatty acids or sterols, for cellular division 
and integrity (Martin & Parton, 2006). Beyond their role in lipid storage, lipid droplets 
participate in inflammatory responses through synthesis of eicosanoids and in metabolic 
disorders such as obesity, atherosclerosis, cancer, and neurodegeneration (Bozza & Viola, 2010; 
Greenberg & Coleman, 2011; Greenberg et al., 2011).  
 
Phospholipids 
 
Phospholipids are composed of a hydrophilic glycerolphosphate head group and a 
hydrophobic diglyceride tail. In aqueous environments, phospholipids align to form mono or bi 
lipid membranes. Choline-containing phospholipids have been particularly implicated in the 
pathophysiology of AD. Phosphatidylcholine (PC) is the major phospholipid in cellular 
membranes and can be metabolized by phospholipases to yield second messengers including 
lysophospholipids and fatty acids (Klein, 2000; Tayebati & Amenta, 2013). Previous studies 
have found altered PC and lysophospholipid levels in plasma (Mulder et al., 2003; Schaefer et 
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al., 2006) and CSF (Walter et al., 2004) AD samples. Many studies have also demonstrated 
changes in phospholipid lipase activity in AD patients (Kanfer et al., 1993; Ross et al., 1998; 
Chalbot et al., 2009) and made links between this activity and cognitive decline ((Gattaz et al., 
2004; Forlenza et al., 2005) reviewed in (Schaeffer et al., 2009)). A particularly interesting study 
discovered a set of ten phospholipids in plasma samples that predicted and distinguish 
cognitively normal participants who would progress to MCI or AD within 2–3 years from those 
destined to remain cognitively normal (Mapstone et al., 2014), suggesting that changes in PCs 
play a predictive and/or causative role in AD pathogenesis.  
 
Phospholipids and neural stem cells 
 
The role of phospholipids has not generally been explored in the context of neurogenesis. 
However, one study knocked out the lysophosphatidic acid receptor to determine the impact on 
neurogenesis in the DG. These mice showed defects in 1-d BrdU+ proliferating cells, DCX+ 
neuroblasts and the survival of these cells in the adult DG (Matas-Rico et al., 2008), suggesting 
that phospholipids are necessary for continued neurogenesis.  
 
I.2.1.5 Cholesterol 
 
Cholesterol is an essential component of cellular membranes where it regulates their 
fluidity. Within the body, cholesterol and triglycerides are shuttled by carrier proteins called 
apolipoproteins (Apo) that regulate their metabolism and distribution (Mahley et al., 1996; Bu, 
2009). There are 6 subtypes of Apos (A, B, C, D, E, H) each with affinity for different  
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Figure 6. Biochemical pathway of triglyceride metabolism.  
In response to excess lipid levels, fatty acids are preferentially converted into neutral lipids and 
packaged as lipid droplets (green). Sequential addition of fatty acids to glycerol forms 
monoacylglycerides (MAG), diacylglycerides (DAG), and triglycerides (TAG) via glycerol 
acyltransferase (GPAT), monoglycerol acyltransferase (MGAT), and diacylglycerol 
acyltransferase (DGAT) enzymes, respectively.  The lipolysis (blue) of TAGs occurs via the 
sequential cleavage of fatty acids by adipose triglyceride lipase (ATGL), hormone sensitive 
lipase (HSL), and monoglycerol lipase (MGL) enzymes, respectively. Free fatty acids are then 
shuttled to the mitochondria for β-oxidation to produce ATP (red). Image adapted from (Moro et 
al., 2008, Am J Physiol Endochrinol Metab), reproduced with permission from the American 
Physiological Society © 2008.  
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lipoprotein particles. Astrocytes and microglia are the main source of ApoE in the brain (Xu et 
al., 2006) where they deliver cholesterol and other essential lipids to neurons through members 
of the low-density lipoprotein receptor family (Herz & Bock, 2002; Herz & Chen, 2006; Lane-
Donovan & Herz, 2014). In AD, the inheritance pattern of ApoE isoforms (ApoE2, ApoE3, or 
ApoE4) is a major determinant of the risk of late-onset Alzheimer’s disease, where the 
inheritance of a single E4 allele increases the risk by a factor of 4, and two E4 alleles increase the 
risk by a factor of 19 (Corder et al., 1993; Corder et al., 1994; Strittmatter & Roses, 1996). ApoE 
isoforms likely impact the aggregation and deposition of AD pathologies. ApoE4 carriers have 
higher Aβ plaque load (Polvikoski et al., 1995; Kok et al., 2009; Reiman et al., 2009) and tau 
phosphorylation (Leoni, 2011). Learning and memory is also impaired in ApoE4 knockin mice 
compared to ApoE3 knockin mice (Grootendorst et al., 2005; Raber, 2008). The E4 allele is also 
a risk factor for atherosclerosis and other neurological disorders including CAA (Greenberg et 
al., 1995), tauopathies and dementia with Lewy bodies (Josephs et al., 2004), Parkinson’s 
disease (Martinez et al., 2005) and multiple sclerosis (Masterman & Hillert, 2004), suggesting a 
common link between lipid metabolism and aberrant protein aggregation. All together, deficient 
cholesterol metabolism provides an appealing hypothesis in the pathogenesis of AD because it 
ties together the ApoE genetic risk, amyloid production and aggregation, and vasculopathy. 
 
I.2.1.5 APOE/cholesterol and neural stem cells 
 
Unfortunately, work demonstrating a role for ApoE or cholesterol on neurogenesis has 
been rare. Levi and Michaelson counted the number of Ki67+ proliferating cells, DCX+ 
neuroblasts, and NeuN+ mature neurons in control, ApoE3 and ApoE4 mice and found no 
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difference in the SVZ and an increase in the DG of ApoE4 mice. When these mice were exposed 
to environmental enrichment, a well-known stimulator of DG neurogenesis (Mustroph et al., 
2012; Gregoire et al., 2014), WT and ApoE3 mice showed a significant increase in proliferation 
and neurogenesis. Unexpectedly, environmental enrichment in apoE4 mice not only did not 
increase neurogenesis but instead, induced apoptosis (Levi & Michaelson, 2007). Li et al., 
studied ApoE knockout mice or mice with knockin alleles for human ApoE3 or ApoE4 and 
showed that neurogenesis is reduced in both ApoE-knockout and ApoE4-knockin mice (Li et al., 
2009). In the DG, ApoE-depletion in Nestin-reporter mice showed an acute increase in the 
proliferation of neural precursors followed by a premature depletion of GFAP+ and Nestin+ 
neural precursors. ApoE directly mediated this effect, as retroviral re-expression of ApoE 
rescued the phenotype (Yang et al., 2011). These studies demonstrate a requirement for ApoE in 
neural precursor activity in the DG. Unfortunately, how ApoE regulates neurogenesis remains 
unknown. 
 
I.2.1.5 Triglycerides-Fatty acids 
 
Metabolites formed from the breakdown of triglycerides are used in signal transduction 
pathways, for membrane biosynthesis, and adenosine triphosphate (ATP) production through β-
oxidation (Figure 6). The mobilization of triglycerides is carried out by triglyceride lipases, 
which sequentially cleave off fatty acids (Zechner et al., 2012). Fatty acids are made up of a 
carbon-hydrogen backbone with a single carboxyl group. Three main criteria are used to classify 
fatty acids, their carbon chain length, the number of double bonds, and their position relative to 
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the carboxyl group (Figure 7). Briefly, fatty acid chains usually contain between 4-28 carbons 
and are either saturated (no double bonds) or unsaturated (one or more double bonds) with 
 
Figure 7. Fatty acid nomenclature and classification  
 
 
 
 
58 
hydrogens. The location of the first double bond relative to the carboxyl group determines the 
omega classification (i.e, when the first double bond is on the third carbon it is called an omega-
3 fatty acid, on the sixth, an omega-6, and on the ninth, an omega-9) (Figure 7).  
Several lines of evidence suggest that defects in fatty acid metabolism may initiate and/or 
accelerate the development of AD (reviewed in (Hussain et al., 2013). Observational studies 
have associated low fish intake and low blood levels of omega-3 fatty acids to increased risk of 
dementia and AD (Gu et al., 2010). On the other hand, high fat diets and increased free fatty 
acids can induce and exacerbate AD pathological hallmarks including, plaque and tangle 
formation (Patil & Chan, 2005; Julien et al., 2010). Chronic administration of docosahaexanoic 
acid (DHA, 22:6), the main source of omega-3 in the brain, enhances long-term memory in 
young and aged rats (Gamoh et al., 1999; Gamoh et al., 2001), and dietary DHA has preventive 
and ameliorative effects on the impairment of spatial learning in Aβ-infused rats (Hashimoto et 
al., 2005a; Hashimoto et al., 2005b). This data indicates that alterations of fatty acid or their 
metabolites can lead to changes in brain function and that changes in the body’s lipid profile can 
lead to AD-associated pathologies in the brain.  
 
I.2.1.5 Fatty acids and neural stem cells 
 
The effect of fatty acids on neurogenesis has only been studied in embryonic neurosphere 
cultures. DHA and omega-3 fatty acids have been studied most frequently because of their 
previously mentioned role in learning and memory. Neurospheres differentiated in the presence 
of DHA have fewer apoptotic cells, proliferate less, and produce significantly more neurons that 
are more developed when compared with the control (Kawakita et al., 2006; Katakura et al., 
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2009). Moreover, when compared to arachidonic acid (AA, 20:4), Sakayori and colleagues found 
that DHA increased the number of neurospheres, whereas AA had no effect. Under 
differentiation conditions, DHA treatment increased the number of neurons, while AA increased 
the number of astrocytes (Sakayori et al., 2011). Building on their previous work, Katakura and 
colleagues simultaneously compared the effects of DHA, eicosapentaenoic acid (EPA, 20:5), and 
AA on gene expression and neurosphere differentiation. They showed that EPA and DHA but 
not AA treatment induced neuronal differentiation with a concomitant increase in NeuroD and 
Map2 mRNA levels. Interestingly, DHA but not EPA or AA inhibited mRNA levels of Hes1, an 
inhibitory factor of neuronal differentiation, while EPA but not DHA activated Hes6, an 
inhibitory factor of Hes1. EPA and DHA but not AA arrested the cell cycle of NSCs through 
increased p21cip1 and p27kip1 levels. These results indicate that omega-3 polyunsaturated fatty 
acids (DHA and EPA), but not AA, increase neuronal differentiation (Katakura et al., 2013). In 
another study, the same group differentiated neural precursor with equivalent concentrations of 
DHA, AA, docosapentaenoic acid (DPA, 22:5), and Oleic acid (OA, 18:1). They again found 
that omega-3 fatty acids (DHA and DPA) increased neuronal fate choice using Tuj-1 and MAP2 
markers, while OA and AA had no effect. In addition, they found no effect of any of these fatty 
acids on astrogliogenesis (Rashid et al., 2013). Together these studies demonstrate that omega-3 
fatty acids support survival and neuronal fate choice and differentiation of embryonic neural 
precursors. On the other hand, saturated fatty acids such as palmitic acid (PA, 16:0) have been 
negatively linked to AD (Patil & Chan, 2005). Treatment of neural precursors with PA dose-
dependently increases caspase-mediated apoptosis altering bax and bcl-2 and leading cleavage of 
caspase-3. Moreover, the increase in apoptosis was partially dependent on MAPK signalling, as 
PA increased the phosphorylation of JNK in a dose-dependent manner and addition of a JNK  
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inhibitor could partially rescue caspase activation and the number of terminal deoxynucleotidyl 
transferase dUTP nick end labelling (TUNEL)+ cells (Yuan et al., 2013; Wang et al., 2014). In 
addition, non-toxic levels of PA were shown to increase astrogliogenesis and Stat3 signalling 
(Wang et al., 2014). Thus, various fatty acids can impact neural precursor behaviour differently. 
The closest links between these results and adult neurogenesis are experiments with high fat diet 
paradigms. Post-natal AA- but not DHA-feeding increased the number of 1day BrdU+ 
proliferating cells in the DG (Maekawa et al., 2009). Moreover, dietary administration of DHA 
in adult rats significantly increased the number of BrdU+/NeuN+ newborn neurons in the DG 
(Kawakita et al., 2006).  
Although the data linking lipids and adult neurogenesis is scarce, emerging studies on 
fatty acid binding and synthesis have yielding interesting results. Fatty acids are distributed in 
the brain via fatty acid binding proteins (FABPs) and loss of FABPs inhibits neurogenesis and 
cognitive function (reviewed in (Liu et al., 2010)). FABPs are intracellular lipid trafficking 
proteins that play crucial roles in taking up fatty acids into the cytoplasm and transporting them 
to appropriate intracellular compartments (Owada, 2008; Storch & McDermott, 2009). Among 
various FABPs -3, -5 and -7 are expressed in the brain. FABP-3 is expressed in neurons of the 
mature brain, while FABP5 is expressed by both glia and neurons pre and post natally. During 
pre and perinatal stages FABP7 is mainly expressed in radial glia and immature astrocytes 
(Owada et al., 1996). In adult rodent brains, immunohistochemistry showed that FABP5 and 
FABP7 are present in NSCs and their neuronal progenitors coexpressing GFAP, Nestin, Sox2 
and DCX but not NeuN in the DG. A marked decrease in NSCs and neural progenitors was 
observed when FABP5, FABP7 or both were knocked out. Although 1-day BrdU+ proliferating 
cells were decreased in all knockout mice, the survival of these cells 28 days after injection was 
 
 
 
 
61 
increased in the FABP7/FABP5 double knockout mice compared to other three genotypes. 
Although this study does not directly study the role of fatty acids in neurogenesis it suggests that 
FABPs are required for DG neurogenesis (Matsumata et al., 2012).  
 
Although, many interesting links have been uncovered in the last decade, more work is 
needed to determine the role of lipids during physiological neurogenesis and whether changes in 
lipid species contribute to alterations in neurogenesis and under pathological conditions  
 
I.2.2 Neurogenesis in humans with Alzheimer’s disease 
 
Studies on neurogenesis in human AD patients have led to variable results. The first 
study showed that protein expression of DCX, PSANCAM, TOAD-64/Ulip/CRMP (TUC-4), 
and NeuroD was increased in Western blots between controls and AD hippocampal samples. 
However, this study did not use age-matched controls, making it difficult to determine the 
meaning of these results (Jin et al., 2004b). Other reports have indicated an increase in glial cell 
proliferation and vascular-associated changes in the presenile AD human hippocampus 
(Boekhoorn et al., 2006a). Crews and colleagues performed cell counts and found a decrease in 
both Sox2- and DCX-positive cells in the hippocampus of AD patients (Crews et al., 2010a). An 
important study by Perry and colleagues measured immunoreactivity of multiple stages of 
neurogenesis in the sub-granular layer and the granule cell layer of the DG and the SVZ at Braak 
stages 1-5.  Musashi-1+ NSCs were significantly diminished in both SVZ and DG in AD patients 
and further decreased with increasing Braak stages. Conversely, immunoreactivities of Nestin 
and PSA-NCAM progenitors were significantly higher in AD and increased in later Braak stages 
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in the DG. In the SVZ, Nestin immunoreactivity was also significantly higher in AD and 
significantly increased in more advanced Braak stages, while no significant differences were 
seen for the other markers. In the DG, DCX was increased in the granule layer but not sub 
granule layer in AD, suggesting this may not be the result of normal neurogenesis (Perry et al., 
2012). In accord with the Perry study, Ziabreva et al., found a 9- fold decrease in Musashi + cells 
in the SVZ of AD patients (Ziabreva et al., 2006). Together, these data although variable, 
suggest a dysregulation of neurogenesis in AD. This variability is likely due to the various ages 
and disease stages of AD compared and the differing markers used to study neurogenesis. More 
studies are needed to characterize how each step of the neurogenic process is altered and how 
they are temporally and spatially modulated with the respect to five AD-associated pathologies.  
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I.3 HYPOTHESIS, OBJECTIVES, AND EXPERIMENTAL RATIONAL 
 
Problem: Alzheimer’s disease leads to widespread degeneration and failing of many cognitive 
functions including learning and memory.  
 
Hypothesis: AD-associated pathologies regulate neural stem cell activity in AD. 
 
Objectives: the goal of this thesis was to uncover mechanisms regulating neural stem cell 
behaviour in Alzheimer’s disease by:  
1) Studying the onset of neurogenic defects in 3xTg-AD mice 
2) Identifying novel and early suppressors of neurogenesis in 3xTg-AD mice and confirm 
their presence in human AD patients 
3) Untangling the molecular mechanisms by which this/these suppressor(s) act to inhibit 
neurogenesis in 3xTg-AD mice. 
 
Experimental rational:  
 
We selected the 3xTg-AD mouse model for these studies for three main reasons: 1) their 
capacity to develop both amyloid plaques and neurofibrillary tangles 2) the fact that their 
pathology progression is slow, aggravated by age and deposits in a spatial pattern similar to what 
is observed in AD patients and 3) because they have age-related memory deficits.  
 
We collaborated with Chemists to adapt novel techniques to localize and identify lipids in 
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the brain by lipid-imaging mass spectrometry (Martin Dufresne and Pierre Chaurand) and in the 
cerebral spinal fluid and plasma by lipidomic mass spectrometry (Alexandra Furtos).  
 
We developed novel tools to study the role of lipids in the regulation of adult neural stem 
cells, including, intracerebroventricular infusion and acute injections of fatty acids and heavy 
fatty acids for metabolic tracing in the brain. We employed classic and modified neurosphere 
assays to assess neural stem cell activation and self-renewal and neural precursor expansion in 
vitro. Moreover, we utilized established ablation protocols to study neural stem cell behaviour in 
vivo. 
This data obtained during my thesis has resulted in the following publications: 
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II.1 ABSTRACT 
Alzheimer’s Disease (AD) affects cognitive modalities that are known to be regulated by 
adult neurogenesis, such as hippocampal- and olfactory-dependent learning and memory. 
However, the relationship between AD-associated pathologies and alterations in adult 
neurogenesis has remained contentious. In the present study, we performed a detailed 
investigation of adult neurogenesis in the 3xTg mouse model of AD, a unique model that 
generates both amyloid plaques and neurofibrillary tangles, the hallmark pathologies of AD. In 
both neurogenic niches of the brain, the hippocampal dentate gyrus and the forebrain 
subventricular zone (SVZ), we found that 3xTg mice had decreased numbers of (i) proliferating 
cells, (ii) early lineage neural progenitors, and (iii) neuroblasts at middle-age (11-months-old) 
and old-age (18-months-old).  These decreases correlated with major reductions in the addition 
of new neurons to the respective target areas, the dentate granule cell layer and the olfactory 
bulb. Within the SVZ niche, cytological alterations were observed that included a selective loss 
of sub-ependymal cells and the development of large lipid droplets within the ependyma of 3xTg 
mice, indicative of metabolic changes. Temporally, there was a marked acceleration of age-
related decreases in 3xTg mice, which affected multiple stages of neurogenesis and was clearly 
apparent prior to the development of amyloid plaques or neurofibrillary tangles. Our findings 
indicate that AD-associated mutations suppress neurogenesis early during disease development.  
This suggests that deficits in adult neurogenesis may mediate premature cognitive decline in AD. 
Keywords: stem cells, hippocampus, subventricular zone, amyloid precursor protein, tau 
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II.2 INTRODUCTION 
There is increasing evidence that perturbations in adult neurogenesis may play a role in 
the cognitive dysfunction associated with aging and Alzheimer’s Disease (AD). For example, 
many molecules linked to the development of AD, including Presenilins, Amyloid Precursor 
Protein (APP), tau, and ApoE4, have recently been shown to be potential regulators of adult 
neurogenesis (Caille et al., 2004; Chuang, 2010b; Lazarov & Marr, 2010). Moreover, when adult 
neurogenesis is experimentally ablated, changes reminiscent of those seen during aging and in 
AD are observed (Rosen et al., 1984; Bacon et al., 1998; Lazarov & Marr, 2010), such as defects 
in hippocampus-dependent learning and memory, olfactory deficits, and olfactory bulb atrophy 
(Mak et al., 2007; Imayoshi et al., 2008; Breton-Provencher et al., 2009; Clelland et al., 2009; 
Deng et al., 2009; Kitamura et al., 2009). Since aging is associated with a significant drop in 
neurogenesis and is also the primary risk factor for AD (Kuhn et al., 1996; Kempermann et al., 
1998; Cameron & McKay, 1999; Knoth et al., 2010), decreases in adult neurogenesis may be 
involved in mediating aging- or AD-related cognitive decline.  
Surprisingly, contradictory conclusions have emerged from previous studies that have 
attempted to link AD to changes in neurogenesis, with both increases and decreases in 
neurogenesis having been reported (Chuang, 2010b; Elder et al., 2010). These differing 
conclusions may reflect variability in key study conditions, including age, types of AD genetic 
mutations, and the stage of development of the amyloid and/or tau pathologies. Specifically, 
since adult neurogenesis is tightly regulated by the neurogenic microenvironment (i.e., adjacent 
cells, extracellular matrix, diffusible factors and circulating signals) (Fuchs et al., 2004; 
Morrison & Spradling, 2008; Walker et al., 2009), experimental models having different types, 
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levels, or localizations of AD-induced pathologies are likely to have diverse effects on neural 
precursor survival, proliferation, migration and/or differentiation.  
In the present study, we used the 3xTg model of AD (Oddo et al., 2003b) to investigate 
the influence of the AD-associated microenvironment on adult neurogenesis.  3xTg mice carry 
the PS1M146V, APPswe and tauP301L human mutations, and provide the closest recapitulation of the 
cellular microenvironment in AD as they progressively develop both classical pathologies, 
amyloid plaques and neurofibrillary tangles (Oddo et al., 2003a; Mastrangelo & Bowers, 2008). 
To systematically evaluate AD-induced changes in neurogenesis, we examined key stages of the 
neurogenic process in both neurogenic regions of the adult brain, the hippocampal dentate gyrus 
(DG) and the forebrain subventricular zone (SVZ) while simultaneously assessing amyloid and 
tau pathology progression. Our findings suggest that the AD microenvironment can suppress 
adult neurogenesis early during disease development and independently of plaque and tangle 
deposition.  
 
II.3 MATERIALS AND METHODS 
II.3.1 Animals 
Experiments were conducted in accordance with the guidelines of the Canadian Council 
of Animal Care and were approved by the institutional animal care committee. The generation of 
the 3xTg-AD mice has been described previously (Oddo et al., 2003b). Briefly, 3xTg-AD mice 
were originally derived by co-microinjecting two independent transgenes encoding human 
APPSwe and the human tauP301L (both under control of the neuron-specific mouse Thy1.2 
regulatory element) into single-cell embryos harvested from homozygous mutant PS1M146V 
knock-in (PS1-KI) mice. The non-transgenic wildtype (WT) mice used are littermates from the 
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original PS1-KI mice and are on the same background as the 3xTg mice (C57BL6/129SVJ). All 
mice were kept in identical housing conditions and given free access to a standard rodent diet 
(#2018, Harlan Teklad, Madison, USA) and water.  
For the present experiments, a total of 17 female WT and 17 female 3xTg mice were 
used. All 34 mice received injections of 5-bromo-2-deoxyuridine (BrdU): twenty-one days prior 
to sacrifice, they were administered three 100 µl intraperitoneal injections of BrdU (1.5 
mg/injection, Sigma, Oakville, Canada) at three-hour intervals.  
 
II.3.2 Tissue processing and collection for immunohistochemical experiments 
 Mice received a lethal dose of chloral hydrate (7%) and were then perfused trans-
cardially with 25 ml of phosphate-buffered saline (PBS) followed by 40 ml of 4% formaldehyde, 
freshly prepared from paraformaldehyde pH 7.4. Perfusion-fixed brains were removed and post-
fixed in 4% formaldehyde for an additional 4 h, and then kept in PBS at 4°C until sectioning. 
Using a mouse brain mold (1mm mouse coronal Alto brain matrice, Harvard Apparatus Canada, 
St Laurent, Canada), each brain was divided into three blocks prior to vibratome sectioning: an 
anterior 3 mm block containing the olfactory bulbs, an intermediate 6 mm block containing the 
forebrain lateral ventricles and hippocampus, and a 4 mm posterior block containing the 
cerebellum and brainstem. Both the anterior and intermediate blocks were sectioned in the 
coronal plane, from rostral to caudal, at 40 µm thickness using a vibrating microtome (Leica 
VT1000S, Leica Microsystems, Richmond Hill, ON, Canada). For the anterior block, the 
olfactory bulbs were serially sectioned into 6 wells of a 6-well plate, such that each well 
contained a series of sections that were 240 µm apart. For the intermediate block, SVZ sections 
were collected beginning when the genu of the corpus callosum became continuous (approximate 
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coordinates Bregma +1.15), and the subsequent 48 sections (=1.92 mm) were collected into a 24-
well plate. The entire hippocampus was then serially sectioned into 6 wells of a 6-well plate, 
such that each well contained a series of 10 sections that were 240 µm apart. Tissue sections 
were collected into an anti-freeze solution (glycerol:ethylene glycol:PBS 1X, 3:3:4) and stored at 
-20°C. 
 
II.3.3 Immunohistochemistry 
Basic immunohistochemical procedures were performed as detailed previously 
(Bednarczyk et al., 2009). The primary antibodies used were: mouse anti-human Ki67 (1:200, 
BD Biosciences, Mississauga, Canada), rat anti-BrdU (1:200, AbD Serotec, Raleigh, USA), goat 
anti-human DCX (1:1000, Santa Cruz Biotechnology, Santa Cruz, USA), mouse anti-rat Mash-1 
(1:100, BD Biosciences), mouse anti-mouse NeuN (1:200, Millipore, Billerica, USA), mouse 
anti-human Tau (HT7) (1:200, Pierce Biotechnology, Rockford, USA), rabbit anti-human 
Amyloid Precursor Protein (Y188) (1:750, Abcam, Cambridge, USA), mouse anti-human PHF-
Tau (AT8) (1:100, Pierce Biotechnology), mouse anti-human PHF-Tau (AT180) (1:20, Pierce 
Biotechnology), mouse anti-human PHF-1 (1:20, courtesy of Dr. Peter Davies, Albert Einstein 
College of Medicine, Bronx, USA). For brightfield immunohistochemistry, primary antibodies 
were detected using species-appropriate biotinylated secondary antibodies (Jackson 
ImmunoResearch, West Grove, USA), the signal was amplified using the avidin-biotin-
peroxidase system (VectaStain ABC Kit, Vector Laboratories, Burlington, Canada), and revealed 
using a 3,3-diaminobenzidine (DAB)-containing solution (Sigma). For fluorescence 
immunohistochemistry, primary antibodies were detected using species-appropriate secondary 
antibodies that were conjugated to either Alexa 555 (1:1000, Invitrogen, Burlington, Canada), 
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Alexa 488 (1:1000, Invitrogen) or Alexa 647 (1:1000, Invitrogen). Fluorescent nuclear 
counterstaining was performed with 0.2 µM Hoechst 33342 (Sigma). Microscopy was performed 
using a motorized Olympus IX81 microscope and/or a Leica SP1 laser-scanning confocal 
microscope.  
The HT7, Y188, AT8, AT180 and PHF-1 antibodies strongly labeled sub-populations of 
neurons on sections from 3xTg mice, and did not produce any staining patterns above 
background on sections from WT mice. The Y188 antibody yielded some diffuse and low level 
staining in WT mice, presumably due to cross-reactivity with endogenous mouse APP. On 
Western blots, the HT7 and Y188 antibodies detected bands only at the appropriate respective 
sizes. 
 
II.3.4 Resin-embedded semi-thin sections 
Some sections processed for brightfield immunohistochemistry with Ki67 were further 
sectioned to 1 µm thickness to improve resolution of the signal. Following application of the 
DAB solution, sections were rinsed in phosphate buffer, fixed with 1% osmic acid (Electron 
Microscopy Science, Hatfield, USA) for 30 minutes, dehydrated in a graded series of ethanols 
and propylene oxide (Fisher Scientific) and then embedded in electron microscopy grade Resin 
(Durcupan ACM, Sigma). Resin-embedded sections were cut at 1 micron thickness on an 
Ultracut E, Reichert Jung ultramicrotome (Leica, Richmond Hill, Canada), counterstained with 
0.5-1% toluidine blue (Fisher Scientific) and mounted on slides. They were then coverslipped 
using Permount (Fisher Scientific), and photographed using a 100X objective. 
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II.3.5 Oil Red O staining 
 40 µm coronal sections through the SVZ were mounted on slides, washed with 60% 
isopropanol in distilled H2O (Fisher Scientific) and incubated in 0.3% Oil Red O solution in 60% 
isopropanol (Allied Chemical, Morristown, USA ) for 10 minutes. Slides were washed once with 
60% isopropanol and three times with distilled H2O. They were then coverslipped with 75% 
glycerol (Fisher Scientific) in distilled H2O. 
 
II.3.6 Estimates of cell numbers  
 In order to estimate changes in the relative numbers of immunohistochemically defined 
cell types, WT and 3xTg sections from the olfactory bulb, SVZ and hippocampus were chosen 
from within pre-determined stereotaxic windows and then precisely matched to equal levels 
using specific tissue landmarks. All cell counting was performed on coded slides by a blinded 
experimenter. 
Hippocampus. For each marker analyzed, quantifications were performed on 5 sections at 240 
µm intervals through the hippocampus from stereotaxic levels -1.3 to -2.3 mm Bregma (for BrdU 
and DCX) or -2.3 to -3.3 mm Bregma (for Ki67). To match the section levels, landmarks were 
used that included size of the hippocampus, shape of the dentate granule layer, thickness of the 
corpus callosum and size of the lateral ventricles. Counts were limited to positive cells within the 
subgranular zone and granular zone of the dentate gyrus. Averages per section were obtained by 
averaging the counts from left and right hemispheres. 
Olfactory bulbs. Relative changes in the number of BrdU(+) cells in the olfactory bulbs were 
measured by using 6 sections at 240 µm intervals from +5.30 to +4.10 mm Bregma. To match 
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the section levels, landmarks including the size and shape of the main olfactory bulb, size and 
shape of the subependymal zone, and the absence of the accessory olfactory bulb were used.  
SVZ. For quantification of markers expressed by SVZ cell populations, 5 sections at 320 µm 
intervals were quantified from +1.15 to -0.15 mm Bregma. To match the section levels, 
landmarks were used that included the genu of the corpus callosum, corpus callosum thickness, 
size of the lateral ventricles, location/size of the anterior and posterior commissures and the 
connection of the lateral ventricles with the dorsal third ventricle. Counts were limited to the 
SVZ and both the left and right hemispheres were included. Averages per section were obtained 
by averaging the counts from left and right hemispheres. 
 Quantifications are shown as uncorrected cell counts per section. In control experiments, 
we found that there was no detectable difference in the size of the objects counted, as nuclear 
profiles had an identical size distribution between WT and Tg mice at 11 months (7.734 ± 0.4539 
vs. 7.205 ± 0.6278 µm), and at 18 months (7.167 ± 0.1211, vs. 6.951 ± 0.2409 µm) (data not 
shown). There were also no apparent differences in the sizes of the brain structures that were 
analyzed, as all of the tissue landmarks indicated above appeared at the same time in all mice, 
regardless of whether they were WT or 3xTg mice, and 11 or 18 months of age. Based on these 
two criteria, the uncorrected cell counts are expected to provide an approximation of relative 
changes in cell numbers between groups.  
Quantification from semi-thin sections.1 µm serial sections through the lateral ventricles at 
0.86mm Bregma were photographed using a 100X objective. Digital images were used to 
reconstruct the walls of the lateral ventricle into one complete ventricle for each animal. 
Counting of ependymal cells which are stained light blue and are in contact with the ventricle, 
sub-ependymal cells which are stained dark blue, proliferating Ki67(+) cells which are stained 
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black, and lipid droplets was achieved using the striatal side of each ventricle (see Fig. 5a) and 
manually tagging each cell type.  
 
II.3.7 Protein isolation and fractionation 
For biochemical analyses, mice were deeply anaesthetised with 100µl/g of a ketamine 
(30mg/ml, Bioniche Animal Health, Belleville, Canada) and xylazine (2mg/ml, Bimeda-MTC, 
Cambridge, Canada) solution, and then perfused intracardially with Phosphate Buffered Saline 
(PBS) pH 7.4 containing protease inhibitors (1 tablet/200ml PBS, Sigma Fast kit containing 12 
inhibitors) and phosphatase inhibitors (1mM pyrophosphate and 50mM sodium fluoride, Sigma). 
For each mouse, the brain was rapidly dissected out and divided into cortex, hippocampus, 
striatum and olfactory bulb. The tissues were immediately flash frozen on dry ice and weighed to 
determine dilution volumes of lysing buffer for each sample. Each brain region was then lysed 
and sequentially separated into soluble, membranous and insoluble protein fractions, as follows. 
Frozen tissues were incubated in Tris Buffered Saline (TBS) (0.05M Tris base, Wisent, St-
Bruno, Canada; 0.138M NaCl, EMD; 2.7mM KCl, EMD, Gibbstown, USA) supplemented with 
protease inhibitors (Complete cocktail tablet, Roche Diagnostic, Laval, Canada) and phosphatase 
inhibitors (10µg/ml Pepstatin, Sigma; 20 µg/ml Fenvalevate, Sigma; 9.8 µg/ml Canthavidin, 
Sigma; 446.10 µg/ml Sodium pyrophosphate, Sigma; 50 mM Sodium fluoride, Sigma). Each 
sample was then homogenized, sonicated for 3X5 seconds at 15 second intervals, and 
centrifuged for 20 minutes at 4ºC at 100 000g. The supernatant containing the soluble fraction 
was then collected and kept at -80ºC. To obtain the membranous protein fraction, the pellet was 
resuspended in buffer (150mM NaCl , EMD; 10mM NaH2PO4, Amresco, Solon, USA; 0.5% 
Deoxycholate, EMD; 1% Triton-X 100, Fisher Scientific; 5% SDS, J.T. Baker, Philipsburg, 
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USA) supplemented with the same protease and phosphatase inhibitors as above. Each sample 
was then homogenized, sonicated 3X5 seconds at 15 second intervals on ice, and centrifuged for 
20 minutes at 4ºC at 100 000g. The supernatant containing the membrane fraction was then 
collected and kept at -80ºC. The remaining pellet was resuspended in 90% formic acid (J.T. 
Baker), homogenized, sonicated 3X5 seconds at 15 second intervals, and centrifuged for 20 
minutes at 4ºC at 100 000g. The supernatant containing the insoluble fraction was collected and 
kept at -80ºC. Formic acid fractions were evaporated using a Savant Speed Vac plus SC110A 
(Thermo Scientific, Waltham, USA) with Savant refrigerated vapour trap RVT 400 (Thermo 
Scientific) for 2-5 hours to remove the formic acid. The proteins were then resuspended in TBS. 
The protein concentration of all fractions was determined using the bicinchoninic acid assay 
(Pierce Biotechnology).  
 
II.3.8 Western blotting 
35-60µg of protein from each sample was boiled in sample buffer containing 0.5M Tris-
HCl, pH6.8 (Fisher Scientific), 15% glycerol (Fisher Scientific), 10% SDS (Fisher Scientific), 
bromophenol blue (Fisher Scientific), and β-Mercaptoethanol (Bishop, Burlington, Canada), 
separated using SDS-PAGE (10% Acrylamide, Bio Rad, Mississauga, Canada), and transferred 
onto a nitrocellulose membrane (0.45µm, Bio Rad). Membranes were immersed in Ponceau Red 
(0.2% Ponceau S, Fisher Scientific, in 11% trichloroacetic acid, Fisher Scientific) to visualize the 
proteins, washed in Tris-buffered saline containing 0.2% Tween (Fisher Scientific) (TBS-T) and 
blocked in 5% skim milk powder (Carnation, Markham, Canada). They were then incubated 
overnight at 4°C with primary antibody. The following antibodies were used: mouse anti-human 
Tau (HT7) (1:1000, Pierce Biotechnology), rabbit anti-human APP (Y188) (1:1000, Abcam), 
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mouse anti-human PHF-Tau (AT8) (1:50, Pierce Biotechnology), mouse anti-human PHF-Tau 
(AT180) (1:100, Pierce Biotechnology) and mouse anti-Xenopus β-actin (1:10 000, Abcam). 
HRP-conjugated secondary antibodies, diluted in blocking solution, were used as follows: 
anti-mouse IgG (1:5000, Bio Rad) or anti-rabbit IgG (1:5000, Millipore). Secondary antibodies 
were detected using the ECL chemiluminescence reagent kit (GE Health Care, Baie d’Urfé, 
Canada) and X-Omat Blue film (Kodak). Membranes were subsequently stripped with Re-Blot 
Plus Mild (Millipore), re-blocked and re-probed as described above. Quantitative density of 
bands was performed using NIH ImageJ software.  Reported values are calculated as measured 
absorbance divided by β-actin absorbance. When reporting fold changes in absorbance between 
WT and 3xTg, the β-actin normalized 3xTg absorbance was divided by the β-actin normalized 
WT absorbance. 
 
II.3.9 Dot Blots 
20µg of protein from each sample was applied to a nitrocellulose membrane (0.45µm, 
Bio Rad) using the Schleicher & Schuell (S&S) Minifold-I Dot-Blot System (Keene, USA).  
When the wells were dry, the membrane was removed and dried on filter paper for 15 minutes.  
The membrane was then blocked in 5% milk in TBS-T for 30 minutes and incubated with the 
mouse anti-human β-amyloid 1-42 (12F4) (1:500, Covance, Emeryville, USA) primary antibody 
for 1 hour. Membranes were washed in TBS-T and incubated with anti-mouse IgG (1:5000, Bio 
Rad) for 30 min at room temperature. Secondary antibodies were detected using the ECL 
chemiluminescence reagent kit (GE Health Care) and X-Omat Blue film (Kodak).  
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II.3.10 Statistical Analyses 
For each animal, the average number of cells per section was first calculated (5-6 
sections/animal), and then the statistical analyses were performed using the average number of 
cells/section/animal (generally 4 animals/group). Unpaired t-tests were performed to compare the 
means between pairs of groups, and were two-tailed unless otherwise indicated. A probability 
value of  p ≤ 0.05 was considered to be statistically significant. All statistical analyses were 
achieved using GraphPad Prism, Version 5.02 (GraphPad Software, Inc, La Jolla, CA, USA). In 
the Results, data are expressed as mean ±standard error of the mean (SEM). For illustrative 
purposes, cell counts obtained from all tissue sections of all animals are presented in the figures 
using vertical scatterplots, with the group means shown as horizontal lines. 
 
II.4 RESULTS 
II.4.1 Region-specific expression of tau/APP human transgenes  
The 3xTg mice were generated by injection of neuron-specific Thy1.2 promoter-driven 
APPswe and tauP301L transgenes into PS1M146V single cell embryos (Oddo et al., 2003b). We began 
by assessing the temporal and spatial expression patterns of the APP and tau transgenes, as well 
as their proximity to the hippocampal and SVZ stem cell niches. 
We first confirmed biochemically that APP and tau transgenes were overexpressed in our 
3xTg mice. Protein lysates were prepared from the cortex, hippocampus, striatum (including the 
striatal SVZ), and olfactory bulbs of 11-month-old WT and 3xTg mice, and each lysate was 
sequentially separated into soluble, membranous and insoluble protein fractions as previously 
described (Calon et al., 2004; Tremblay et al., 2007; Julien et al., 2008; Phivilay et al., 2009) 
(see Materials and Methods). When the soluble fractions were probed with HT7 (a 
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phosphorylation-independent antibody against human tau) and the membrane fraction was 
probed with Y188 (an antibody against human APP) (Fig. 1), 3xTg mice were found to have 
significantly higher levels of both tau (Fig. 1A) and APP (Fig. 1B) than their age-matched WT 
controls. Both antibodies also showed some cross-reactivity against the respective WT mouse 
proteins. Densitometry measurements for tau and APP, normalized against β-actin, confirmed 
overexpression of these proteins in the cortex (tau 1.3x, APP 1.5x), hippocampus (tau 4.6x, APP 
1.6x), striatum (tau 1.9x, APP 1.5x) and olfactory bulbs (tau 2.8x, APP 1.4x) relative to WT 
controls.  
Transgene expression in each of these brain regions was visualized using multi-label 
fluorescence immunohistochemistry. Brain sections from both middle-aged (11-month-old) and 
old-aged (18-month-old) 3xTg mice displayed strong and specific immunoreactivity for HT7 and 
APP. In the hippocampus, CA1 pyramidal neurons that were HT7(+), APP(+), or 
HT7(+)/APP(+) were clearly apparent, increasing in number and intensity from 11 to 18 months 
of age (Fig. 1C).  There were no HT7(+) or APP(+) cells observed within the neurogenic DG, 
but some HT7(+) fibers were present within the hilus (data not shown). In the striatum, HT7(+) 
fibers were abundant and could be observed extending to the edge of the striatal SVZ at both 11 
and 18 months, while APP was not detectable (Fig. 1D). Neither APP nor HT7 was detectable 
within the SVZ itself. In the olfactory bulb, APP(+) neurons were observed in the mitral cell 
layer, and HT7 immunoreactivity was not detected (Fig. 1E). Finally, in the cortex, sub-
populations of cortical neurons were observed that were HT7(+), APP(+), or HT7(+)/APP(+); 
these cells increased in number and expression from middle-aged to old-aged 3xTg mice, and 
were observed both on caudal brain sections at the level of the hippocampus (Fig.1F) and rostral 
sections at the level of the striatum.  
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Collectively, these results demonstrate that the APP and hTau transgenes are strongly 
expressed in AD-relevant brain areas, and that they are not directly expressed by the neurogenic 
cells within the SVZ or DG.  
 
II.4.2 Alterations in adult neurogenesis in the 3xTg hippocampus 
In order to study hippocampal neurogenesis in the 3xTg mice, we divided the multi-step 
neurogenic process into two main stages: (1) a proliferative stage, in which activated neural stem 
cells produce rapidly dividing progenitors and neuroblasts, and (2) a post-mitotic stage, in which 
proliferating neuroblasts stop dividing, mature, and can functionally integrate into hippocampal 
circuitry.  
Immunohistochemistry for Ki67, a marker of cell proliferation, revealed a significant 
decrease in the proliferative phase of hippocampal neurogenesis in 3xTg mice. Ki67 
quantifications showed that cell proliferation was decreased by more than 80% in 11-month-old 
3xTg mice compared to WT controls (8.68 ± 1.44 vs. 1.62 ± 0.43 cells/section, p= 0.0033; 
n=4/group) (Fig. 2A-C). Proliferation decreased further with age in both groups, and by 18 
months was too low to accurately quantify (data not shown). 
A concurrent decrease in the 3xTg hippocampal neuroblast population was likewise 
observed. Fluorescence immunohistochemistry for Doublecortin (DCX), a marker for the 
proliferative and post-mitotic neuroblast population, revealed highly significant reductions in 
DCX expression at both 11 and 18 months of age (Fig. 2D-F). In 11-month-old 3xTg mice, DCX 
expression was decreased by 89% compared to age-matched WT mice (29.19 ± 5.02 vs. 2.97 ± 
0.65 cells/section, p= 0.0020; n=4/group). In 18-month-old mice, an age-related decrease in 
DCX(+) cells was observed in both WT and 3xTg mice, and the number of DCX(+) cells 
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remained 85% lower in 3xTg mice (8.60 ± 3.40 vs. 1.28 ± 0.45 cells/section, p=0.0770; 
n=4/group) (Fig. 2F). Strikingly, there was no significant difference between the 11-month 3xTg 
mice and 18-month WT mice (Fig. 2F). 
To determine whether the above deficits in the 3xTg mice ultimately led to the addition 
of fewer new cells to the dentate granule cell layer, mice were injected with BrdU 21 days before 
sacrifice and the number of BrdU-retaining granule cells was quantified. Compared to WT mice, 
11-month-old 3xTg mice were found to have a 64% reduction in the number of BrdU-retaining 
cells within the subgranular zone and granule cell layer of the dentate gyrus (2.17 ± 0.40 vs. 0.80 
± 0.35 cells/section, p= 0.0343; n=6 (WT), n=5 (3xTg)) (Fig. 2G-I). At 18 months of age, the 
number of BrdU (+) cells was too low to assess in both WT and 3xTg groups (data not shown).  
Thus, both the proliferative and post-mitotic stages of hippocampal neurogenesis are 
highly decreased in 3xTg mice. 
 
II.4.3 Reduced neurogenesis in the 3xTg forebrain SVZ and olfactory bulb 
Cells produced in the forebrain SVZ stem cell niche contribute to the plasticity of the 
forebrain and play an essential role in olfaction. To assess SVZ neurogenesis in 3xTg mice, we 
sub-divided the SVZ/olfactory bulb (OB) neurogenic process into two main stages: (1) a 
proliferative stage comprised of activated stem cells, rapidly dividing progenitor cells and 
migratory neuroblasts, and (2) a post-mitotic stage in which neuroblasts have migrated to the 
olfactory bulb and differentiated into olfactory bulb neurons.  
Expression of multiple markers revealed a generalized decrease in cells in the 
proliferative stage of neurogenesis in 3xTg mice. First, immunohistochemistry for Ki67 at 11 
months of age showed that the total proliferating cell population in 3xTg mice was reduced by 
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45% compared to WT mice (557.2 ± 39.50 vs. 299.60 ± 34.07 cells/section, p=0.0026; 
n=4/group) (Fig. 3A-D,G). At 18 months, both WT and 3xTg mice had undergone an aging-
dependent reduction in Ki67, but the difference had increased to 60% (369.4 ± 72.24 vs. 147.3 ± 
10.82 cells/section, p=0.0228; n=4/group) (Fig. 3E-G). Interestingly, there was no statistical 
difference in SVZ proliferation between 11-month-old 3xTg mice and 18-month-old WT mice 
(Fig. 3G). Next, to confirm that the reduction in SVZ cell proliferation involved a decrease in 
progenitor and intermediate neuroblast populations, we performed immunohistochemistry for 
Mash-1, a marker of neuronal progenitors and neuroblasts (Fig. 3H-L). Quantification showed 
that 3xTg mice had a 35% decrease in Mash-1(+) cells at 11 months of age (317.3 ± 24.23 vs. 
204.6 ± 33.19 cells/section, p=0.0369; n=4 (WT), n=3 (3xTg)) (Fig. 3 H,I,L). At 18 months, 
3xTg mice still had 30% fewer Mash-1(+) cells (195.1 ± 13.83 vs. 136.0 ± 13.49 cells/section, 
p=0.0222; n=4/group) (Fig. 3 J-L). Immunoreactivity for the neuroblast marker, DCX, was also 
visibly decreased in 3xTg mice relative to age-matched controls at both 11 and 18 months of age 
(data not shown). 
We next assessed the longer term fate of dividing SVZ cells. In the SVZ, stem cells 
divide approximately every 28 days, progenitors divide approximately every 15 hours, and 
neuroblasts migrate to the olfactory bulb within 14 days of being produced (Morshead et al., 
1994). Using the 21 day BrdU-retaining paradigm described earlier, we quantified the number of 
BrdU-retaining cells in the SVZ (a measure of how many stem cells divided during the BrdU 
pulse) and in the olfactory bulb (a measure of SVZ-derived neurons added to the bulb).  In the 
SVZ, there was a 41% decrease in the number of BrdU(+) cells in 11-month-old 3xTg mice 
(20.60 ± 5.03 vs. 12.10 ± 3.49 cells/section; p=0.0529; n=4/group) (Fig. 4A-C). There remained 
a 38% difference at 18 months (p=0.1196; data not shown and Fig. 4C). In the olfactory bulb, 
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there was a 30% decrease in BrdU(+) cells in 11 month old 3xTg mice (146.40 ± 11.56 vs. 
102.13 ± 14.62 cells/section; p= 0.0063; n=4/group) (Fig. 4D-F), and no significant difference by 
18 months of age (data not shown and Fig. 4F).  
 Together, the above results reveal deficits at all stages of SVZ/OB neurogenesis in 3xTg 
mice, and that these changes are already apparent by middle-age. 
 
II.4.4 Structural changes within the SVZ of 3xTg mice 
 To determine the effects of the previous findings on the cellular organization of the SVZ, 
we used semi-thin sections to examine the structural characteristics of the 3xTg SVZ at higher 
resolution. Pre-embedding immunohistochemistry was performed for the proliferative marker 
Ki67, sections were counterstained with toludine blue, and the walls of the lateral ventricles were 
reconstructed from photomicrographs of the 1 µm serial sections as described in the Materials 
and Methods.  
Quantification of the reconstructed ventricles revealed that i) the overall number of 
Ki67(+) cells decreased significantly in the 3xTg mice (26.67 ± 0.67 vs. 13.00 ± 4.51 cells/1µm 
section, p= 0.0400; 1 ventricle/animal, n=3/group) (Fig. 5B,E,F); ii) there was a significant 
decrease in the number of subependymal cells in the 3xTg mice (146.7 ± 8.57 vs. 96.67 ± 14.44 
cells/1µm section, p= 0.0408; 1ventricle/animal, n=3/group) (Fig. 5C,E,F); and iii) there was no 
change in the number of ependymal cells lining the ventricle (93.33 ± 1.86 vs. 101.0 ± 34.51 
cells/1µm section, p= 0.8353; 1ventricle/animal, n=3/group) (Fig. 5E,F). Intriguingly, 3xTg 
ependymal cells contained large, cytoplasmic deposits reminiscent of lipid droplets (0.33 ± 0.33 
vs. 28.00 ± 5.13 lipid droplets/1µm section, p=0.0058; 1 ventricle/animal, n=3/group) (Fig.5D-
F). These droplets measured from 2-6 µm, were almost exclusively found in the 3xTg mice, and 
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were most abundant in the ventral region of the ventricle. Staining of 40 µm SVZ sections with 
Oil Red O, a lipid-specific stain, confirmed that these structure were lipid droplets (Fig. 5G). 
Thus, 3xTg mice possess marked changes in the SVZ niche that include losses of proliferating 
cells and sub-ependymal cells, as well as metabolic abnormalities in ependymal cells. 
 
II.4.5 Status of AD-associated amyloid and tau pathologies  
Previous studies have shown that 3xTg mice exhibit a progressive and age-dependent 
formation of AD-associated amyloid plaques and neurofibrillary tangles (Oddo et al., 2003a; 
Oddo et al., 2003b; Mastrangelo & Bowers, 2008). Development of these pathologies occurs 
through a multi-stage process that is sensitive to modulation by a variety of physiological 
parameters, such as housing conditions and diet (Lazarov et al., 2005; Lim et al., 2005; 
Halagappa et al., 2007; Hu et al., 2010). We therefore investigated the stage and localization of 
amyloid and tau pathologies in our own 11-month-old 3xTg mice.  
 To evaluate the development of amyloid pathology (Fig. 6A), we first assessed 
accumulation of the soluble Aβ1-42 metabolite of APP, an early step in the formation of amyloid 
plaques. Dot blots of the soluble protein fractions of brain lysates from 11-month-old 3xTg and 
WT mice were probed with the 12F4 antibody against Aβ1-42; this revealed an accumulation of 
Aβ1-42 in lysates of the cortex, hippocampus, striatum and olfactory bulbs that was specific to 
3xTg mice (Fig. 6B). To determine whether soluble Aβ1-42 had yet formed insoluble oligomers or 
plaques, we also probed the insoluble fractions of our protein lysates, but no Aβ1-42 was detected 
in these fractions (not shown). Importantly, these same insoluble protein fractions did contain 
aggregates of tau (Fig. 6F). Two additional lines of evidence indicated that Aβ1-42 had not yet 
been deposited as insoluble extracellular plaques in our 11-month-old 3xTg mice. First, when 
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3xTg tissue sections were processed for immunohistochemistry using the 12F4 antibody, which 
is selective for extracellular Aβ1-42  on tissue sections (Mastrangelo & Bowers, 2008), no Aβ1-42  
immunoreactivity was detected (data not shown). Second, thioflavin-S staining, which readily 
detects plaque-associated β-pleated sheets, did not reveal any extracellular aggregations (data not 
shown).  Together, these data indicate that amyloid pathologies are at a relatively early stage of 
progression in the 11-month-old 3xTg mice used in this study. 
We also assessed the stage of development of tau pathologies. In AD, tau accumulates in 
hyperphosphorylated states within the somato-dendritic compartment of neurons. Formation of 
neurofibrillary pre-tangles and tangles is associated with a temporal sequence of phosphorylation 
events that can be identified using specific antibodies, including AT8 (serine 202 and threonine 
205 phosphorylation), AT180 (threonine 231 and serine 235 phosphorylation), and PHF-1 
(serine 396 and 404 phosphorylation). These epitopes delineate early, intermediate, and late 
pathology states, respectively (Deters et al., 2008) (Fig. 6C). In 11-month-old 3xTg mice, 
biochemical analyses revealed prominent increases in AT8-immunoreactive bands at 
approximately 50KDa in the soluble fractions from the hippocampus (6.4x), striatum (2.7x) and 
olfactory bulbs (3.6x) relative to age-matched controls (Fig.6D). The same analysis for AT180 
likewise identified increases in the hippocampus (2.7x), striatum (1.3x) and olfactory bulbs 
(2.0x) (Fig. 6E). In both cases, these changes were strongest in the hippocampus, and in neither 
case was tau hyperphosphorylation detected in the cortical samples. Interestingly, samples 
blotted with the AT8 antibody also yielded a 3xTg-specific band at approximately 17KDa in all 
brain regions, which may correspond to a previously identified 17 KDa neurotoxic fragment of 
tau (Park & Ferreira, 2005). Finally, we probed our insoluble protein fractions with hTau; this 
 
 
 
 
86 
revealed the appearance of a prominent hTau-reactive band below 50KDa that was specific to the 
hippocampus of 3xTg mice (Fig. 6F), indicating that tau had become filamentous and insoluble. 
To further localize the progression of tau pathology, we performed 
immunohistochemistry for AT8, AT180 and PHF-1 (a marker of tangle-associated tau paired 
helical filaments) (Fig.6G-K). In 11-month-old 3xTg mice, there were large numbers of AT8-
immunoreactive neurons in the hippocampal CA1 region (Fig. 6G) and relatively fewer 
AT180(+) neurons (Fig. 6H). These neurons had pronounced immunoreactivity in their cell 
bodies and basal dendritic processes. By 18 months of age, the number of AT8(+) neurons had 
decreased (Fig. 6G) while AT180(+) cells had increased (Fig. 6H), consistent with progression to 
an intermediate stage of tau hyperphosphorylation. Moreover, immunohistochemistry for PHF-1 
revealed the appearance of small numbers of PHF-1(+) CA1 neurons at 18 months (Fig. 6I). 
Within the dentate gyrus stem cell niche, AT8(+) neurons were observed scattered in the hilus of 
11-month 3xTg mice (Fig. 6J). AT180(+) neurons were also found in the hilus of 11- month 
3xTg mice and in rare upper dentate granule neurons of 18-month-old 3xTg mice (Fig. 6K). 
Outside the hippocampus, small numbers of neurons labelled with these markers of tau 
hyperphosphorylation were present in the amygdala and cortex, but no immunoreactivity was 
observed in the striatum, striatal SVZ, or olfactory bulbs (data not shown).  
Together, these results show that amyloid plaque and neurofibrillary tangle development 
are at early-to-intermediate stages of development in our 11-month-old 3xTg mice. 
 
II.5 DISCUSSION 
In this study, we investigated neural precursor populations in the brains of middle-aged 
and old 3xTg mice. We demonstrate a major reduction in adult neurogenesis in 3xTg mice that is 
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widespread and already present by middle-age, prior to plaque and tangle formation. Our 
principal findings are that (i) in both neurogenic niches of the adult brain, the hippocampus and 
forebrain SVZ, 3xTg mice have fewer proliferating cells, neural progenitors and neuroblasts, 
resulting in decreased numbers of adult-born cells being added to the dentate granule cell layer 
and the olfactory bulbs; (ii) levels of neurogenesis in middle-aged 3xTg mice are similar to those 
in old wildtype mice, indicating a marked acceleration of aging-related changes in neural stem 
cell activity; (iii) in the forebrain SVZ, there is a selective loss of sub-ependymal cells and a 
pronounced accumulation of large lipid droplets within ependymal cells, suggestive of 
significant organizational and metabolic changes within this stem cell niche; and (iv) 
disturbances of adult neurogenesis are clearly evident at early stages of amyloid and tau 
pathology progression, before the appearance of the hallmark Aβ plaques and tangles. Given the 
important roles of the hippocampal and forebrain stem cell systems in learning and memory and 
overall brain plasticity, these findings suggest that early disturbance in the adult brain’s 
neurogenic regions may be a contributing factor to AD-induced premature cognitive decline.  
 
II.5.1 Age-related decreases in adult neurogenesis are accelerated prior to plaque and 
tangle formation in 3xTg mice 
 As mammals age, both the SVZ and hippocampal neurogenic niches undergo significant 
structural changes and reductions in their rates of neurogenesis (Kuhn et al., 1996; Eriksson et 
al., 1998; Kempermann et al., 1998; Cameron & McKay, 1999; Luo et al., 2006; Knoth et al., 
2010). Since stem cells are, by definition, long-lived and exposed to the noxious effects of both 
extrinsic and intrinsic effectors of damage (Van Zant & Liang, 2003), they are likely to have a 
selective vulnerability to aging-related changes and aging-related neurodegenerative diseases 
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such as AD. Moreover, stem cells may not only be the victims of aging-related changes, but also 
an important contributing factor to the tissue aging process when they are damaged or 
deregulated.  
Our analyses revealed that middle-aged 3xTg mice have prominent reductions in both 
early proliferating progenitor populations and later post-mitotic stages of DG and SVZ 
neurogenesis. Furthermore, in both these stem cell niches, the neurogenic parameters examined 
in middle-aged 3xTg mice were found to be reduced, highlighting a significant and widespread 
acceleration of aging-dependent decreases.  Within the SVZ of 11-month-old 3xTg mice, there 
was a 41% reduction in the number of 21-day BrdU-retaining cells, consistent with either 
depletion or increased quiescence of the SVZ stem cell population. Previous examination of cell 
proliferation in 3xTg mice had identified a reduced expression of the mitotic marker, 
phosphohistone-3, in both the DG and the SVZ (Rodriguez et al., 2008; Rodriguez et al., 2009); 
however, these earlier studies did not further characterize the phosphohistone-3 (+) cells or any 
other aspects of the neurogenic pathways, thus the overall impact of the 3xTg model on 
neurogenesis remained to be determined (Chuang, 2010b).  
More detailed analysis of the 3xTg SVZ revealed a selective depletion of cells within the 
subependymal compartment, where stem cells, transit-amplifying progenitor cells, neuroblasts, 
oligodendrocyte progenitors and astrocytes are normally located (Doetsch et al., 1997). We also 
identified a highly significant increase in the number of large lipid droplets observed within the 
cytoplasm of SVZ ependymal cells. This may be significant because ependymal cells are a 
crucial element of the SVZ niche, and are actively involved in the secretion, transport and 
absorption of molecules into and from the cerebrospinal fluid. Lipid droplets are cellular stores 
of neutral lipids such as triglycerides and steryl esters (Goodman, 2008), and their appearance is 
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indicative of significant metabolic/energetic changes within the SVZ niche. Since the cellular 
organization of the human SVZ appears to differ somewhat from that of the mouse (Sanai et al., 
2004; Curtis et al., 2007a), it will be important to determine if similar changes in cellular 
organization and metabolism occur in the SVZ of AD patients. 
The accelerated age-related deficits in neurogenesis occurred prior to the overt formation 
of AD-associated neuropathologies. We found that Aβ1-42 had accumulated within the soluble 
fraction of our lysates, but had not yet been deposited as insoluble extracellular plaques. For tau, 
phosphorylation-specific antibodies showed that early and intermediate stages of hyper-
phosphorylation were present at 11 months, and only at 18 months did we begin to detect late-
stage PHF-1 staining of fibrillar tau. The timing of amyloid and tau pathologies measured in our 
mice is significantly delayed in comparison to the original description of the 3xTg mouse model 
(Oddo et al., 2003b), however our analysis of these pathologies is highly consistent with a very 
thorough and more recent testing of pathology development in these mice (Mastrangelo & 
Bowers, 2008). This later onset of pathologies has been attributed to sex differences, 
neuroinflammatory factors, and “drift” of transgenic characteristics (Mastrangelo & Bowers, 
2008), and is likely further complicated by the sensitivity of pathology development to housing 
conditions such as environmental enrichment and diet (Lazarov et al., 2005; Lim et al., 2005; 
Halagappa et al., 2007). Our finding that widespread decreases in adult neurogenesis occur prior 
to plaque formation is in line with other identified plaque-independent effects of β-amyloid, such 
as perturbations of synaptic transmission (Hartley et al., 1999; Hsia et al., 1999). A greater 
understanding of the reasons and consequences of these changes may provide important clues to 
understanding how neural precursor activity is altered in AD. 
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II.5.2 Potential mechanisms of neural precursor regulation in the 3xTg model 
The mechanisms by which adult neurogenesis may be dys-regulated in AD have yet to be 
fully understood. Previous studies have examined neurogenesis in transgenic AD mouse models 
carrying single mutations used to generate the 3xTg model. A study on PS1M146V-KI mice 
showed reduced DG neurogenesis, reporting a 25% reduction in proliferation by BrdU and a 
35% reduction in new mature neurons by BrdU/NeuN at 3 months of age (Wang et al., 2004; 
Chuang, 2010b).  Another study in female Thy-1-APPswe mutant mice showed no difference in 
proliferation by BrdU or new mature neurons by BrdU/NeuN, but a decrease of almost half of 
the newly born neurons by DCX at 5 months of age. However, at 25 months they reported a 3-
fold increase in proliferation, a 6-fold increase in new mature neurons, and a 3-fold increase in 
newly born neurons in the DG (Ermini et al., 2008; Chuang, 2010b). A studying looking at 
neurogenesis in the DG of 8- to 10-week-old male tau-P301L transgenic mice found no change 
in Ki67, 28day BrdU or DCX (Boekhoorn et al., 2006b). None of these studies examined the 
SVZ of their mice. Thus it is possible that the PS1 mutation dominates over the APP and tau 
mutations in the 3xTg model. Interestingly, the PS1/γ-secretase complex is also an essential 
regulator of the Notch signalling pathway (De Strooper et al., 1999; Struhl & Greenwald, 1999), 
which is required for maintenance of adult neural stem cell populations (Alexson et al., 2006). 
 There are also numerous possibilities through which the stem cell niche, or regulatory 
microenvironment, could be impacted by AD mutations or mutant proteins. APP is cleaved to 
generate soluble APP (sAPP) and soluble Aβ1-42. Aβ1-42 administration has been shown to affect 
neural precursor proliferation and differentiation in culture and in vivo (Haughey et al., 2002a; 
Haughey et al., 2002b; Lopez-Toledano & Shelanski, 2004), and could gain access to neural 
stem cell niches by axonal transport and synaptic release (Lazarov et al., 2005; Szodorai et al., 
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2009) or by accumulation in the CSF (Lue et al., 1999; McLean et al., 1999). sAPP is released 
extracellularly from APP-expressing cells and has been shown to preferentially bind to neural 
precursors and potentially regulate neural precursor proliferation (Caille et al., 2004). Besides 
metabolites of APP, there is also recent evidence that PS1 mutations can alter hippocampal 
neurogenesis through non-cell autonomous mechanisms involving changes in microglial-secreted 
factors (Choi et al., 2008). Furthermore, AD is associated with reductions in cholinergic 
neurotransmission, which is an important positive regulator of hippocampal neurogenesis (Itou et 
al., 2010) and has yet to be studied in 3xTg mice. 
We identified three additional noteworthy and novel alterations occurring within the 
vicinity of the DG and/or SVZ stem cell niches in 3xTg mice. First, we observed accumulations 
of large lipid droplets within the SVZ ependymal layer, indicative of significant metabolic 
alterations within the SVZ niche. This is a particularly intriguing finding given that ApoE4, the 
strongest genetic risk factor known for sporadic AD, is likewise involved in lipid transport. 
Second, 3xTg mice possessed tau-overexpressing fibers in the striatum, directly adjacent to the 
SVZ (Fig. 1D); neurotransmitters, such as dopamine, released from these fibers normally 
contribute to the regulation of SVZ neural precursor activity (Kippin et al., 2005). Third, we 
identified neurons in the hilus of the dentate gyrus that were immunoreactive for hyper-
phosporylated tau (Fig. 6J,K); hilar neurons normally form synapses onto newly born 
hippocampal neurons and regulate their maturation through GABAergic mechanisms (Tozuka et 
al., 2005; Ge et al., 2006; Liu et al., 2006; Ge et al., 2007). More detailed examination of the 
possible impact of these alterations is warranted.  
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II.5.3 Impact of deficits in neurogenesis on cognitive impairments in AD 
Our findings add to the growing body of evidence that important biological changes 
occur prior to the development of hallmark pathological features of AD. The number of plaques 
and levels of secreted Aβ do not correlate well with the clinical onset of AD (Arriagada et al., 
1992; Samuel et al., 1994). Similarly, the number of tangles is only slightly more predictive of 
overall cognitive dysfunction in human AD (McKee et al., 1991; Arriagada et al., 1992). 
Interestingly, in our study, the changes in neurogenesis in 3xTg mice were already well 
established prior to the deposition of amyloid plaques and neurofibrillary tangles. A previous 
study in 3xTg mice reported cognitive impairments as early as 4 months of age, prior to plaque 
and tangle formation, and in the absence of any reported cell death (Billings et al., 2005; 
Gimenez-Llort et al., 2007). Instead, they showed that these deficits correlated with the levels of 
intraneuronal Aβ42. This suggests that cognitive impairments are an early symptom in the 3xTg 
and cell death has not been reported in this model. Thus the causes of early cognitive impairment 
remain elusive, but could possibly involve deficits in neurogenesis.  
When considering how the deficits in neurogenesis observed in the 3xTg mice might 
relate to the symptomology of AD, it is also important to recognize the distinction between 
genetically determined lifespan and actual lifespan. The gap between the two varies considerably 
between species, as many factors contribute or alter the lifespan of an animal. For example, 
humans have the ability to control their environment by changing their diet, physical activity, 
education, stress, and medical attention, all of which have been shown to impact on lifespan 
(Christensen & Vaupel, 1996; Faragher et al., 2009; Fontana et al., 2010; Kenyon, 2010; 
Rockenfeller & Madeo, 2010).  It is possible that, with the increased knowledge of these factors, 
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humans have pushed the limits of their genetically determined lifespan beyond its programmed 
capability. This could explain why AD is a disease only naturally found in humans. 
II.5.4 Conclusions 
 Alzheimer’s Disease is often regarded as a form of accelerated aging. Here, using 
the 3xTg model of AD, we found an acceleration of aging-related changes in both the mitotic 
and post-mitotic stages of adult neurogenesis. These changes occurred before development of the 
pathological hallmarks of the disease (Fig. 7). Although neurogenic activity was found to be 
diminished in 3xTg mice, recent studies have shown that environmental enrichment can promote 
hippocampal neurogenesis in at least some AD mouse models (Hu et al., 2010; Lazarov & Marr, 
2010). Given the important contribution of adult neurogenesis to learning, memory, and overall 
brain plasticity, it will be important to determine whether preventing or reversing age-related 
declines in the production of new neurons can functionally compensate for AD-associated 
deficits. 
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Figure 1 
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Figure 1. APPswe and tau P301L transgene expression in the brains of 11-and 18- month-
old 3xTg mice  
(A,B) Western blot analysis of protein levels in the cortex (Ctx), hippocampus (Hipp), striatum 
(Str/SVZ), and olfactory bulbs (OB) of 11-month-old wildtype (WT) and 3xTg mice, probed for 
either A, hTau in the soluble fraction using the HT7 antibody, or B, APP in the membrane 
fraction using the 12F4 antibody. (C-F) Immunofluorescence labelling for hTau and APP in C, 
hippocampus, D, striatum/SVZ, E, olfactory bulb, and F, cortex of 11-month-old wildtype (WT-
11), 11-month-old 3xTg (3XTg-11), and 18-month-old 3xTg (3XTg-18) mice. For each panel, 
images on the right are high magnification micrographs of a region corresponding to the boxed 
area. Scales bars; in C,F = 200µm (inset = 40 µm), in D = 300 µm (inset = 60 µm), in E= 350 
µm (inset = 40 µm). Abbreviations: SVZ (subventricular zone), DG (dentate gyrus), MCL 
(mitral cell layer). 
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Figure 2 
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Figure 2. Proliferation, neurogenesis and survival of newly born cells are all reduced in the 
dentate gyrus of the 3xTg hippocampus.  
(A-C) Immunoreactivity for the proliferative marker Ki67 in 11-month-old A, wildtype (WT-11) 
and B, 3xTg (3XTg-11) mice. Insets show higher magnification of cells indicated with arrows. 
C, Number of Ki67(+) cells/section of the hippocampus quantified from each group. (D-F) 
Fluorescence immunohistochemistry for the neuroblast marker DCX in 11-month-old D, 
wildtype (WT-11) and E, 3xTg (3XTg-11) mice. Nuclei are counterstained with Hoechst 33342. 
F, Number of DCX(+) cells/section of dentate gyrus quantified from each 11-month-old and 18-
month-old group. (G-I) Immunoreactivity for 21 day BrdU-retaining cells in 11-month-old G, 
wildtype (WT-11) and H, 3xTg (3XTg-11) mice. I, Number of Ki67(+) cells quantified from 
each section. In all panels, arrows indicate positive cells. Statistical analysis was performed on 
the average number of cells/section/animal for each group. p≤0.05 (*), p≤0.01 (**), not 
significant (ns). Scale bar; in H = 60µm (for A-H).  
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Figure 3 
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Figure 3. Cell proliferation and neural progenitors are decreased in the 3xTg SVZ. 
(A-G) Immunoreactivity for the proliferative marker Ki67 and (H-L) the progenitor cell marker 
Mash-1 in the SVZ.  A, Low magnifications of Ki67 in 11-month-old wildtype (WT-11) B, 11-
month-old 3xTg (3XTg-11). (C-F) High magnifications of Ki67 in boxed area. (H-K) High 
magnifications of Mash-1 in boxed area. Note the reduced numbers of both Ki67(+) and Mash-
1(+) nuclei in the 3xTg mice at each age. G, Number of Ki67(+) cells quantified from each 
section. L, Number of Mash-1(+) cells quantified from each section. Statistical analysis was 
performed on the average number of cells/section/animal for each group. p≤0.05 (*), p≤0.01 
(**), not significant (ns). Scale bars; in B = 350 µm (for A,B), in K = 100µm (for C-F, H-K). 
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Figure 4 
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Figure 4.  Decreased numbers of 21 day BrdU-retaining cells in the SVZ and olfactory 
bulbs of 3xTg mice. 
(A-C) Fluorescence immunohistochemistry for 21-day BrdU-retaining cells in the SVZ of A, 11-
month-old wildtype (WT-11) and B, 11-month-old 3xTg (3XTg-11) mice. Arrowheads identify 
all BrdU-immunoreactive nuclei. C, Quantification of the number of BrdU(+) cells/section in 11- 
and 18- month old WT and 3xTg mice. (D-F) Immunohistochemistry for BrdU in the olfactory 
bulbs of D, WT-11 and E, 3xTg-11 mice, showing BrdU-immunoreactive nuclei distributed 
mainly within the internal granule cell layer. F, Quantification of the number of BrdU(+) 
cells/section of the olfactory bulb, showing a significant decrease in 11-months 3xTg mice 
compared to age-matched WT mice. Statistical analysis was performed on the average number of 
cells/section/animal for each group p≤0.05 (*), p≤0.01 (**), not significant (ns). Scale bars; in B 
= 350 µm (for A, B), in E = 350 µm (for D, E).  
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Figure 5 
 
 
  
 
 
 
 
104 
Figure 5.  Cytological alterations in the SVZ of 3xTg mice. 
Montages of the walls of the lateral ventricles were reconstructed from micrographs of 1 µm 
semi-thin sections from 18-month-old WT and 3xTg mice, as described in Materials and 
Methods. A, Schematic of the lateral ventricle with blue boxes representing where E and F are 
located and red box where G is located. The number of B, Ki67(+) cells, C, subependymal cells, 
and D, lipid droplets were quantified. (E-F) Note that 18-month-old 3xTg mice have significant 
reductions in the number of Ki67(+) cells and subependymal cells compared to age-matched 
controls. Also, while the number of ependymal cells is unchanged (not shown), there is a major 
increase in the appearance of large lipid droplets within the cytoplasm of ependymal cells. G, Oil 
Red O staining of lipid droplets on 40µm sections of SVZ. In E, open arrowhead identifies a 
representative ependymal cell, long arrow identifies a representative subependymal cell and short 
arrow identifies a representative Ki67(+) cell. Arrowheads in F indicate lipid droplets. Statistical 
analysis was performed on the average number of cells/ventricle/animal for each group.  P≤0.05 
(*). Scale bar; in G = 25µm (for E-G), inset in F = 5µm. Abbreviations: CC (corpus callosum), 
Str (Striatum), LV (lateral ventricle). 
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Figure 6 
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Figure 6.  Temporal and spatial localization of AD-associated neuropathologies.  
A, Schematic representation of APP cleavage and development of Aβ plaques. APP cleavage 
generates multiple intracellular and extracellular metabolites (AICD, P3, sAPP, Aβ). Under 
normal physiological conditions, APP is cleaved mainly by α-sec and γ-sec to generate sAPPα 
and P3 fragments. Under pathological conditions, APP is cleaved mainly by β-sec leading to the 
generation of sAPPβ, and PS1/γ-sec cleavage is upregulated which results in increased 
production of the soluble Aβ1-42 metabolite. With increasing time and concentration, Aβ1-42 
oligomerizes and eventually forms insoluble aggregates, resulting in amyloid plaque deposition. 
B, Biochemical detection of Aβ1-42 peptide by dot blot. Accumulation of Aβ1-42 is detected in 
the soluble protein fractions from the cortex (Ctx), hippocampus (Hipp), striatum (Str/SVZ) and 
olfactory bulbs (OB) of 11-month-old 3xTg mice but not WT mice. C, Schematic of 
time/pathology-associated tau hyperphosphorylation during development of neurofibrillary 
tangles.  AT8, AT180 and PHF-1 antibodies recognize phosphorylation-specific sites associated 
with early, intermediate and late stages of hyperphosphorylation, respectively. (D-F), 
Biochemical detection of tau hyperphosphorylation status by Western blotting. The soluble 
fractions from the cortex, hippocampus, striatum and olfactory bulbs of 11-month-old wildtype 
(WT) and 3xTg mice were probed with D, AT8 and E, AT180 antibodies. Note that AT8 gave an 
expected band at approximately 50 KDa as well as an approximately 17 KDa fragment. AT180 
yielded bands at approximately 55 and 60 KDa. Both AT8 and AT180 were increased most 
strongly in the hippocampus. Densitometry quantifications are reported in Results. F, The 
insoluble fraction of hippocampal protein lysates were probed with the phosphorylation-
independent tau antibody, HT7. Note the appearance of a strong, 3xTg-specific band just below 
50 KDa. (G-K) Detection of tau hyperphosphorylation in the hippocampus by fluorescence 
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immunohistochemistry. In the CA1 layer of the hippocampus of 11- and 18-month-old mice, 
immunoreactivity specific to 3xTg mice was detected for G, AT8 and H, AT180. Note that 
somatodendritic accumulation of AT8 was highest at 11 months, while AT180 was highest at 18 
months. I, Rare CA1 cells immunoreactive for PHF-1 were observed solely in the 18-month 
3xTg mice. (J-K) In the dentate gyrus of the hippocampus, neurons immunoreactive for J, AT8 
and K, AT180 were present in the hilus of 11-month-old 3xTg mice (arrowheads). At 18 months, 
occasional AT180(+) neurons in the outer granule cell layer were also observed (arrow). Scale 
bars; in I,K = 60µm (for G-I), and (J,K) respectively. Abbreviations: AICD (APP intracellular 
domain), sAPP (soluble amyloid precursor protein), sec (secretase), GZ (granular zone). 
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Figure 7 
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Figure 7.  Summary of observations in the middle-aged 3xTg hippocampus and SVZ. 
Schematic representation of our findings in the hippocampus (A) and SVZ (B) of 11-month-old 
wildtype (WT-11) and 3xTg (3XTg-11) mice. A, In the CA1 layer of the hippocampus, there is 
abundant expression of the APP (yellow) and tau (HT7) transgenes in 3xTg pyramidal neurons 
including sub-populations of AT8(+) (light blue) and AT180(+) (dark blue), indicating they are 
at early to intermediate stages of tau pathology. In the DG, there are HT7(+) fibers and AT8(+) 
and AT180(+) cell bodies in the hilus of 3xTg mice. These pathological events in the CA1 and 
hilus are correlated with decreased numbers of proliferating cells (black nucleus/Ki67), 
neuroblasts (DCX) and 21-day label-retaining cells (green nucleus/BrdU) within the SGZ 
neurogenic niche when compared to 11-month-old controls. B, In the SVZ, 3xTg mice possess 
fewer total numbers of subependymal cells, including fewer total proliferating cells (black 
nucleus/Ki67), neuroblasts (DCX), neural progenitors (Mash-1) and activated/proliferative stem 
cells (label-retaining BrdU) when compared to the controls. The number of ependymal cells is 
unchanged, however in 3xTg mice they frequently contain large cytoplasmic lipid droplets (grey 
circles). No APP or tau transgene expression is present within the SVZ itself, but HT7(+) fibers 
are abundantly present in the parenchyma of the immediately adjacent striatum (purple fibers). 
Question marks indicate some potential routes through which AD-associated mutations and 
pathologies might affect the DG or SVZ neurogenic niches (see Discussion). Abbreviations: DG 
(dentate gyrus), SGZ (subgranular zone), GZ (granular zone), LV (lateral ventricle), Str 
(striatum), SE (subependyma), E (ependyma).  
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III.1 ABSTRACT 
Lipid metabolism is fundamental for brain development and function, but its roles in 
normal and pathological neural stem cell (NSC) regulation remain largely unexplored. Here, we 
uncover a novel fatty acid-mediated mechanism suppressing endogenous NSC activity in 
Alzheimer’s disease (AD). We found that postmortem AD brains and 3xTg-AD mice accumulate 
neutral lipids within ependymal cells, the main support cell of the forebrain NSC niche. Mass 
spectrometry and microarray analyses identified these lipids as oleic acid-enriched triglycerides 
that originate from niche-derived rather than peripheral lipid metabolism defects. In wild-type 
mice, locally increasing oleic acid was sufficient to recapitulate the AD-associated ependymal 
triglyceride phenotype, rapidly de-regulate the Akt-FoxO3 NSC preservation pathway, and 
inhibit NSC-mediated regenerative capacity. These studies support a novel pathogenic 
mechanism in which AD-induced perturbation of fatty acid metabolism within niche ependymal 
cells suppresses the homeostatic and regenerative functions of adult NSCs. 
 
Keywords: Alzheimer’s disease, stem cell, lipids, fatty acid, ependymal. 
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III.2 INTRODUCTION 
Preservation of stem cell activity within adult tissues is essential for maintaining tissue 
structure and function. In the brain, experimental inhibition of neural stem cell (NSC) activity 
leads to deficits in learning and memory, mood and stress regulation (Snyder et al., 2001; 
Imayoshi et al., 2008; Sakamoto et al., 2011; Sakamoto et al., 2014). In addition, following 
neural damage, NSC-derived progeny are re-directed to areas of degeneration, where they are 
involved in wound-healing and cell replacement, and can serve as a target for therapeutic 
manipulations (Kolb et al., 2007; de Chevigny et al., 2008; Erlandsson et al., 2011).  NSC 
activity decreases naturally during aging and is dysregulated in models of neurodegenerative 
diseases, suggesting an involvement in aging- and disease-associated cognitive deficits (Demars 
et al., 2010; Hamilton et al., 2010; Lazarov & Marr, 2010; Lazarov et al., 2010; Bouab et al., 
2011; Hamilton et al., 2013). Thus, dissecting the mechanisms involved in NSC dysregulation 
could provide new opportunities for preventive and regenerative therapeutic strategies for 
neurodegeneration. 
Within the lateral ventricle subventricular zone, NSCs are ideally positioned to be 
regulated by environmental signals. Systemic signals reach NSCs via their contacts with the 
cerebrospinal fluid (CSF) and SVZ blood vessels (Mirzadeh et al., 2008; Tavazoie et al., 2008; 
Codega et al., 2014). A major source of local signals are the adjacent ependymal cells, which 
constitute approximately 25% of cells within this NSC niche (Doetsch et al., 1997) and surround 
NSCs in pinwheel structures within the walls of the lateral ventricles (Mirzadeh et al., 2008). 
Ependymal cells provide a critical barrier mediating the exchange of ions, macromolecules and 
immune cells between the brain and the circulating CSF, secrete a variety of molecules that 
regulate NSC activity, and have recently been identified as a site of lipid synthesis and storage 
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(Hamilton et al., 2010; Bouab et al., 2011; Etschmaier et al., 2011). Recently, lipids have gained 
attention in the regulation of NSC behavior. Lipid metabolism genes were shown to be among 
the major classes of transcriptional differences between quiescent and activated NSCs (Codega et 
al., 2014). Moreover, brain fatty acid metabolism is required for hippocampal neurogenesis 
(Matsumata et al., 2012; Chorna et al., 2013; Knobloch et al., 2013) and exercise-induced 
cognitive enhancement (Chorna et al., 2013).  
Interestingly, Alzheimer’s disease (AD) is associated with declines in both neurogenesis-
regulated cognitive processes and aberrations in lipid metabolism. Indeed, lipid accumulations 
were one of the five original AD-associated tissue pathologies first reported by Alois Alzheimer 
himself (Alzheimer, 1907). More recently, links have strengthened between aberrant lipid 
metabolism and neurodegeneration in AD (Fraser et al., 2010; Astarita et al., 2011; 
Podtelezhnikov et al., 2011; Tanzi, 2012; Hussain et al., 2013), while epidemiological studies 
have demonstrated that AD risk factors include peripheral metabolic conditions such as insulin 
resistance, obesity and dyslipidemia (reviewed in (Pasinetti & Eberstein, 2008)). However, 
deeper mechanistic insights into the role of abnormal lipid metabolism in AD have been hindered 
by the technical complexity involved with localizing, identifying, and determining the biological 
functions of individual lipid species in the brain.  
 In the present study, we developed novel methodologies to overcome these 
limitations, allowing us to uncover a new pathological mechanism in AD. Our results reveal that 
lipid metabolism defects originating within a major neurogenic niche can disrupt NSC-mediated 
regeneration and plasticity. 
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III.3 MATERIAL AND METHODS 
III.3.1 Human specimens 
Tissue samples were obtained from the human brain bank of the Centre de recherche de 
l’Institut universitaire en santé mentale de Québec, which required informed consent before 
donation. Experiments were conducted in accordance with the Ethics Committee at the Institut 
universitaire en santé mentale de Québec. 
III.3.2 Mice 
Experiments were conducted in accordance with the guidelines of the Canadian Council 
of Animal Care and were approved by the institutional animal care committee of the University 
of Montreal and the CRCHUM. Experiments were performed using either male C57BL6 mice 
(Charles River) or female 3xTg-AD mice and strain controls (below). 
 
3xTg-AD mice and strain controls. The generation of the 3xTg-AD mice has been 
described previously (Oddo et al., 2003a). Briefly, 3xTg-AD mice were originally derived by co-
microinjecting two independent transgenes encoding human APPSwe and the human tauP301L 
(both under control of the neuron-specific mouse Thy1.2 regulatory element) into single-cell 
embryos harvested from homozygous mutant PS1M146V knock in (PS1-KI) mice. Wildtype mice 
are the PS1-knock-in mice background strain, a product of a cross between C57BL/6J females 
(B6) and 129S1/SvImJ males (129S). Ages are specified in figure legends. All mice were kept in 
identical housing conditions and given free access to a standard rodent diet (#2018, Harlan 
Teklad) and water.  
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III.3.3 Tissue fixation and processing 
Mouse 
Mice received a lethal dose of ketamine (Bimeda-MTC)/xylazine (Bayer 
Healthcare)/acepromazine (Boehringer Ingelheim Canada Ltd) and were then perfused 
transcardially with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde pH 7.4. 
The brains were removed and postfixed in 4% paraformaldehyde for 24 h. The entire forebrain 
and hippocampus of each animal was cut into 40 µm coronal sections using a vibrating 
microtome (Leica VT1000S) and the tissue sections were stored at -20°C in an antifreeze 
solution (glycerol:ethylene glycol:PBS, 3:3:4) until use. 
 
Human  
Human brains were sliced into 0.5 cm-thick slabs that were fixed by immersion with 4% 
PFA in 0.1 M PB (pH 7.4) for 48 h. The slabs containing the striatum were stored at 4°C in 0.1 
M PBS (pH 7.4) with 15% sucrose and 0.1% sodium azide. They were then cut into 50 µm-thick 
coronal sections using a freezing microtome and the tissue sections were stored at -20°C in an 
antifreeze solution (glycerol:ethylene glycol:PB, 3:3:4) until use. 
 
III.3.4 SVZ microdissections 
Microdissected SVZs were obtained from freshly dissected adult mouse brains as 
follows. A 2-mm-thick coronal section through the forebrain (corresponding to the region 
between 3 and 5 mm posterior to the anterior edge of the olfactory bulbs) was cut in a coronal 
mouse brain mold. Using a dissecting microscope, a fine-tipped tungsten needle was used to 
dissect out a block of SVZ tissue, by first making lateral cuts through the corpus callosum 
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(dorsally) and above the anterior commissures (ventrally), and then tracing the gray-white 
boundaries at the SVZ/ striatum and SVZ/septum borders. A block of striatal tissue of similar 
size was cut from the center of the adjacent striatum for biochemical comparison and to provide 
a control for SVZ microdissection purity. 
 
III.3.5 In vivo surgical procedures 
Intracerebroventricular osmotic pumps. For intracerebroventricular infusions, mice 
were locally injected with buprivacaine (Hospira) and operated under isoflurane anesthesia 
(Baxter). Cannulae attached to 7 day Alzet osmotic pumps (0.5 µl/h infusion rate, model 1007D; 
Durect), were stereotaxically implanted at 0.0mm anteroposterior and 0.9mm lateral to Bregma 
according to manufacturer`s instructions. Pumps contained either Vehicle (fatty acid-free bovine 
serum albumin, as above), 10 mM 12C-oleic acid conjugated to Vehicle, or 10mM 13C-oleic acid 
conjugated to Vehicle (the latter for metabolic labeling studies). 
 
SVZ regeneration assay. Assay was performed based on Doetsch et al. (Doetsch et al., 
1999b). 2% Cytosine b-D-arabinofuranoside hydrochloride (AraC) (Sigma) was dissolved in 
either vehicle (FAF BSA) or 500µM Oleic acid conjugated to FAF-BSA (as above) and was 
infused using 7 day osmotic pumps (as above).  Pumps were excised from the mice 6 days after 
implantation and the mice were perfused for tissue analysis 24 hours later.  
 
Acute intracerebroventricular injections. A 10 µl Hamilton syringe (26s/2”/2) 
(Hamilton Company) was used to perform stereotaxic injections into the lateral ventricle of 
C57BL6 mice (0.0mm anteroposterior and 0.9mm lateral to Bregma with a depth of -1.5mm 
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below the skull). 2µl of Vehicle or 500µM oleic acid was slowly injected (1µl/min) into the 
lateral ventricle. With an approximate CSF volume of 8µl, the effective oleic acid concentration 
is thus estimated at 100 µM, matching the in vitro conditions. Mice were sacrificed 4 hours post-
injection, ipsilateral and contralateral SVZs and their respectively striata were microdissected, 
lysed and then run for Western blotting (as below). 
 
Extraction of cerebrospinal fluid and plasma. 7-month wild-type and 3xTg-AD mice 
were used for isolation of both cerebrospinal fluid (CSF) and blood plasma. CSF was extracted 
from the cisterna magna of anaesthetized mice using a pulled glass capillary tube. Approximately 
5-7 microliters were obtained from each mouse. Blood samples were collected from the posterior 
vena cava. Interval between anaethesia injection and blood collection was approximately 5 
minutes. Blood samples were transferred to a microtainer containing K2EDTA (BD Biosciences) 
inverted 20 times, and the plasma extracted after centrifuging at 1000 g for 15 minutes at 4°C. 
All samples were stored at −80°C until lipid extraction. 
 
III.3.6 Oil Red O staining 
40 µm (mice) and 50 µm (human) coronal floating sections were washed with 60% 2-
propanol (Fisher), incubated in 0.3% Oil Red O (Allied Chemical) for 10 minutes, then rinsed in 
60% 2-propanol followed by once with distilled H2O. 
 
III.3.7 Electron microscopy  
40 µm coronal sections through the SVZ from WT and 3xTg-AD mice (n=3/group) were 
rinsed in phosphate buffer, fixed with 1% osmic acid (Electron Microscopy Science) for 30 
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minutes, dehydrated in a graded series of ethanols and propylene oxide (Fisher) and then 
embedded in electron microscopy grade Resin (Durcupan ACM, Sigma). Resin-embedded 
sections were mounted on the tip of a resin block for sectioning. Ultrathin sections were cut with 
an ultramicrotome (Reichert Ultracut S; Leica Canada), collected on bare square-meshed copper 
grids, stained with uranyl acetate and lead citrate, and examined with an electron microscope 
(Philips CM100; FEI) 
 
Quantification of lipid droplet containing SVZ cells. At least 50 ependymal (cells 
contacting the ventricle with a very light nucleus, and possessing cilia) and 50 non-ependymal 
cells (cells under the ependymal cells, absence of cilia) were evaluated from each mouse 
(n=3/condition). The quantifications were done directly on the electron microscope, for the 
presence of lipid droplet within the cells. Electron micrographs were obtained using an AMT 
digital camera.  
 
III.3.8 Laser desorption-ionization imaging mass spectrometry (IMS) 
Tissue coating. Silver and gold were deposited over the tissues sections following 
previously published protocols with the following changes (Thomas et al., 2012; Dufresne et al., 
2013). For silver deposition, tissue sections were mounted on a silver pre-coated microscope 
slide (50 nm thick silver layer) and subsequently received a 14±2 nm thick silver layer by 
sputtering. For gold deposition, tissue sections were mounted on an Indium-Tin-Oxide 
microscope slide (Delta Technologies, Stillwater, MN) and coated with a 28±3 nm thick layer of 
gold deposited by sputtering. Matrix deposition was carried out in a sublimation apparatus 
(Chemglass Life Science, Vineland, NJ) as previously described (Chaurand et al., 2011). For 
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DAN, sublimation protocol was optimized for a fixed vacuum of 5 × 10−2 Torr monitoring 
temperature, time of application, and matrix deposited amounts measured with a high-precision 
balance to ensure the best MALDI IMS efficiency (Thomas et al., 2012). 
Mass spectrometry. IMS, MS and MS/MS spectra acquisition were performed on either a 
MALDI TOF/TOF Ultraflextreme mass spectrometer or a SolariX XR 7T FT-ICR mass 
spectrometer both equipped with SmartBeam II Nd:YAG/355 nm laser (Bruker Daltonics, 
Billerica, MA). For TOF MS analyses: profiling MS data were acquired by summing 10 times 
250 laser shots from the selected tissue sections. IMS data were acquired under delayed 
extraction conditions and in reflectron geometry using 250 shots per pixel at 10 µm lateral 
resolution with a spectral resolution of 15,000 at m/z 881. For LDI analysis, the laser energy was 
set in the same range as for conventional MALDI experiments providing a few micro joules of 
energy on target. Acceleration voltage was set to 25 kV and all other instrumental parameters 
were optimized for maximum signal to noise ratio. Lipid characterization was performed by 
comparing accurate mass measurements (less than 10 ppm) with the LIPID MAPS prediction 
tool (http://www.lipidmaps.org/.html) and confirmed by MS/MS measurements acquired in 
LIFT-TOF/TOF. MS and MS/MS data were processed using flexAnalysis v3.4 software. IMS 
data were recalibrated after acquisition with flexAnalysis Batch Process v3.4 software using the 
silver/gold clusters as internal mass standards. IMS data were reconstructed and visualized using 
flexImaging v4.0 software. 
For FT-ICR analyses: profiling MS data were acquired by summing 10 times 100 laser 
shots from the selected tissue sections with a spectral resolution of 500,000 at m/z 881. IMS data 
were acquired using 100 shots per pixel using a 10 µm lateral resolution and with a spectral 
resolution of 50,000 at m/z 881. Lipid characterization was performed by comparing accurate 
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mass measurements (less than 1 ppm) with the LIPID MAPS prediction tool 
(http://www.lipidmaps.org/.html) and confirmed by MS/MS using CID fragmentation mode 
according to previously described methods (Cheng et al., 1998). All the data MS and MS/MS 
data were processed using DataAnalysis v3.4 software. IMS data were reconstructed and 
visualized with flexImaging v4.0 software. 
 
III.3.9 Liquid chromatography-mass spectrometry (LC-MS) 
Methyl-tert-butyl ether Lipid extraction. Plasma and cerebrospinal fluid lipid extraction 
was performed according to (Matyash et al., 2008). Briefly, 200 µl of MS-grade methanol 
containing internal standards IS 2, 3, 4, 5, used to follow each class of lipid through the lipid 
extraction protocol (Figure S2B), was added to a 20 µl plasma or 5µl CSF aliquots, placed into 
glass tubes with Teflon-lined caps, and vortexed. One ml of Methyl tert-butyl ether (MTBE, 
Fisher) was added and the mixture was incubated for 1 h at room temperature in a shaker. Phase 
separation was induced by adding 250 µl of MS-grade water (Fisher). After 10 min of incubation 
at room temperature, the sample was centrifuged at 1,000 g for 10 min, the upper (organic) phase 
was collected, and the lower phase was re-extracted with 2 ml of the solvent mixture 
(MTBE/methanol/water 10:3:2.5, v/v/v). Combined organic phases were dried under a nitrogen 
stream.  Extracted lipids were re-solubilized in 300 µl (plasma) or 100µl (CSF) of MS-grade 2-
propanol (Fisher) containing IS1.   
 
LC-MS. LC-MS separations were carried out on a Synapt G2-S instrument coupled to an 
Acquity UPLC Class I system (both from Waters). Elution was performed at 550 µL/min on a 
CSH C18, 1.7 um, 2.1 x 75 mm chromatographic column maintained at 65oC. The eluents 
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consisted of 10 mM Ammonium Formate, 0.1% formic acid and 40 % acetonitrile in water 
(eluent A) and 10 mM Ammonium Formate, 0.1% formic acid, 10% acetonitrile and 90% 2-
propanol (eluent B). The initial mobile phase contained 15% B and was maintained for 0.2 min 
in the beginning of the run. The following gradient elution was then applied: 15 to 30% B from 
0.2 to 2 min; 30 to 50% B from 2 to 2.5 min; 50 to 80% B from 2.5 to 11 min; 80 to 99% B from 
11 to 11.5 min; hold at 99% B for 0.9 min. Eluent B was then decreased from 99 to 15% in 0.1 
min and held constant for up to 16 min to permit column equilibration. The auto-sampler was 
maintained at 10oC to avoid sample degradation. The injection volume of the plasma extracts 
was 1 µL and 2 µL for analyses in positive and negative mode respectively. Aliquots of 5 µL 
were injected from CSF extracts for positive mode analysis and 6 µL of pooled triplicate 
extractions that were 3-fold concentrated were injected for negative mode. Injections were 
randomized in order to diminish potential instrument bias during the acquisition. The 
electrospray interface was operated either in positive or negative ion mode. Mass spectra were 
acquired in MSe mode from m/z 100 to 1200 with a scan time of 0.3 s. Collision energy ramps of 
20 to 35 V and 20 to 45 V were applied in the trap and transfer cells respectively. Leucine 
encephalin was used in the lock-spray every 10 s for accurate mass correction. MassLynx was 
used for instrument control and data acquisition while TargetLynx and MetaboLynx were used 
for data processing. Injection list was as described in Figure S2A. Quality control Internal 
standard (1) was used to ensure the reproducibility of sample injections in the MS (Figure S2). 
Graphs of normalized peak area were achieved by normalizing the extracted ion counts for each 
m/z peak area to the volume of sample injected and then multiplying by initial sample dilution 
ratio. 
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III.3.10 Microarray 
RNA was isolated from snap-frozen SVZ microdissections using the RNeasy mini 
microarray kit as per manufacturer’s instructions (Qiagen). For each sample, 5µg of RNA was 
reverse transcribed using Superscript II reverse transcriptase. The cDNA was purified using 
Qiagen PCR purification column as per the manufacturer’s protocol. Following purification, 1 µg 
of purified cDNA (in a total volume of 40 µl) was mixed with 40 µl of 5' Cy3 labeled random 
nonamers (Trilink Biotechnology) and heated at 95°C for 10 minutes and snap cooled in 
ice/water slurry for 10 minutes. The samples were then mixed with 10 µl of 10mM dNTP mix, 8 
µl of water and 2 µl of Klenow fragment (3'to 5' exo-) (NEB) and incubated at 37ºC for 2 hours. 
The labeling reaction was stopped by adding 10 µl 0.5M EDTA and then isopropanol 
precipitated with the addition of 11 µl 5M NaCl. The labeled DNA was resuspended in 40 µL 
water and quantified using a Nanodrop. Following quantification, 4 µg of labeled material was 
dried by Speedvac and resuspended in a total of 3.3 µl of tracking control solution. 
Hybridizations were carried out using the SurePrint G3 Mouse GE 8x60K Microarray (Agilent 
Technologies) containing probes targeting 39,430 Entre Gene RNAs and 16,251 lincRNAs. 
Arrays were scanned at 5µm resolution using a GenePix4000B scanner (Molecular Devices). 
Data from scanned images were extracted using GenePix 6.1 (Axon). Chip annotations file was 
updated to a more recent version (20130207).   Expression data was analyzed using 
Bioconductor packages (http://www.bioconductor.org/) and R statistical language (www.r-
project.org). Bioconductor limma (Smyth et al., 2005) package was used to background correct, 
log2-transform, aggregate and quantile-normalize the median probe intensities.  Probe intensities 
were averaged when more than one probe was associated with a given probe identifier. The 
resulting matrix showing 55,681 probes as rows and 8 samples as columns was filtered to 
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exclude lincRNA entries and probes in intensities below background in more than half of the 
samples. 32,684 probes were used as input for linear modeling using the method available in 
limma which uses a moderated t-statistic to assess significance. A 3xTg-AD vs WT in 7 months 
was evaluated and probes presenting a p-value lower than 0.005 and a fold-change greater than 
1.4 or lower than –1.4 were considered for further analysis. Enrichment analysis was performed 
using the Database for Annotation, Visualization and Integrated Discovery (DAVID, 
http://david.abcc.ncifcrf.gov/) (Huang da et al., 2009a; Huang da et al., 2009b) and through the 
use of Ingenuity Pathways Analysis (IPA) (Ingenuity Systems, www.ingenuity.com).  High-level 
and low-level categories resulting from the IPA Functional Analysis were manually curated.  In 
addition to manual curation of the gene lists, IPA results and manufacturer Gene Ontology 
annotations, the Bioconductor R package GO.db 2.9 (20130302) (Carlson) were used to retrieve 
genes involved in lipid-related activities.   
	  
III.3.11 Neurosphere assays  
Neurospheres were generated according to a procedure modified from Reynolds and 
Weiss (Reynolds & Weiss, 1992). 2 month-old C57BL6 mice were euthanized using 
ketamine/xylazine/acepromazine. Both SVZs, including their associated striata were dissected 
into ice cold HBSS (Wisent), dissociated to single cells using papain (Worthington), diluted to 
30 ml in DMEM/F-12 (3:1; both from Invitrogen) supplemented with 2% B27 (Invitrogen), 
1µg/ml fungizone (Invitrogen), 1% penicillin/streptomycin (Wisent) and 20 ng/ml EGF (Sigma) 
and seeded in 75cm2 flasks to generate primary neurospheres. To generate secondary 
neurospheres, primary neurospheres were mechanically dissociated and re-seeded at 1.5cells/µl 
in 24 well plates in the same media as above. 
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Preparation and treatment with oleic acid-albumin complexes. Fatty acid-free bovine 
serum albumin (FAF-BSA) (Bioshop) was dissolved in 0.1M Tris-HCl pH 8.0. Oleic acid (OA) 
(Sigma) was conjugated to FAF-BSA at a molar ratio of 5:1. A 10mM stock solution was 
sterilized by filtration and used for subsequent working dilutions. OA was added to newly 
dissociated primary neurospheres at the concentrations indicated and with a final dilution volume 
of < 0.01%. Concentration range was selected based on dose responses analyses. Fatty acid-free 
BSA was used as the vehicle control at equal final volumes. To test the effect on neurosphere 
initiation, OA was added on the day of plating. To test the effect on neurosphere growth OA was 
added four days post-plating. Neurosphere number and diameter were quantified after 10-13 d in 
vitro. 
 
Self-renewal assay. Dissociated primary neurospheres were grown into secondary 
neurospheres in the presence of Vehicle, 50µM or 100µM oleic acid for 10-14 days (as above) 
(n=6 experiments). 60 secondary neurospheres (diameter approximately 200 µm) were then 
handpicked from each condition using a micropipette and in inverted microscope (4X total 
magnification) and transferred to a 1.5 mL tube, dissociated for 5 minutes, the cell density 
determined by using a hemocytometer, and the cells re-plated at 1.5 cells/µl in regular 
proliferation media (as above). After 7 days tertiary neurospheres were counted and measured. 
Self-renewal capacity was determined by normalizing the neurosphere number to the 
neurosphere cell density. To estimate the number of neural stem cells within each neurosphere, 
the normalized number was divided by the number of cells (12 000) and the neurospheres (60) 
plated. 
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TUNEL and proliferation assay. To assess proliferation and cell death, dissociated 
neurospheres were plated in proliferation media (as above with addition of 1% Fetal bovine 
serum) containing either Vehicle, 50µM or 100µM of oleic acid onto poly-L-lysine coated 
chamber slides at a density of 25 000cells/cm2 for 2 days. Standard immunocytochemistry was 
performed for Ki67 (as above). The TUNEL assay for cell death was performed following the 
secondary antibody step and according to manufacturer’s instructions (Roche) with omission of 
the dUTP enzyme as a negative control and addition of DNAse (Sigma) as a positive control. 
	  
Carboxyfluorescein Diacetate, Succinimidyl Ester (CFSE) cell division assay. To assess 
proliferation, dissociated neurospheres were treated with 1µM CSFE (Life technology) at 1 
million cells/ml for 8 minutes at 37°C. The reaction was quenched with 100% FBS and washed 
with PBS and DMEM/F-12 (3:1; both from Invitrogen). Labeled cells were subsequently plated 
onto poly-L-lysine coated dishes at a density of 12 500cells/cm2 in proliferation media (as above 
with addition of 1% Fetal bovine serum) containing either Vehicle, 50µM or 100µM of oleic acid 
or differentiation media (as above with omission of EGF) for 3 days. The cells were then 
harvested, washed and run on an LSRII cytometer (BD Biosciences), and data analysis was 
performed using FlowJo v7.6.5 (Tree Star). 
 
III.3.12 Immunohistochemistry  
Immunohistochemical procedures were performed as detailed previously (Gregoire et al., 
2014). Mouse anti-human Ki67 was used at 1:100 (BD Biosciences). For brightfield 
immunohistochemistry, primary antibodies were detected using species-appropriate biotinylated 
secondary antibodies (Jackson ImmunoResearch), the signal was amplified using the avidin-
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biotin-peroxidase system (VectaStain ABC Kit, Vector Laboratories), and revealed using a 3,3-
diaminobenzidine (DAB)-containing solution (Sigma). Microscopy was performed using a 
motorized Olympus IX81 microscope.  
 
Quantifications of immunohistochemistry. All quantifications were performed on coded 
slides by a blinded experimenter. For quantification of markers expressed by SVZ and dentate 
gyrus cell populations, 4-6 ventricles from sections at 120 µm intervals through the striatal SVZ 
or dentate gyrus were quantified. Counts were limited to the subventricular zone and subgranular 
zone respectively and both the left and right hemispheres were included.  
	  
III.3.13 Western blotting 
Western blotting was performed as previously described (Hamilton et al., 2010). The 
following antibodies were used: phospho-AKT (Ser473) (1:1000, Cell Signaling), phospho-
FoxO1(Thr24)/3a (Thr32)/4 (Thr28)(1:1000, Cell Signaling), phosphoFoxO3a 
(Ser318/321)(1:1000, Cell Signaling), beta-actin (1:20 000, Abcam). HRP-conjugated secondary 
antibodies, were used at following dilutions: anti-mouse IgG (1:5000, Bio Rad) or anti-rabbit IgG 
(1:5000, Millipore). Secondary antibodies were detected using the Clarity (Bio-Rad) and 
ChemiDoc (Bio-Rad). Quantitative densitometry of bands was performed using Image Lab 
version 4.1 (Bio-Rad).   
 
III.3.14 Statistical Analyses 
All statistical analyses were achieved using GraphPad Prism, Version 5.02 (GraphPad 
Software, Inc). Statistical analysis used a two-tailed unpaired or paired Student’s t-test and as 
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indicated in figure legends. Error bars represent mean ± standard error of the mean (SEM). 
Significance level was set at p ≤ 0.05. 
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III.4 RESULTS 
III.4.1 AD-associated suppression of neurogenesis coincides spatially and temporally with 
aberrant triglyceride accumulations within ependymal cells of the subventricular zone NSC 
niche 
  
The triple-transgenic AD (3xTg-AD) mouse is a unique AD model that undergoes an 
age-related accumulation of both amyloid plaques and neurofibrillary tangle pathologies, closely 
resembling the AD microenvironment (Oddo et al., 2003a). We have previously shown that 
NSC-derived neurogenesis is suppressed in 3xTg-AD mice at both 11- and 18-months of age, 
and that this suppression occurs prior to appearance of the amyloid plaques and neurofibrillary 
tangles, suggesting that other mechanisms are involved (Hamilton et al., 2010). By examining 
younger ages, we found that 5-month old 3xTg-AD mice already have a significant suppression 
of Ki67-positive proliferating cells in the subventricular zone (SVZ) (Figure 1A,C) and dentate 
gyrus (Figure 1D) NSC niches. Notably, we discovered that this suppression occurred 
concomitant to a specific accumulation of Oil Red O (ORO)-positive neutral lipid droplets along 
the brain-CSF barrier, including the forebrain subventricular zone (SVZ) NSC niche (Figure 1B). 
Electron microscopy of the SVZ niche revealed that lipid droplets were found uniquely in 
ependymal cells of the brain-CSF barrier and did not accumulate in the sub-ependymal 
populations of neural precursors themselves (Figure 1E,F). ORO-positive lipid droplets 
continued increasing with age in ventricular zones along the entire anterior-posterior axis of 
3xTg-AD mice; however, even at 11 months of age, they were never detected outside of the 
ventricular zone in control or 3xTg-AD mice (Figure 1G,H), identifying the brain-CSF barrier as 
a novel and selective site of aberrant lipid metabolism.  
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We tested whether aberrant lipid accumulations are also found in human AD brain 
samples (Figure 1I,J). Remarkably, we found similar lipid accumulations along the lateral 
ventricles in post-mortem brain tissues from 9 AD patients (78.0 ± 2.89 years old) and 5 age-
matched cognitively normal individuals (79.6 ± 5.88 years old) (Figure 1I,J, Figure S1A,B and 
Table S1 for patient information). Four of the five controls presented sparse ORO staining of the 
ependymal layer along the majority of the ventricular wall (Figure 1I). In contrast, the majority 
of AD brains showed dense accumulations of ORO at the basal surface of the ependyma (Figure 
1J), with four of the nine presenting a mixture of dense and sparse areas (Figure S1A,B). 
Although it is not currently possible to prospectively identify AD patients during early 
adulthood, collectively, these mouse and human data suggest that AD-induced lipid 
accumulations are an early event in the disease. 
 
We next developed a novel Imaging Mass Spectrometry (IMS)-based lipidomics strategy 
that would allow us to identify the species of lipids accumulating within the SVZ niche. IMS is a 
unique form of mass spectrometry that employs laser desorption-ionization to collect mass 
spectra data at high-resolution intervals across a tissue section, thereby revealing the spatial 
distribution of individual biomolecules within the unperturbed tissue architecture. IMS revealed 
that lipid accumulations in the SVZ niche are selectively enriched in triglycerides. Twelve 
distinct triglycerides were found to be increased by 2- to 27- fold in the SVZ niche of 3xTg-AD 
mice compared to strain controls (Figure 1K). The four largest increases occurred in triglycerides 
having structures of 50:1, 52:2, 54:2, 54:3 (total carbons:unsaturations) (Figure 1L), and IMS ion 
density maps illustrated a specific enrichment of these triglycerides along the ventricular borders.  
(Figure 1M and Figure S1C).  
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Together, these data reveal a selective accumulation of triglycerides within the forebrain 
NSC niche in postmortem human AD brains and 3xTg-AD mice, and at least in 3xTg-AD mice, 
this accumulation coincides with impaired adult neurogenesis during early adulthood. 
 
III.4.2 AD-associated triglycerides accumulating in the SVZ niche are enriched in oleic acid 
and can be recapitulated in wild-type mice by intracerebroventricular oleic acid infusion 
 
Fatty acids can have varying effects on energy metabolism, intracellular and cell-cell 
signaling, gene expression and membrane properties. We therefore identified the constituent 
fatty acids of the accumulating ependymal triglycerides using tandem mass spectrometry. 
Sequential ionization of the three most increased triglycerides yielded predictions of oleic acid 
(18:1), palmitic acid (16:0), stearic acid (18:0), palmitoleic acid (16:1), eicosenoic acid (20:1) 
and eicosadienoic acid (20:2) side-chains in an approximately 7:5:3:1:1:1 ratio (Figure 2A). 
Interestingly, these fatty acids are closely related within a common fatty acid biosynthetic 
pathway (Figure 2B).  
 
Since oleic acid (OA) was the major fatty acid accumulating in the SVZ niche, we 
investigated the consequences of increasing local OA levels in the SVZ of wild-type mice. 
Remarkably, OA administration to wild-type mice for 7 days by direct intracerebroventricular 
(ICV) infusion resulted in formation of ORO-positive ependymal lipid droplets that closely 
resembled those of 3xTg-AD mice and human AD patients (Figure 2C,D). Moreover, IMS 
showed a concomitant increase in AD-associated triglycerides (Figure 2E). We therefore directly 
traced the incorporation of the infused OA by performing a more sensitive in vivo metabolic 
 
 
 
 
133 
labeling procedure that uses OA comprised entirely of heavy 13C (“13C OA”)(Figure 2F-H). 
Comparison of IMS spectra between 13C OA and regular 12C OA showed that OA infusion into 
wild-type mice is sufficient to generate virtually all the AD-associated triglycerides. For 
example, 13C OA shifted the triglyceride 50:1 by exactly 18.060 atomic units (incorporation of 1 
OA side-chain), the triglyceride 52:2 by 18.060 and 36.120 atomic units (incorporation of up to 2 
OA side-chains) (Figure 2F,G), the triglyceride 54:2 by 18.060 and 36.120 atomic units 
(incorporation of up to 2 OA side-chains) and the species 54:3 by 18.060, 36.120 and 54.180 
atomic units (incorporation of up to 3 OA side chains). Uptake of 13C OA into each of the 12 
AD-associated triglycerides is summarized in Figure 2H and shows that 11 of the 12 AD-
associated triglycerides are replicated in wild-type mice by ICV infusion of OA. These metabolic 
labeling experiments also demonstrated that OA at the brain-CSF barrier can be metabolized 
locally to generate longer chain and polyunsaturated fatty acids, as some AD-associated 
triglycerides contained 13C OA that had been elongated (56:4, 56:5), reduced (52:2, 52:3), 
saturated (52:2, 54:2) and/or desaturated (54:4, 56:4, 56:5). Thus, these in vivo metabolic 
labeling experiments reveal that elevation of a single fatty acid, OA, is sufficient to induce 
ependymal lipid droplet accumulation, and that locally increased OA can be metabolically 
processed to replicate the AD-associated triglyceride phenotype. 
 
III.4.3 AD-associated triglycerides and their component fatty acids originate from local 
rather than systemic sources  
 
As accumulating ependymal lipids may originate from multiple sources, we studied the 
plasma and CSF of 3xTg-AD mice using a liquid chromatography mass spectrometry (LC-MS)-
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based lipidomic approach (See Methods and Figure S2). Unexpectedly, concentrations of the 12 
AD-associated triglycerides and their associated free fatty acids were unchanged between 3xTg-
AD mice and their strain controls in both these circulating fluids (Figure 3A,B). Conversely, 
cholesterol was increased in the plasma (Figure S3E) but not within the SVZ (Figure S1D) of 
3xTg-AD mice, showing that central and peripheral lipid profiles are distinct. We therefore 
explored whether lipid metabolism was altered within the SVZ niche itself.  
 
Gene expression in the SVZ of 3xTg-AD versus control mice was compared using a 
55,681-probe genome-wide microarray, and revealed 993 significantly up- or down-regulated 
genes (fold change ≥ 1.4 and p≤0.005) (Figure 3C). Functional analysis of this dataset identified 
Cellular Metabolism (comprised of carbohydrate, nucleic acid, amino acid and lipid metabolism) 
as one of the top five significantly altered categories, along with neurogenesis-related categories 
such as Cognitive Function, Cell Cycle and Proliferation and Cellular Differentiation (Figure 3D 
and Table S2). Manual and database-mediated extraction of lipid-related genes revealed that 142 
of the 993 significantly modulated changes (= 14.3%) were lipid-related (Figure 3E, and Table 
S3), including genes implicated in various aspects of fatty acid metabolism (i.e., PLA2, SCD1, 
ELOVL7, FABP5, LIPIN2 and NPC1).  
 
Together, these data show that AD-associated triglycerides accumulating in SVZ 
ependymal cells are unlikely to originate in the periphery, and identify the SVZ niche itself as a 
novel site of AD-associated alterations in lipid metabolism gene expression. 
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III.4.4 Elevated oleic acid levels suppress NSC activation and the AKT-FoxO3a NSC 
preservation pathway in vitro and in vivo 
 
Although fatty acid synthesis is essential for maintaining high levels of NSC activity 
(Knobloch et al., 2013), little is known about the roles played by specific fatty acids in NSC 
regulation. We therefore investigated the biological impact that AD-associated increases in oleic 
acid within the SVZ niche have on NSC function.  
	  
We found that OA concentration is a critical determinant of NSC colony formation in in 
vitro neurosphere assays. Specifically, doubling the OA concentration was sufficient to convert it 
from a positive to a negative regulator of neurosphere number (Figure 4A-F and Figure S4A-D). 
Neural precursors exposed to elevated OA at the time of initial plating (when neurosphere 
growth requires NSC activation) generated 50% fewer neurosphere colonies (Figure 4A,B), 
while neural precursors exposed to the same OA concentration after 4 days in vitro (when 
neurosphere growth is driven by proliferation of progenitors) were unaffected (Figure 4C,D). 
Consistent with this data, neurosphere self-renewal assays showed that when OA and vehicle-
treated spheres of equal sizes were dissociated and re-plated under identical neurosphere-forming 
conditions, there were 20% fewer neurosphere-initiating NSCs in OA-treated neurospheres 
(Figure 4E,F). Flow cytometry and immunocytochemistry confirmed that 100µM OA inhibits 
division of a sub-population of neural precursors but does not have a generalized impact on 
either proliferation or cell death (Figure S4E-G). Thus, in vitro, OA selectively inhibits 
expansion of the NSC pool. 
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We then used a well-characterized SVZ regeneration model in order to evaluate whether 
excess OA can suppress NSC activation within the more complex in vivo environment. In this 
model, cytosine arabinoside (AraC) is used to eliminate the constitutively proliferating 
progenitor cells, leaving behind only NSCs that selectively repopulate the SVZ niche (Doetsch et 
al., 1999b). When OA was co-infused during AraC-induced depletion of proliferating SVZ cells, 
it significantly inhibited the NSC-mediated recovery of SVZ cell proliferation (Figure 4G-I). 
Interestingly, recovery of neural precursor proliferation also tended towards a decrease in the 
dentate gyrus, a NSC niche not in direct contact with ependymal cells, suggesting that lipid 
alterations at the brain-CSF barrier can penetrate deeper into the brain (Figure 4I). Thus, 
increased OA at the brain-CSF barrier can suppress NSC activation, adversely impacting their 
ability to maintain CNS homeostasis. 
 
Building on our microarray analysis, we performed an Ingenuity Pathway Analysis (IPA) 
to uncover critical stem cell regulatory pathways that are altered in 3xTg-AD mice. This 
highlighted multiple members of the FoxO family of transcription factors (FoxO4, FoxO1, 
FoxO3a) (Supplemental Table 3), which has been previously shown to control NSC self-renewal 
(Paik et al., 2009; Ro et al., 2013). Since FoxO3a in particular is necessary and sufficient for 
NSC preservation (Renault et al., 2009; Schmidt-Strassburger et al., 2012), we evaluated 
whether it is directly regulated by OA. In vitro, neural precursors treated with OA showed a 
rapid increase in phosphorylation of FoxO3a and its upstream kinase, AKT, within 2-4 hours 
(Figure 4J-L). Remarkably, a single ICV injection of OA into wild-type mice also induced rapid 
phosphorylation of the AKT-FoxO3a pathway within the ipsilateral SVZ, (Figure 4M-P) 
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corroborating the in vitro observations. Thus, locally increasing a single fatty acid, OA, is 
sufficient to dysregulate NSC signaling and activity.  
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III.5 DISCUSSION 
 
We identified lipid metabolism abnormalities within the adult NSC niche of AD mice and 
patients and used recently developed methodologies to dissect their impact on NSC activity. Our 
data reveal a novel mechanism of stem cell dysregulation in which adult NSC activity is 
suppressed via disease-induced perturbations of niche fatty acid metabolism.  
 
Previous studies have shown that brain fatty acid synthesis is required for hippocampal 
neurogenesis (Knobloch et al., 2013) and for exercise-induced neurogenesis and cognitive 
enhancement (Chorna et al., 2013). Conversely, alterations in lipid metabolism are associated 
with many cognitive disorders, including Huntington’s, Parkinson’s, Niemann-Pick’s and 
Alzheimer’s diseases (Sharon et al., 2003; Adibhatla & Hatcher, 2008; Martinez-Vicente et al., 
2010; Merlo et al., 2010; Guschina et al., 2011; de la Monte & Tong, 2014). However, the 
complexity of brain lipid identification and localization has presented a major obstacle to 
deciphering the role of specific brain lipids under normal and pathological conditions. Using 
novel imaging techniques, we identified a selective accumulation of 12 triglycerides enriched 
with oleic acid side chains in ependymal cells at the brain-CSF barrier. Oleic acid elevation was 
sufficient to not only recapitulate the AD-associated triglyceride profile, but also to selectively 
suppress NSC expansion in vitro, diminish NSC regenerative capacity in vivo, and disrupt the 
critical AKT-FoxO3 signaling pathway involved in long-term NSC preservation. Thus, like 
many other niche signals, specific fatty acids can influence NSC maintenance via regulation of 
NSC activation and quiescence. 
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A key mechanistic feature of our findings is that AD-associated lipid metabolism 
disturbances are particularly prominent in the ependymal niche cells that surround NSCs. Brain 
ependymal cells possess the structural and enzymatic characteristics necessary for protecting and 
processing a wide variety of molecules in the CSF, thus forming an important barrier at the 
brain-CSF interface. Interestingly, however, the aberrant accumulation of oleic acid-enriched 
triglycerides at the brain-CSF interface occurred in the absence of changes in circulating 
triglycerides or fatty acids and correlated with extensive changes in local lipid metabolism gene 
expression, suggesting that AD is, in part, a metabolic disease of the brain.  
 
Our data also raise a number of important questions. First, since aberrant ependymal lipid 
metabolism is observed in both AD patients and a genetic mouse model carrying three early 
onset dementia-causing genes, it will be important to determine how these genes regulate lipid 
metabolism within ependymal cells. It also remains to be determined whether peripheral lipid 
metabolism disturbances associated with insulin resistance, obesity and dyslipidemia (AD risk 
factors) can exacerbate local fatty acid-mediated mechanisms of NSC dysregulation. 
Interestingly, our data from the 3xTg-AD mouse model leads to a clear prediction that AD is 
associated with early onset lipid metabolism changes that suppress adult neurogenesis beginning 
in early adulthood; testing this prediction in humans awaits the development of diagnostic and 
imaging tools that can allow identification of pre-AD individuals and measurement of their in 
vivo neurogenesis and ependymal fatty acid levels.  
 
Collectively, this work shows that excessive levels of OA at the ependymal surface of the 
brain result in the deterioration of neurogenic niches in AD. Future work focused on fatty acid 
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metabolism at the brain-CSF barrier may lead to new therapeutic approaches to prevent cognitive 
decline and improve stem cell-mediated brain repair during AD. 
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III.6 FIGURES AND LEGENDS 
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Figure 1: Reduced neurogenesis in 3xTg-AD mice correlates with aberrant triglyceride 
accumulations within ependymal niche cells in the SVZ of AD mice and patients  
 (A-B) Ki67+ proliferating cells (A) and Oil Red O staining (B) in the SVZ niche of 5-
month old wild-type (WT) and 3xTg-AD mice. (C-D) Quantification of Ki67+ cells in the SVZ 
(C) and dentate gyrus (D) of WT (n=4) and 3xTg-AD (n=4) mice. (E-F) Representative electron 
micrographs (E) and quantifications (F) of lipid droplets in 3xTg-AD ependymal cells versus 
sub-ependymal cells (n=3 mice). (G-J) Oil red O staining of coronal sections containing the 
lateral (LV) and third ventricle (3V) of 11-month WT (G) and 3xTg-AD (H) mice, or (I-J) of 
transverse sections containing the lateral ventricle and the SVZ of normal individuals (CTRL) (I) 
and Alzheimer disease (AD) patients (J). Panels at right show representative higher 
magnification images. (K-M) Imaging mass spectrometry showing selective triglyceride 
accumulation surrounding the lateral ventricle of 5-month old 3xTg-AD mice. Structures (total 
carbons:unsaturations) of the 12 enriched triglycerides  with their associated total ion counts (K). 
Table of mass/charge (m/z) ratios and fold changes of the four most enriched triglycerides (50:1, 
52:2, 54:2, 54:3) (L) along with representative ion density maps (M). Scale bars in A, 100µm, in 
F, 1 µm and 2 µm respectively, in G (for G,H) and I (for I,J) 100µm and 10 µm respectively, in 
M 200µm. Error bars = mean±sem. Unpaired t-test * p≤0.05, ** p≤0.005, *** p≤0.0005.  
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Figure 2: Intracerebroventricular oleic acid infusion is sufficient to recapitulate the AD-
associated triglyceride phenotype in wild-type mice 
(A) Tandem mass spectrometry of the three major triglycerides (50:1, 52:2, 54:2) to 
identify their fatty acid side-chains. Shown is the fractionation pattern from the sodium-adducted 
triglyceride 50:1. Inset table summarizes the combined fractionation patterns of the three major 
triglycerides, showing a predominant enrichment of oleic acid (red). (B) Fatty acid biosynthesis 
pathway involved in the production and subsequent processing of oleic acid (18:1). Fatty acids 
identified as enriched in the 3xTg-AD SVZ are shown in red. Enzymes involved at each step are 
shown, and include the SCD, ELOVL and FASD gene families. (C-E) Intracerebroventricular 
(ICV) infusion of vehicle (C) or oleic acid (D) for 7 days, with boxed areas magnified at right. 
(E) Representative imaging mass spectrometry ion density maps following vehicle or oleic acid 
(OA) infusion, showing an AD-associated triglyceride that is induced by OA infusion. (F-H) 
Imaging mass spectrometry following metabolic labeling with 12C OA versus 13C OA (F), with 
sample ion density maps of 52:2 (G). Table summarizing the number of 13C OA chains 
incorporated into each AD-associated triglyceride (H). Scale bars in C (for C,D) 200µm and 
10µm respectively and in E and G 200µm. Error bars = mean ±sem. (*) in C-E denotes ipsilateral 
injection side. 
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Figure 3: Lipid metabolism is altered within the SVZ of 3xTg mice 
(A-B) LC-MS analysis of lipid species within plasma and CSF of WT (n=4) and 3xTg-
AD (n=4) mice. Normalized peak area for the four major AD-associated triglycerides (A) and 
their associated fatty acids (B) showing no significant differences. (C-E) Microarray of 
microdissected SVZs of 7-month old mice wild-type (n=4) and 3xTg-AD (n=4). Volcano plot 
(C). Ingenuity Pathway Analysis of differentially regulated categories, hand-curated into 
thematic categories (D). Heatmap of differentially regulated lipid-related genes, grouped 
hierarchically. Lipid-related genes were extracted from the list of 993 modulated genes manually 
and by cross-referencing with the Gene Ontology terms "lipid", "lipoprotein", "triglyceride" and 
"fatty acid" (E). Error bars = mean±sem. 
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Figure 4: Oleic acid inhibits neural stem cell activation in vitro and in vivo 
(A-D) Primary neurospheres from C57BL6 mice were dissociated and re-plated under 
neurosphere-forming conditions, and treated with either vehicle or oleic acid (50 or 100 µM) on 
the day of plating (D0, neural stem cell activation) (A,B), or four days later (D4, progenitor 
expansion) (C,D). (E,F) Neural stem cell self-renewal was assessed in dissociated secondary 
neurospheres plated in identical conditions after 10 days of continuous treatment with OA or 
Vehicle. Timeline is shown in (E), and neural stem cell number is quantified in (F). (G-I) 
Intracerebroventricular (ICV) infusion of oleic acid in vivo. Schematic of AraC SVZ 
regeneration assay (G) with quantification of Ki67+ proliferating cells in the SVZ (H) and 
dentate gyrus (DG)(I). (J-P) Acute regulation of the AKT-FoxO3a pathway by oleic acid in vitro 
(J-L) and in vivo (M-P). Dissociated primary neurospheres from C57BL6 mice were plated and 
grown in the presence of EGF for two days, acutely treated for 2 or 4 hours with either Vehicle 
or 100µM Oleic acid, and analyzed by Western Blotting. Shown is a representative western blot 
from one experiment (J), and densitometric quantifications for signals for phosphorylated AKT 
(pAKT) (K) and  phosphorylated FoxO3a (pFoxO3a) (L). Schematic of ICV injection of oleic 
acid (M). Western blotting for pAKT and pFoxO3a in lysates of ipsilateral SVZ microdissections 
4 hours following a single ICV injection of Vehicle or Oleic acid (N), quantified in (O, P). Error 
bars = mean ±sem. Unpaired t-test H, I, O, P or paired t-test B, D, F, K, L * p≤0.05, ** p≤0.005, 
*** p≤0.0005.  
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Supplemental Figure 1: Oil Red O-stained sections from remaining human brains and ion 
density maps of 8 additional AD-associated triglycerides.  
Oil Red O staining of sections from the remaining 2 control (CTRL) (A) and 6 
Alzheimer’s disease (AD) (B) brains. Representative ion density maps from imaging mass 
spectrometry of the eight additional triglycerides accumulating surrounding the lateral ventricle 
of 3xTg-AD mice (C). Ion density map for cholesterol (D). Structures represent (total 
carbons:unsaturations). Scale bars in A (for A, B) represent 100µm and in C and D represent 
200µm. 
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Supplemental Figure 2: Liquid chromatography mass spectrometry (LC-MS) sample list 
and internal standards.  
(A) Schematic of LC-MS sample injection list. The column was washed with 2-propanol 
(IPA) three times, followed by three quality controls (QC1, QC2, QC3 (human plasma 
mixtures)), followed by triplicates of each WT and 3xTg-AD plasma or cerebrospinal fluid 
sample, loaded in random order. (B) Table of internal standards used either during (2-5) or after 
(1) the plasma and CSF lipid extractions.  (C-D) Representative mass spectra of mass/charge 
800-1000 showing the triglyceride elution range with internal standard 5 at 857.8371 in plasma 
(C) and CSF (D). 
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Supplemental Figure 3: LC-MS detects all major lipid classes in both plasma and CSF 
samples.  
Representative chromatographs of plasma (A, C) and CSF (B, D). Positive mode showing 
the elution of lipid species phosphocholines (PC), phosphoethanolamines (PE), 
(phosphoinositols (PI), sphingomyelin (SM), cholesterol (Cho) and triglycerides (TG). Negative 
mode showing elution of free fatty acids (FFA), phosphocholines (PC), phosphoethanolamines 
(PE), (phosphoinositols (PI), sphingomyelin (SM). Cholesterol was only detected in plasma 
samples, and was increased in 3xTg mice (E). Error bars = mean ± sem. Unpaired t-test * 
p≤0.05. 
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Supplemental Figure 4: Neural precursors treated with oleic acid 
(A-D) Primary neurospheres from C57BL6 mice were dissociated and re-plated under 
neurosphere-forming conditions, and either treated with on the day of plating (D0, neural stem 
cell activation) (A, B) or four days later (D4, progenitor expansion) (C, D). Cells were treated 
with Vehicle (fatty acid-free bovine serum albumin) or 50µM or 100µM oleic acid conjugated to 
the Vehicle. Representative micrographs of neurospheres treated on D0 (A) and their sizes (B) 
and treated on D4 (C) and their sizes (D). (E-G) Dissociated primary neurospheres from C57BL6 
mice plated in the presence of EGF and treated on the day of plating with Vehicle (fatty acid-free 
bovine serum albumin) or 50µM or 100µM oleic acid conjugated to the Vehicle for 2-3 days. 
Quantification by flow cytometry of Carboxyfluorescein Diacetate, Succinimidyl Ester (CFSE), 
a cell division assay (E), shows a 7-9% increase in CFSE retention in response to 100 µM oleic 
acid, indicating that OA does not have a generalized effect on neural precursor division, but 
inhibits the proliferation of a small sub-population (representative example from 3 independent 
experiments). As a positive control, cells were differentiated without EGF. Quantification of 
immunocytochemistry experiments for Ki67 (proliferation) (F) and TUNEL (cell death) (G), 
expressed as percentage of Hoechst-positive nuclei, showing that there is no significant change 
in the overall number of cycling or dying cells. Scale bar in A) (for A,B) represents 200um. Data 
from 3 independent experiments. 
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Supplementary Table 1: Patient information for human brains.  
Table of patient and pathology data (A). Braak staging refers to methods used to classify 
the degree of pathology in diagnosed AD patients. N/D: not determined, N/A: not available. 
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IV.1 NEUROGENESIS IN ALZHEIMER’S DISEASE 
 
The aim of this thesis work was to uncover mechanisms regulating NSC behaviour in 
AD. While studies were emerging on neurogenesis in AD mouse models, conflicting findings led 
us to study how the various steps of neurogenesis change as a result of aging, neuropathology 
development, and neurogenic niches. In my first paper (Chapter 2), we demonstrated that APP 
and human Tau transgenes are strongly expressed in AD-relevant brain areas, and that the 
neurogenic cells within the SVZ and DG do not directly express them. Characterization of the 
proliferation, differentiation, and survival of neural precursors in the hippocampal DG and 
SVZ/OB, showed that all steps of neurogenesis were greatly impaired in 11- and 18-month-old 
female 3xTg-AD mice. Within the SVZ, we found a 30-45% loss in the total numbers of cells 
expressing Ki67, MASH1, BrdU between WT and 3xTg mice. Consistent with this, 
quantification of the total cell numbers in the SVZ was also 35% less. Within the SVZ, post-
mitotic cells make up approximately 28% of the niche cells, while the remaining cells are 
comprised of approximately 33% neuroblasts, 22% NSCs and niche astrocytes and 10% 
progenitors (Doetsch et al., 1997). Therefore, it appears that 3xTg-AD mice have a proportional 
loss of neural precursors and total SVZ cells at 11 and 18 months of age. However, since we 
have yet to pinpoint a time point when one population is lost prior to the other we cannot say 
which precedes the other. When it comes to stem cell number and newborn neuron survival, 
unfortunately in our first study we did not double label BrdU+ cells with markers of NSCs 
(GFAP/Sox2 or Nestin/Sox2) or mature neurons (NeuN) or glia (GFAP). The label-retaining 
BrdU paradigm used is based on the principle that all dividing cells will incorporate BrdU upon 
DNA synthesis in S-phase. However, following a post-chase period of 21 days, the vast majority 
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of labeled cells including rapidly dividing cells including the neural progenitors and neuroblasts 
will have diluted out the label, while quiescent or slowly dividing NSCs and cells that 
incorporated the label prior to their last division (newborn mature neurons or glia) will maintain 
the label and can be detected by immunohistochemistry. Thus, we cannot conclude that the cells 
we have quantified are definitive NSCs or mature neurons. What we can say is that under normal 
circumstances, neuroblasts born in the SVZ migrate to the OB and make up approximately 90% 
of the LRC-BrdU+ cells in the OB ((Bouab et al., 2011) Figure 4p). Therefore, the number of 
BrdU+ cells in the SVZ would represent the number of quiescent or slowly dividing cells and 
those in the OB should give a pretty good estimate of the number of new neurons in the OB. 
Since the adult born mature neurons in the dentate gyrus remain in the dentate gyrus the label-
retaining population should include both NSCs and mature neurons. In addition, a major caveat 
of this technique to keep in mind is that many cellular processes can result in synthesis of new 
DNA without the cell going through mitosis. However, the most commonly used BrdU paradigm 
and thus the one employed in this study (50 mg/kg) does not detect DNA repair and apoptosis, 
two processes that potentially involve DNA synthesis (Cooper-Kuhn & Kuhn, 2002).  
An interestingly point that comes from this first study is that the DG had an 80% loss in 
Ki67 positive cells between WT and 3xTg mice at 11 months while the SVZ only showed a 45% 
loss. There are many possible reasons for why DG cells are inhibited prior to the SVZ. One 
explanation could be that in AD and in the 3xTg-AD mouse model, amyloid and tau pathology 
deposit in a stereotypical manner, beginning in more caudal regions including the entorhinal 
cortex and hippocampus and progresses to more rostral regions including the forebrain with age 
and disease progression. This could make DG cells susceptible at earlier time points to further 
inhibitory signals. In addition, the DG is in general a much more quiescent niche than the SVZ 
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and could therefore be more vulnerable to depletion, while the SVZ could resist for a longer 
period of time. 
 
In order to begin untangling the possible mechanisms inhibiting neurogenesis, we next 
characterized the phosphorylation status of tau and the deposition of amyloid beta (Aβ). 
Interestingly, we found that the deficits in neurogenesis occurred prior to the development of 
neurofibrillary tangles and Aβ plaques and instead, correlated with aberrant lipid accumulations 
within the SVZ niche. This work suggested that deficits in neurogenesis are a prominent feature 
in this AD model and that frank Aβ plaques and neurofibrillary tangles do not correlate with 
these deficits. Our project was in progress when two papers by Rodriguez et al., came out, 
demonstrating sex differences in the onset of neurogenic deficits in the 3xTg-AD model. In the 
DG, they compared male and female mice and found early deficits in proliferation starting at 4 
months of age in the dorsal blade of the DG in female mice, while in male mice, this decrease 
was delayed, only reaching significance at 9 months of age. Within the ventral blade, females 
showed significant deficits at 12 months, while males showed deficits at 6 months of age 
(Rodriguez et al., 2008). In the SVZ, they only studied male mice and showed that proliferation 
was inhibited beginning at 3 month of age (Rodriguez et al., 2009). Together, this work provided 
clear evidence that neurogenesis was inhibited in both the SVZ and DG of a mouse model that 
recapitulates the major AD-associated pathologies and cognitive symptoms (Chapter 1, Figure 
5). 
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IV.2 IDENTIFICATION AND QUANTIFICATION OF LIPID ACCUMULATION IN 
ALZHEIMER’S DISEASE 
 
In my second paper (Chapter 3), we took a multidisciplinary approach to study the 
mechanisms underlying defective neurogenesis in the 3xTg-AD mice. To determine if deficits in 
neurogenesis could be contributing to the cognitive deficits in AD, we first set out to determine if 
the onset of cognitive decline in 3xTg-AD mice correlated with deficits in neurogenesis in 
female 3xTg-AD mice. We found that at 5 months, 3xTg-AD mice had fewer proliferating neural 
precursors in both the DG and SVZ. Further analysis has shown that 2-month old 3xTg-AD mice 
already present deficits in proliferation and neurogenesis in both the DG and SVZ (data not 
shown). However, we have yet to perform an in depth time course of ages prior to 2 months of 
age. Intriguingly, at both 2  (data not shown) and 5 months of age we found a gross accumulation 
of neutral lipids within ependymal cells along the entire ventricular axis. 
To determine if this lipid accumulation was a phenotype present in AD patients, we used 
the same neutral lipid stain on the lateral ventricle of human AD patients and age-matched 
controls. Remarkably, we found a similar accumulation of neutral lipids within AD ependymal 
cells. The role of lipids in regulating neural precursor function had not been extensively studied, 
however, this struck us as an emerging and interesting field. After reviewing the literature we 
found many circumstantial links between neurodegeneration and aberrant lipid metabolism 
(reviewed in (Hussain et al., 2013)). Observational studies associated low fish intake and low 
blood levels of omega-3 fatty acids to increased risk of dementia and AD (Gu et al., 2010). On 
the other hand, high fat diets and increased free fatty acids can induce and exacerbate AD 
pathological hallmarks including, plaque and tangle formation (Patil & Chan, 2005; Julien et al., 
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2010) and gliosis and inflammation (Gupta et al., 2012). Diets rich in polyunsaturated fatty acids 
improve mouse cognitive decline in aging and AD mutant mice (Fernandez-Fernandez et al., 
2012). However, technical hurdles in the identification and localization of lipids in the brain 
needed to be overcome in order to dissect their contribution to NSC regulation. To address this, 
we began a collaboration with the laboratory of Dr. Pierre Chaurand, a leader in the technique of 
laser desorption ionization, a method used to detect and measure proteins and lipids within the 
intact tissue architecture. The development of optimal conditions for lipid identification by the 
Chaurand lab, allowed us to identify, localize and quantitate the precise lipid species 
accumulating within the ependymal zone. After measuring major lipid classes, we found 12 
specific triglycerides increased between 2-27 fold in 3xTg-AD mice. Triglycerides are stored in 
response to excess fatty acid levels, thus we used tandem mass spectrometry to fractionate the 
side chains of each of the top 3 triglycerides to determine the component fatty acid chains. This 
analysis yielded 6 fatty acids of oleic acid (OA, 18:1), palmitic acid (PA, 16:0), stearic acid (SA, 
18:0), palmitoleic acid (POA, 16:1), eicosenoic acid (EA, 20:1) and eicosadienoic acid (EDA, 
20:2) side-chains in an approximately 7:5:3:1:1:1 ratio. Interestingly, the three human studies 
that looked at fatty acid levels in AD brains found increases in the levels of OA (reviewed in 
Hussain et al. 2013). Fraser, Astarita, and Cunnane, measured fatty acid levels in multiple brain 
regions of AD patients and age-matched controls. Fraser et al., found an increase in PA and OA 
and a decrease in SA in the frontal and temporal lobe of AD patients (Fraser et al., 2010). While 
Astarita et al., showed an elevation of POA and OA in the mid-frontal cortex and hippocampus 
of AD patients (Astarita et al., 2011). Moreover, Cunnane et al., found a 10-20% increase in OA 
isomers and a 12-14% decrease in DHA composition in AD brains (Cunnane et al., 2012). ICV 
infusion of OA into WT mice led to neutral lipid accumulation resembling that seen in the 3xTg-
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AD mice, implying that an elevation of free OA levels may be the initiating factor for the 
observed triglyceride accumulation. Importantly, ICV infusion of heavy-labelled C13-OA in WT 
mice recapitulated the 11 of the 12 triglycerides seen in the 3xTg-AD mice, suggesting that the 
SVZ possesses the enzymes necessary for the elongation, reduction, saturation, and desaturation 
of fatty acids. This was an interesting observation, as it is the first demonstration that ependymal 
cells actively metabolize lipids. This data led us to hypothesize that elevated OA levels in the 
SVZ niche were contributing to the deficits in neurogenesis seen in the 3xTg-AD mice. 
 
IV.3 SOURCES OF ABERRANT BRAIN LIPID ACCUMULATION IN ALZHEIMER’S 
DISEASE 
 
To further understand why the brain accumulates lipids in AD, we considered the 
possibility of local and peripheral sources. Indeed, mounting evidence suggested that the brain 
fatty acid profile is altered in AD and may depend on that of the periphery. Cunnane et al., 
measured and identified plasma and brain lipids altered between non-cognitively impaired (NCI), 
mild-cognitively impaired (MCI), and AD patients. The main differences they found were in the 
levels of plasma free OA and OA isomers, being 80% lower in AD and 70% lower in MCI 
compared to NCI. Free linoleic acid (18:2) and the sum of free omega-6 fatty acids were 50-80% 
lower in AD and MCI than in NCI. Compared to the NCI group, neither free DHA nor the sum 
of free omega-3 fatty acids was significantly changed in MCI or AD. After looking at multiple 
brain regions, they found that AD brains had 12-14% lower DHA composition specifically in 
phosphatidylserines of the mid-frontal and superior temporal cortex. Moreover, in the superior 
temporal and midfrontal cortex, OA isomers were 10-20% higher in AD. Therefore the only 
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correlation between brain and serum fatty acid levels was in total DHA% in phosphotidylserine 
of the mid-frontal cortex and superior temporal cortex in AD compared to NCI (Cunnane et al., 
2012). In our study, we measured lipid levels in plasma and CSF extracts from WT and 3xTg-
AD mice, paying particular attention to the triglycerides and component fatty acids observed in 
the 3xTg-AD lipid inclusions. Interestingly, we found no changes in any of the 12 triglycerides 
or their component fatty acid chains, again suggesting that aberrant OA-accumulation in the SVZ 
arises from local SVZ metabolism defects and not the periphery. Indeed, microarray analysis on 
microdissected SVZs from WT and 3xTg-AD mice, showed differential gene profiles of over a 
hundred genes related to lipid metabolism including an up regulation of SCD-1, the rate-limiting 
enzyme in the synthesis of OA from SA. Intriguingly, during brain development, OA is 
synthesized in the periventricular zone coinciding with a spike in SCD-1 activity (Polo-
Hernandez et al., 2010; Polo-Hernandez et al., 2014). In humans, it has been demonstrated that 
AD patients have an increase in the ratio of OA/SA and concomitant elevation of mRNA levels 
of SCD-1 (Astarita et al., 2011). Compellingly, previously work has shown that macrophages 
treated with Aβ become activated and selectively increase SCD-1 activity (Uryu et al., 2003). 
Thus, it will be interesting to determine if reducing Aβ levels decreases OA in AD. Another way 
OA could accumulate is by defective triglyceride lipolysis. Along these lines, adipose 
triglyceride lipase (ATGL) is the rate-limiting enzyme the lipolysis of triacylglycerol to 
diacylglycerol (Chapter 1, Figure 6) and ATGL-knockout mice selectively accumulate neutral 
lipids within ependymal barriers (Etschmaier et al., 2011). Thus, an activation of OA synthesis 
and/or an inhibition of lipolysis enzymes could lead to the storage of triglycerides within 
ependymal cells in AD. Our data collectively supports a model in which a trigger, possibly Aβ, 
up regulates SCD-1 activity, this in turn increases the levels of circulating OA in the brain and 
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causes it to be deposited in lipid droplets in the SVZ. 
IV.4 REGULATION OF NEURAL STEM CELLS BY FATTY ACIDS 
 
After establishing that elevated local OA levels were likely the signal leading to 
triglyceride accumulation, we wondered whether altered OA levels could be a factor contributing 
to the inhibition of neural precursor behaviour in AD. We took advantage of the in vitro 
neurosphere assay to first assess the impact of various concentrations of OA. A dose-response of 
0.001uM-1000uM of OA showed that at low concentrations (0.001-50uM) OA either had no 
effect or slightly increased neurosphere numbers, while at concentrations higher than 50uM an 
inhibition of neurosphere number was observed (unpublished data and Chapter 3). We chose 50 
and 100 uM for our further studies as this was the range used in most fatty acid studies and 
because one induced a positive effect and the other a negative affect on neurosphere growth in 
our hands. Concurrently, a few groups began treating neural precursors with fatty acids. Sakayori 
and colleagues grew embryonically derived neurospheres in the presence of DHA and AA and 
showed that DHA increased neurosphere number while AA had no effect (Sakayori et al., 2011). 
While others differentiated embryonic neurospheres in the presence of DHA, AA, EPA, DPA, 
PA or OA (Sakayori et al., 2011; Katakura et al., 2013; Rashid et al., 2013; Yuan et al., 2013; 
Wang et al., 2014). Overall, these studies found that DHA in particular, repeatedly enhanced 
neuronal fate choice and differentiation and other polyunsaturated omega-3 fatty acids such as 
EPA and DPA have similar effects (Kawakita et al., 2006; Katakura et al., 2009; Sakayori et al., 
2011; Katakura et al., 2013; Rashid et al., 2013). AA, an omega-6 fatty acid has shown 
conflicting results (Sakayori et al., 2011; Rashid et al., 2013). OA, an omega-9 fatty acid had no 
effect on neural precursor differentiation in vitro (Rashid et al., 2013) but enhanced neuronal 
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differentiation in explants and slice cultures (Polo-Hernandez et al., 2014). Lastly, PA a 
saturated fatty acid promoted astrogliogenesis at low doses and apoptosis at high doses (Yuan et 
al., 2013; Wang et al., 2014).  
To gain insight into whether OA was modulating NSC or progenitor behaviour, we 
divided the neurosphere assay into two phases, NSC activation and progenitor cell expansion. 
We found that 100uM OA inhibited neurosphere number only when treated during NSC 
activation. This suggested that high OA selectively inhibits NSC activation. To make sure that 
the decrease in neurosphere number was not due to changes in cell death or generalized 
proliferative defects, we performed a TUNEL apoptosis assay in combination with 
immunocytochemistry for Ki67 and observed no differences. To determine if OA was 
modulating NSC self-renewal, we developed a technique that would allow us to assess the 
number of stem cells per neurosphere. This method demonstrated that OA treated spheres 
contained fewer NSCs. Together, our in vitro data showed that increased OA levels could 
selectively inhibit the activation of adult NSCs. Thus, a more detailed map of how fatty acids 
impact NSC proliferation and differentiation will provide important information on how changes 
in lipid levels can modulate brain activity and function.  
We next wanted to determine if OA inhibited NSC activation in vivo. To do this, we 
employed a well-established AraC regeneration assay in which AraC is ICV infused for 6 days to 
eliminate all the constitutively proliferating progenitors and neuroblasts leaving only quiescent 
NSCs (Doetsch et al., 1999b). Doetsch et al., performed a detailed characterization of the 
dynamics of SVZ depletion and regeneration following AraC treatment (Doetsch et al., 1999b). 
Using the same paradigm employed in our study, Doetsch and colleagues found that after 6 days 
of AraC, only ependymal cells, tanycytes, and type B cells remained. To identify which cells 
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divided at different survivals after AraC treatment, [3H] thymidine or BrdU was injected 1 hr. 
before sacrifice and mice were sacrificed 0, 0.5, 1, 2, and 3 days after pump removal and the 
labeled cells were characterized by electron microscopy. At 0 days, no 3H-thymidine-labeled 
cells were encountered, At 0.5 day and 1 day, 99% dividing cells were identified at the EM in the 
injected hemisphere: 97% corresponded to type B cells and two to microglia (Fig. 4A and Table 
1). None corresponded to ependymal cells or tanycytes. In our study we co-infused 500uM of 
OA or vehicle during the 6 days of SVZ depopulation (Doetsch et al., 1999b). We sacrificed one 
group of mice at 0 or 1 day after pump removal. At 0 days we counted the number of Ki67+ 
proliferating cells and found no significant difference between vehicle and OA treated, 
suggesting that the depopulation of SVZ cells occurred at the same level in both groups (data not 
shown). However, at the 1 day time point we found a decrease in the number of Ki67+ in the OA 
treated group. The fact that SVZ depopulation was the same strongly suggests that OA 
selectively inhibited the regeneration capacity of type B NSCs. Interestingly, the DG also 
showed inhibited proliferation, however it did not reach statistical significance. Together, these 
experiments uncovered a novel mechanism by which increased OA could inhibit NSC and 
neurogenesis in AD. 
An interestingly finding from this study is that DG proliferation is inhibited in the 3xTg-
AD mouse model and following anti-mitotic AraC treatment even though no ependymal cells are 
present in the DG. This suggests that it is not necessarily the lipid-laden ependymal cells that 
directly inhibit neurogenesis. They may simply be the consequence of excess accumulation of 
lipids in the environment not dissimilar to amyloid plaques that appear to be the mere 
consequence of elevated amyloid levels. This hypothesis should be tested in two ways. First, 
identifying the exact mechanisms that lead to excess OA-enriched triglycerides in ependymal 
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cells. It has been previously shown that SCD-1 the main enzyme responsible for OA synthesis is 
expressed within the periventricular regions of the SVZ (Polo-Hernandez et al., 2014) and our 
microarray data found an increase in the transcription of this gene within microdissected 3xTg-
AD SVZs. Determining if elevated SCD-1 expression in ependymal cells is sufficient to cause 
the AD-associated triglyceride profile and if inhibiting this activation can reverse the neurogenic 
deficits are part of the revisions for the publication of this paper and will provide insight into the 
role of ependymal cells in the inhibition of neurogenesis in AD. Second, LDI-MS on 
hippocampal brain sections can be performed and to reveal if excess lipids are reaching the DG. 
More work is needed to prove which cell types specially produce OA under normal and 
pathological conditions. New data has shown that fatty acid synthase, the key enzyme of de novo 
lipogenesis is active in adult neural precursors and that conditional deletion of fatty acid synthase 
in Nestin+ neural precursors impairs adult DG neurogenesis and the increase in proliferation 
seen after exercise (Chorna et al., 2013; Knobloch et al., 2013). Therefore, uncovering how fatty 
acids and lipids in general are produced and metabolized within the brain is an important novel 
field of study that will surely provide much needed information in the future. Another point we 
have not addressed is how OA gets transmitted to NSCs. It is likely that fatty acid binding 
proteins (FABP)s that are involved in shuttling fatty acids between cells play a role in this 
process. FABP5 and FABP7 are present in NSCs and their neuronal progenitors coexpressing 
GFAP, Nestin, Sox2 and DCX but not NeuN in the DG. Importantly, a marked decrease in NSCs 
and neural progenitors is observed when FABP5, FABP7 or both are knocked out. Intriguingly, 
FABP7 but not FABP5 levels are increased in the serum of multiple dementia-related diseases 
including AD and Parkinson’s disease (Teunissen et al., 2011) and FABP3 levels are decreased 
in the brains of AD and down syndrome patients (Cheon et al., 2003).  
 
 
 
 
174 
 
IV.5 OLEIC ACID AND THE AKT-FOXO3 NEURAL STEM CELL PRESERVATION 
PATHWAY 
 
To begin to unravel the molecular mechanism of how OA inhibits NSC activation we 
looked back into our microarray analysis to find genetic links between lipids and neural stem cell 
regulation. The FoxO transcription factor family particularly stood out, as it had been previously 
linked to metabolism and adult NSC preservation (Paik et al., 2009; Renault et al., 2009; 
Schmidt-Strassburger et al., 2012; Ro et al., 2013; Yeo et al., 2013). We performed an acute 
stimulation experiment where neural precursors were treated with OA for various periods of time 
and measured the response of the AKT-FoxO signalling. Remarkably, we found that OA could 
acutely induce AKT phosphorylation and the phosphorylation of its downstream FoxO3 in vitro. 
To mimic this experiment in vivo, we performed a single OA ICV injection and sacrificed the 
mice at various time-points and similarly found a robust activation of the AKT-FoxO3 pathway. 
To determine if the hyper-activation of the AKT-pathway by OA is a necessary component of 
the inhibition of NSC activation we have since performing two experiments (Annex). In vitro, 
we treated neurospheres with vehicle or OA alone or in combination with a PI3K-inhibitor 
(LY2094002). As previously, OA inhibited neurosphere number when compared to vehicle 
alone. However, when combined with LY, OA lost its negative effect, instead producing the 
same number of neurospheres as vehicle treated with LY. This data provides evidence that the 
effects of OA require modulation of P13K-AKT-signalling. Due to the continued difficulty in 
labeling and targeting NSCs in vivo, we used a novel approach to target ventricle contacting 
GFAP-expressing NSCs using electroporation or electropermeabilization, a molecular biology 
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technique in which an electrical field is applied to cells in order to increase the permeability of 
the cell membrane, allowing chemicals, drugs, or DNA to be introduced into the cell (Barnabe-
Heider et al., 2008). In this study, we electroporated GFAP-cre in R26-flox-stop-flox-EYFP 
mice to induce the excision of the flox sites and allows for the expression of YFP in GFAP+ 
cells and their progeny. To test the effects of OA on ventricle-contacting GFAP-expressing 
NSCs we placed 7-day osmotic pumps containing vehicle or OA immediately following 
electroporation. After 7 days, we sacrificed the mice and quantified the number of YFP+ cells 
per ventricle. This analysis revealed an inhibition of the number of YFP+ NSCs in the OA 
treated group, however it did not reach statistical significance p = 0.08. To determine if this 
reduction required modulation of AKT-signalling we performed a second experiment where 
GFAP-cre and AKT-kinase dead were co-electroporated prior to pump placement. In this 
experiment, we found the number of YFP+ NSCs to be more similar between vehicle and OA p 
= 0.2. Together, these experiments provide in vitro and in vivo evidence that the negative effects 
of OA required the activation of AKT-signalling. In the future, we plan to perform similar 
experiments using mutant FOXO3a plasmids to determine if it is indeed the downstream target 
of AKT in this context.  
These experiments show that lipid-sensing signalling occurs in NSCs and that changes in 
lipid levels can regulate the quiescence or activation status of NSCs through these pathways. 
Fitting with this, Codega et al. performed a microarray on purified quiescent vs. active SVZ 
NSCs and found lipid metabolism genes to be one of the main differentiating gene classes 
between the two, suggesting a role for lipids in NSC regulation (Codega et al., 2014). Together, 
this work suggests that in AD, chronically elevated OA levels dysregulate the AKT-FoxO3 
pathway and NSC behaviour possibly by promoting early over proliferation leading to premature 
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NSC exhaustion or by directly inhibiting NSC activation.  
IV.6 GENERAL CONCLUSIONS 
 
Identifying novel, effective therapeutics for AD is one of the major unmet medical needs 
of our time. Although billions of dollars have been invested into AD research and clinical trials, 
it remains the most prevalent and costly neurodegenerative disease with no cure or disease 
modifying therapies. Amyloid beta has kept the AD field fixated for the last hundred years and 
although these studies have provided important insight, the etiology and pathophysiology 
underlying AD remains a mystery. Novel therapies will require a fresh way of thinking about AD 
research. New techniques and technologies from multiple fields can be harnessed to enact a 
multidisciplinary systems approach. Current techniques are available from cell biology and 
regenerative medicine fields including exogenous implantation of new cells or endogenous 
stimulation of existing cells. These methods could allow for enhanced or sustained levels of 
neurogenesis throughout life and are useful for a wide-range of neurological disorders. In AD, 
the main target would be to prevent or restore the neuronal dysfunction and loss. There are, 
however, many hurdles to the application of these therapies for AD, including getting the cells to 
survive in a less than ideal environment and to integrate into an already existing complex brain. 
With this in mind, enhancing endogenous neurogenesis would be more amenable to widespread 
implementation in patients as delivery of exogenous implantation therapies requires invasive 
procedures. Thus, understanding the factors regulating neurogenesis under normal and 
pathological conditions will bring us closer to determining the elements needed to enhance and 
sustain appropriate levels of neurogenesis throughout life and following damage or degeneration. 
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Indeed, uncovering AD-associated factors that impinge on neurogenesis gives us clues as to why 
neurodegeneration may be happening and provides targets for regeneration.  
My thesis work has demonstrated that neurogenesis is impeded in the 3xTg-AD mouse 
model of AD. Therefore, not only is the brain microenvironment toxic to existing cells, it may 
also be inhibiting its only source of regenerative potential. Our data implicates fatty acids as 
novel regulators of adult neurogenesis. We localized and identified deficient lipid metabolism as 
a novel player in AD and provided important new links between AD-associated brain lipid 
metabolism defects and how they can impact a neurogenic niche and its activity. 
An important prediction from these studies is that one or all of the three mutations found 
in the 3xTg-AD mouse triggers abnormal lipid metabolism. At present the only upstream link 
between these mutations and lipid metabolism come from the study that shows that Aβ can 
trigger SCD-1 expression (Uryu et al., 2003). It would thus be interesting to study lipid 
accumulation in APP (Swedish), PS1 (M146V), and tau (P301L) single mutant mice to gain 
insight into which mutation triggers aberrant lipid metabolism.  
Although we have only scratched the surface of how lipid metabolism can impinge on 
neurogenesis and neurodegeneration, we are hopeful that in the future, these findings will have 
therapeutic value.  
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immunohistochemistry, quantifications and western blotting. We collaborated with Carl Julien 
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study was principally conceived by my supervisor and we wrote the article together.  
 
For the second article “Elevated oleic acid levels within the forebrain niche suppress 
neural stem cell activation in Alzheimer’s disease” (Chapter 3), I developed the concepts, carried 
out the experiments, analysed data and co-wrote the paper. We provided the sections for the 
collaboration with Martin Dufresne and the lab of Pierre Chaurand who developed and carried 
out IMS experiments and analysed data. Sandra Joppé helped with neurogenesis experiments and 
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Abstract
In the brains of adult vertebrates, including humans, neurogenesis occurs in restricted niches where it maintains cellular turnover
and cognitive plasticity. In virtually all species, however, aging is associated with a significant decline in adult neurogenesis. More-
over, an acceleration of neurogenic defects is observed in models of Alzheimer’s disease and other neurodegenerative diseases,
suggesting an involvement in aging- and disease-associated cognitive deficits. To gain insights into when, how and why adult
neurogenesis decreases in the aging brain, we critically reviewed the scientific literature on aging of the rodent subventricular
zone, the neurogenic niche of the adult forebrain. Our analysis revealed that deficits in the neurogenic pathway are largely estab-
lished by middle age, but that there remains striking ambiguity in the underlying mechanisms, especially at the level of stem and
progenitor cells. We identify and discuss several challenging issues that have contributed to these key gaps in our current knowl-
edge. In the future, addressing these issues should help untangle the interactions between neurogenesis, aging and aging-associ-
ated diseases.
Introduction
Aging is associated with a generalized reduction in the ability of
adult tissues to maintain and repair themselves. At the cellular level,
this decline in homeostatic and regenerative capacity can be attrib-
uted to both time-dependent (‘chronological aging’) and division-
dependent (‘replicative aging’) mechanisms (Rando, 2006; Liu &
Rando, 2011). Adult stem cells are unique in that they need to resist
both chronological and long-term replicative aging processes. In the
adult brain, the subventricular zone (SVZ) of the forebrain lateral
ventricles represents the principal reservoir of neural stem cells
(NSCs). NSCs of the SVZ continue to generate new neurons and
glial cells during adulthood, contributing to the ongoing turnover of
olfactory bulb interneurons and forebrain glial cell populations
(Menn et al., 2006; Lledo et al., 2008; Imayoshi et al., 2010). In
response to brain injury, migrating NSC-derived progeny are also
re-routed to areas of degeneration, where they can serve as a target
for therapeutic manipulations (Kolb et al., 2007; de Chevigny et al.,
2008; Erlandsson et al., 2011). However, NSC-derived neurogenesis
undergoes a marked decline over the course of aging, resulting in
reduced tissue function; in rodents, for instance, olfactory bulb neu-
ronal replacement is an early target of aging, affecting olfactory rec-
ognition, discrimination and identiﬁcation tasks (Enwere et al.,
2004; Rey et al., 2012). Furthermore, certain neurodegenerative con-
ditions such as Alzheimer’s and Parkinson’s disease also show
defective SVZ neurogenesis and an acceleration of aging-associated
olfactory deﬁcits, suggesting that declining neurogenesis may ulti-
mately contribute to age-related cognitive diseases (Mesholam et al.,
1998; Winner et al., 2011). To increase the ability of NSCs to main-
tain and repair the aging brain, it is essential to achieve a clearer
understanding of when, how and why the aging process intersects
with the regulation of adult neurogenesis.
Development and aging of the neurogenic lineage
Prior to adopting their mature adult phenotype, NSCs evolve
through several distinct developmental stages during which they
possess different properties and perform different biological func-
tions (Alvarez-Buylla et al., 2001) (see Fig. 1).
During embryonic development of the central nervous system
(CNS), the main biological function of the early precursors of NSCs
is tissue growth. In their ﬁrst phase, the precursors of NSCs corre-
spond to primitive neuroepithelial cells (NEPs). NEPs span the
one-cell-layer thick neural tube, contacting both the inner ventricular
surface and the outer pial surface, and they divide symmetrically to
rapidly expand their population. The onset of asymmetric cell divi-
sions initiates a second phase, when the accumulation of differenti-
ated progeny and consequent thickening of the neural tube cause
NEPs to transition into radial glial cells (RGCs). Once thought to
mainly serve a scaffolding function, it is now recognized that RGCs
generate the neurons, oligodendrocytes and astrocytes of the devel-
oping CNS, either directly or indirectly via intermediate progenitor
cells (IPCs) (Noctor et al., 2004; Kriegstein & Alvarez-Buylla,
2009; Hansen et al., 2010). In the ﬁnal stages of development, a
subpopulation of RGCs begins assembling the SVZ niche that will
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maintain NSCs during adulthood. They do so by retracting their api-
cal processes while maintaining ventricular contact at their basal sur-
face, subsequently converting into either ventricle-lining ependymal
cells or ventricle-contacting SVZ astrocytes (Merkle et al., 2004;
Spassky et al., 2005).
The biological function of NSCs undergoes a major change when
they begin shifting into a mode dedicated to tissue maintenance.
This maintenance phase begins in the postnatal period and continues
throughout adulthood. In the forebrain, SVZ astrocytes continue
functioning as postnatal and adult NSCs (aNSCs) (Doetsch et al.,
1999; Imura et al., 2003; Morshead et al., 2003). These aNSCs are
highly quiescent, dividing only once every 2–3 weeks (Morshead
et al., 1994) to generate highly proliferative, transiently amplifying
progenitors (TAPs) that give rise to migratory, fate-committed neu-
roblasts and glioblasts (Suzuki & Goldman, 2003). Neuroblasts born
in the SVZ migrate along the rostral migratory stream and differenti-
ate into olfactory bulb interneurons (Lois & Alvarez-Buylla, 1994)
that are critical for odour recognition (Breton-Provencher et al.,
2009; Mouret et al., 2009) and short-term olfactory memory (Bre-
ton-Provencher et al., 2009). Forebrain ependymal cells rarely
divide, but remain capable of neurogenesis under pathological con-
ditions (Carlen et al., 2009).
aNSCs are ideally positioned within the niche to be dynamically
regulated by environmental signals. Their basal processes contact
the lateral ventricle at the center of spirals of ependymal cells
termed pinwheels (Mirzadeh et al., 2008; Nam & Benezra, 2009),
while their apical processes contact SVZ blood vessels (Shen et al.,
2008; Tavazoie et al., 2008). Combinatorial extrinsic signals arising
from adjacent aNSCs, TAPs, neuroblasts, ependymal cells, extracel-
lular matrix molecules, the cerebrospinal ﬂuid (CSF) and the vascu-
lature interact with cell-intrinsic mechanisms to control proliferation,
self-renewal capacity, fate determination, migration, differentiation
and survival (Fuchs et al., 2004; Morrison & Spradling, 2008; Suh
et al., 2009; Walker et al., 2009). Under basal conditions, aNSCs
mainly divide asymmetrically, allowing them to maintain the stem
cell pool while also generating rapidly dividing TAPs (Morshead
et al., 1998). Moreover, aNSCs also retain the ability to return to a
symmetric mode of division to expand stem cell numbers after
injury (Parent et al., 1997; Zhang et al., 2004; Lugert et al., 2010).
In spite of having this ability, adult neurogenesis still declines dur-
ing aging (Fig. 1). A signiﬁcant number of studies have investigated
this decline–so what have we learned about the underlying mecha-
nisms of SVZ aging?
Aging and SVZ neurogenesis: what do we really know?
We surveyed the scientiﬁc literature for published peer-reviewed
studies on the topic of age-related impairments in forebrain neuro-
genesis, and found 20 articles that have investigated this issue using
rodent models. Comparison of the assumptions, experimental
designs, methods, primary data, interpretations and conclusions
revealed considerable heterogeneity and inconsistencies across these
parameters. To begin developing a clearer picture, we therefore
divided adulthood into three age ranges, identiﬁed here as Young
adult (2–6 months of age), Middle-aged (6–14 months), and Old
(greater than 14 months) (see Fig. 2). According to these criteria,
we found that of the 20 studies examining age-related changes in
SVZ neurogenesis, 15/20 compared Young adult with Old stages
(Kuhn et al., 1996; Tropepe et al., 1997; Jin et al., 2003; Enwere
et al., 2004; Maslov et al., 2004; Luo et al., 2006; Molofsky et al.,
2006; Belluardo et al., 2008; Ahlenius et al., 2009; Acosta et al.,
2010; Frinchi et al., 2010; Stoll et al., 2011a,b; McGinn et al.,
2012; Shook et al., 2012), 8/20 made Young adult to Middle-age
comparisons (Kippin et al., 2005; Chen et al., 2006; Luo et al.,
2006; Molofsky et al., 2006; Tanaka et al., 2007; Medrano et al.,
2009; Bouab et al., 2011; Shook et al., 2012), and 3/20 compared
Fig. 1. Changes in neural stem cells and neurogenesis during development and aging. Prior to adulthood and during the developmental period of central ner-
vous system (CNS) growth, adult neural stem cells (aNSCs) pass through three morphologically and functionally distinct phases. Initially, neuroepithelial stem
cells are dividing symmetrically to expand their numbers. When neuroepithelial cells begin dividing asymmetrically to generate neurons and glial cells, they
transition into radial glial cells. As formation of the main populations of differentiated neural cell types nears completion, forebrain radial glial cells retract their
peripheral radial process and differentiate into either ventricle-contacting subventricular zone (SVZ) astrocytes or ventricle-lining ependymal cells, setting up the
SVZ niche. SVZ astrocytes are aNSCs of the postnatal and adult forebrain. During adulthood, aNSC function shifts to forebrain maintenance; aNSCs primarily
divide asymmetrically, maintaining the size of the stem cell pool while generating new neuroblasts and glioblasts. As adulthood continues into Middle-age and
Old age, neurogenic output decreases dramatically. Visible changes include alterations within the aNSC pool (comprising fewer ventricle-contacting SVZ astro-
cytes and some conversion of astrocytes into ependymal cells), a reduction of total numbers of transiently amplifying progenitors (TAPs), neuroblasts, and pro-
liferating cells (including aNSCs, TAPs, and some neuroblasts). The question mark reﬂects that it is unknown whether ventricle-contacting astrocytes disappear
or simply withdraw their ventricle contacting process.
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50–70% (Ki67, BrdU) at 10–14 months of age (Luo et al., 2006;
Tanaka et al., 2007; Belluardo et al., 2008; Bouab et al., 2011),
resulting in a downstream 76% decrease in BrdU+ neurons that are
contributed to the olfactory bulbs (Bouab et al., 2011), and both
these results match ﬁndings obtained using Old mice (above).
At the level of aNSCs and TAPs, (i) immuno-labelling and elec-
tron microscopy studies indicate a 65–75% reduction in TAPs (Luo
et al., 2006; Bouab et al., 2011); (ii) the number of label-retaining
slowly dividing cells decreases by about 67% (Bouab et al., 2011);
(iii) the number of pinwheels decreases by about 68% (Shook et al.,
2012) and (iv) the number of ventricle-contacting astrocytes (GFAP/
gamma-tubulin-expressing cells) decreases by 73% (Shook et al.,
2012). In the case of the neurosphere assay, the data generally
indicate that there is no major difference in numbers of neuro-
sphere-forming cells. However, as discussed further in the following
section, experimental differences such as neurosphere assay parame-
ters and mouse strains that were used preclude reliable comparison
of data across these studies (Tropepe et al., 1997; Kippin et al.,
2005; Chen et al., 2006; Medrano et al., 2009; Bouab et al., 2011).
Collectively, comparison of the Middle-age and Old data reveals
that all the neurogenesis parameters tested remained relatively stable
after Middle-age in rodents. This is illustrated in Fig. 2B, which
shows a compilation of the age-related differences in numbers of
proliferating cells, TAPs and neuroblasts described above.
We still do not know what is occurring at the aNSC and TAP
stages
Despite the compelling data showing that adult forebrain neurogenesis
is highly diminished between Young adult and Middle-age time-points
(above), the causes, mechanisms and exact nature of the changes
occurring at the levels of the aNSC and TAP populations remain strik-
ingly nebulous. For example: Are aNSCs decreased in number or is
their activity compromised? Are TAPs not produced or are they gener-
ated but fail to amplify in number? Are changes in the aNSC and/or
TAP populations caused by cell-autonomous mechanisms or are they
the result of aging of the local and systemic environments? There are
numerous reasons for the continued uncertainty surrounding such key
questions, as discussed further in the following section.
Why haven’t we learned more about the causes of
neurogenic impairments during aging?
Our review of the literature revealed at least two recurrent and prob-
lematic issues in the ﬁeld of aging and neurogenesis. These issues
have made it impossible to extract a more complete picture of the
cellular events taking place in the aging SVZ (and particularly at the
level of the aNSCs and TAPs) using the currently published data.
Problem 1: the assumption that aging = old
The ﬁrst obvious problem stems from the fact that aging is a vaguely
deﬁned process for which there are few known measurable features,
leading to a wide disparity in study conditions. This can be contrasted
with disorders such as Alzheimer’s disease, which is deﬁned by spe-
ciﬁc pathological hallmarks, spatial and temporal patterns of progres-
sion, and functional criteria, facilitating consensus on key study
parameters. To study aging in a rigorous scientiﬁc manner, it is there-
fore essential to deﬁne its biological features more clearly.
A principal biological feature of aging is a reduction in the ability
of adult tissues to maintain and repair themselves. When does this
reduced capacity for adult tissue homeostasis begin? On the one
hand, some aspects of the aging process may start the moment our
ﬁrst cell is born. However, considering the overwhelming impor-
tance of proper embryonic development for organismal survival, it
is likely that strong evolutionary pressure ensures homeostatic integ-
rity during the critical development period. Moreover, it would be
challenging to distinguish deleterious aging-associated events from
the rapid and profound cellular changes that normally occur during
development (i.e. Fig. 1). To establish a more practical framework
for studying the aging process, it is therefore useful to deﬁne it as a
process that (i) begins once a cell has completed its rapid develop-
mental changes and ﬁrst reaches the stable phenotype that it will
maintain throughout adulthood; (ii) occurs at a rate related to chro-
nological age but is also regulated by factors such as epigenetics
and cell–cell interactions and (iii) continues progressing until death.
Three informative predictions emerge when these criteria are applied
to the study of adult neurogenesis.
(i) Aging of aNSCs may begin very early
As illustrated in Fig. 1, adult neurogenesis is compromised long
before reaching an Old age. Interestingly, cognitive decline in
humans may also begin as early as the 20 s (Salthouse, 2009). If a
biological ‘clock’ controls aNSC replicative aging and the onset of
the decline in neurogenesis, it is likely that we would be able to
detect it even as soon as the early postnatal period, when aNSCs
have transitioned through their developmental neuroepithelial and
radial glial stages and have begun adopting their quiescent adult
phenotype, i.e. when their biological function shifts from tissue
growth to tissue maintenance (Fig. 1).
(ii) Aging may occur at different rates across tissues and cell
types
There are large variations in both the basal rates of cell production
and the lifespan of differentiated cells across different tissues, partic-
ularly between high turnover tissues such as the epidermis, intestinal
epithelium and hematopoietic system, and low turnover tissues such
as the brain and spinal cord. To avoid being misled, aging-related
studies should be designed using tissue-speciﬁc criteria.
(iii) Focusing on Old time-points could be deceptive
As aging is a progressive process, the most logical approach to anal-
ysing it would be to study multiple time-points that are prior to or
within the actual period of neurogenic decline. The tendency to
study Old time-points has allowed us to identify the consequences
of the aging process; however, focusing on the remnants of neuro-
genesis that are left after decline has already occurred does not pro-
vide insight into the causes of the process, and could incorporate
additional sources of variability, such as aging-related diseases and
‘survivor bias’.
As seen in the previous section, it is clear that aging does not
equal Old in terms of adult neurogenesis. If we are to successfully
identify the mechanisms that are responsible for the age-related
decline in neurogenesis, it will be essential to deﬁne the cellular and
molecular events that are occurring prior to the appearance of age-
related declines in neurogenesis.
Problem 2: the blurred line between NSCs and progenitors
Accurate interpretation of many of the studies cited here required
careful re-evaluation of the primary data, due to an unfortunate
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tendency in the literature to interchangeably use such terms as stem
cells, progenitor cells, stem-progenitors and precursors (Seaberg &
van der Kooy, 2003). This problem originates largely from the cur-
rent inability to accurately identify aNSCs and to precisely delineate
between the early aNSC and TAP stages of neurogenesis.
aNSCs in vivo are rare in the adult, and spend most of their time
in quiescence, rendering them a challenge to detect and study even
in young adults. aNSCs are found within the GFAP-expressing
astrocyte population (Doetsch et al., 1999; Imura et al., 2003; Mors-
head et al., 2003) and TAPs express Dlx2, Mash1 and/or Olig2
(Doetsch et al., 2002; Aguirre & Gallo, 2004; Parras et al., 2004;
Menn et al., 2006); however, these markers are not speciﬁc, and
there is a lack of widely accepted markers that can enable discrimi-
nation of the early lineage stages. Division-based labeling
approaches, such as cell cycle-based markers and long-term label
retention approaches, will be inherently imprecise in the context of
aging as there are changes in cell cycle lengths or the frequency of
exit from quiescence. Furthermore, changes in S-phase nucleotide
incorporation are a reﬂection of changes in proliferative activity
rather than cell numbers. Even changes in the number of morpho-
logically deﬁned cell types (such as ventricle-contacting GFAP+ as-
trocytes, putative aNSCs) are complicated by the caveat that the
cells may remain present and retain aNSC function or capability,
but have simply retracted their ventricle-contacting process.
Evidence for aNSCs initially came from in vitro studies showing
that isolated cells from the adult CNS can respond to growth factors
to generate neurospheres, which can then be induced to differentiate
into neuronal and glial lineages upon growth factor withdrawal
(Reynolds & Weiss, 1992). The neurosphere assay subsequently
emerged as an informative and powerful approach for gaining
insights into the biology of aNSCs and TAPs; however, it requires
meticulous care and attention to technical details to obtain results
that are valid, reproducible and interpretable (Coles-Takabe et al.,
2008; Pastrana et al., 2011). As described earlier, however, there
has been little consensus among studies concerning changes in neur-
osphere numbers with aging, and this variability probably stems
from the methodological inconsistencies evident in the experimental
protocols used. Moreover, there are important questions pertaining
to the interpretation of results obtained with the neurosphere assay,
particularly in aging studies. For instance, to what extent can non-
aNSCs (such as early TAP cells) be reprogrammed to generate self-
renewing neurospheres in vitro (Doetsch et al., 2002)? And will
aNSCs always grow into neurospheres in vitro, regardless of their
state in vivo (activated vs. quiescent vs. senescent)?
In light of the current technical limitations and challenges, great
care should be taken to make precise conclusions that take into
account the limitations of the methods used, and to avoid using all-
encompassing terms that mis-identify or blur the cell types impli-
cated (Seaberg & van der Kooy, 2003). Thus, at present, our under-
standing of the changes occurring to aNSCs vs. TAPs during aging
remains limited.
Possible mechanisms leading to age-related decline in
neurogenesis
Tissue aging is mediated by at least two forms of cellular aging.
Chronological aging affects all cells and refers to the time-depen-
dent deterioration in cellular functioning that occurs as a result of
normal ‘wear and tear’. Proliferating cells are additionally subject to
replicative aging, the deterioration in proliferative capacity resulting
from division-coupled telomere shortening and DNA damage (Ran-
do, 2006; Liu & Rando, 2011; Longo et al., 2012). Such aging pro-
cesses lead to a mitotic ‘clock’, a ﬁnite number of possible cell
divisions after which cells become senescent (the ‘Hayﬂick limit’;
Hayﬂick, 1965). In the case of adult neurogenesis, age-related
impairments could therefore be the result of (i) cell-autonomous
aging mechanisms occurring within the aNSC lineage itself; (ii)
non-cell-autonomous aging mechanisms occurring within the local
and systemic regulatory environments, or a combination of these
two processes. Cell-autonomous and/or non-cell-autonomous aging
processes can then ultimately impact upon any level(s) of the multi-
step neurogenic pathway, such as (i) cell cycle properties of aNSCs
and TAPs; (ii) expansion capacity of the TAP population; (iii) cell
death at any stage of the neurogenic pathway and (iv) lineage speci-
ﬁcation and fate choice (Fig. 3).
Cell autonomous causes?
Cells are generally believed to possess two main control systems to
restrict their proliferative potential: telomere shortening and cyclin-
dependent kinase inhibitors (Mandal et al., 2011). These control
systems act by increasing the cell cycle length and by promoting
entry into reversible quiescence or irreversible senescence. Such cell
cycle control is likely to be particularly beneﬁcial at younger ages,
preventing oncogenic transformation within the stem cell population,
but may be detrimental for neurogenic plasticity at later ages. In par-
ticular, as described below, there is striking evidence that circum-
venting these systems can help to prevent and/or reverse the effects
of aging on adult neurogenesis.
Telomerase is a reverse transcriptase that is highly expressed in
immortal embryonic stem cells and whose enzymatic activity coun-
teracts the telomere-shortening effects of cell division. Increasing
telomerase activity in cultured cells confers the ability for unlimited
proliferation, enabling them to avoid senescence (Bodnar et al.,
1998). Telomerase is generally absent within the adult brain, but it
remains detectable in the SVZ–olfactory system (Caporaso et al.,
2003). In late-generation telomerase knockout mice, there is wide-
spread acceleration of tissue aging, including suppression of SVZ
neurogenesis (Wong et al., 2003; Ferron et al., 2004). Remarkably,
these changes (including deﬁcits in SVZ neurogenesis and olfaction)
can actually be reversed by restoring telomerase expression in the
knockout mice (Jaskelioff et al., 2011).
Cyclin-dependent kinase inhibitors are classiﬁed into two
branches: the INK4 family (P16INK4a, p15INK4b, p18INK4c, p19INK4d)
and the Cip/Kip family (p21Waﬂ1/Cip, p27Kip1 and p57Kip2) (Sherr &
Roberts, 1999; Kim & Sharpless, 2006). The INK4 tumour suppres-
sion pathway is activated during aging in many tissues including the
bone marrow, liver, heart and renal cortex (Krishnamurthy et al.,
2004; Burd et al., 2013) and brain (Molofsky et al., 2006). Studies
have used p16INK4a-deﬁcient and p16INK4a-overexpressing mice to
assess the impact on self-renewal in hematopoietic stem cells, neural
stem cells and pancreatic islets and have concluded that p16INK4a
expression is one cause of aging in these tissues (Janzen et al.,
2006; Krishnamurthy et al., 2006; Molofsky et al., 2006). In all
three cell types, p16INK4a deﬁciency partially abrogated the age-
induced decline in proliferation. Expression of the INK4 family is
normally repressed by factors such Bmi1 and Hmga2. The transcrip-
tion factor Bmi1 promotes cell proliferation and self-renewal by
inhibiting INK4a/Arf, and Bmi-1-deﬁcient mice show widespread
deﬁcits, including inhibited proliferation in the postnatal SVZ (Mol-
ofsky et al., 2003, 2006). The transcriptional modulator Hmga2 is a
negative regulator of p16INK4a and p19ARF during development, but
is itself negatively regulated by the let-7 family of microRNAs,
whose expression increases during aging (Nishino et al., 2008).
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Expression of the Cip/Kip family member, p21, is likewise elevated
during aging in the cerebellum (Legrier et al., 2001), and p21-
knockout mice show an initial increase in proliferation followed by
a premature exhaustion of proliferation (Kippin et al., 2005).
One caveat to the interpretation of these studies on telomerase
and cell cycle regulators is that, although they demonstrate a role in
preventing and/or reversing aging-related changes in proliferation
and neurogenesis, it nevertheless remains uncertain whether age-
related changes to these systems are themselves involved in the
aging process (Burd et al., 2013). Studies have yet to provide direct
evidence for which cell types express altered levels of these proteins
during aging, as changes in cell cycle dynamics could impact expan-
sion of aNSCs and/or the TAP cells (Fig. 3A). Also, studies that
have looked at the effects of over-expressing or inhibiting these
pathways have rarely used more recently developed tissue-speciﬁc
or temporally controlled methods, and thus induce widespread deﬁ-
cits that make it difﬁcult to interpret the exact mechanism of the
observed effects.
Non-cell-autonomous causes?
The potential non-cell-autonomous causes of neurogenesis impair-
ments can conceptually be divided into reduced neurogenesis-pro-
moting signals and increased neurogenesis-inhibiting signals
(Fig. 3B). Within the young adult SVZ, a growing list of secreted
factor families has now been implicated in stem cell regulation and
neurogenesis, including (but not limited to) Ephrins (Conover et al.,
2000), Shh (Ahn & Joyner, 2005; Balordi & Fishell, 2007a,b),
EGFs (Kuhn et al., 1997; Doetsch et al., 2002; Pastrana et al.,
2009), FGFs (Kuhn et al., 1997; Frinchi et al., 2008), TNF-a
(Tropepe et al., 1997), Notch-Delta (Carlen et al., 2009; Imayoshi
et al., 2010), Noggin (Lim et al., 2000; Peretto et al., 2004), BMPs
(Lim et al., 2000; Peretto et al., 2004; Colak et al., 2008) and Wnts
(Adachi et al., 2007), making it easy to envisage that a de-regula-
tion of such factors could lead to impaired neurogenesis with age.
Exogenous application of some of these factors has been shown to
increase neurogenesis in older brains (Jin et al., 2003; Enwere et al.,
2004; Paliouras et al., 2012), showing that the ability of the SVZ to
respond to extrinsic signals is at least partially preserved during
aging. However, this does not prove that altered levels of these fac-
tors play a role during aging. To the contrary, the data investigating
whether endogenous quantities of these factors actually changes in
the SVZ during aging are mixed (Enwere et al., 2004; Frinchi et al.,
2010; Werry et al., 2010). Moreover, although declining receptor
levels for some factors have been reported (Enwere et al., 2004),
such reductions are probably secondary to the age-related loss of the
SVZ cells themselves.
Given the lack of information concerning actual changes occur-
ring with age, it appears that greater emphasis should be placed
on identifying aging-associated changes that take place within the
neurogenic environment and assessing their signiﬁcance for adult
neurogenesis. For example, some insight has recently been pro-
vided by a study using a parabiosis approach to link the circula-
tory systems of young adult and old mice, demonstrating that
age-related changes in blood-borne factors contribute to decreasing
neurogenesis (Villeda et al., 2011). Several other changes have
also recently been documented within the aging neurogenic envi-
ronment, including alterations in the composition of the CSF
(Zhang et al., 2005; Baird et al., 2012), ependymal cell loss from
stenosis of the ventricle walls (Shook et al., 2012) and accumula-
tion of lipid droplets within the aging ependyma (Bouab et al.,
2011). Importantly, aging of neural precursors and of their
A
B
Fig. 3. Possible mechanisms underlying impaired neurogenesis during aging. (A) Reduced neurogenic output could occur by alterations occurring at multiple
stages of the neurogenic pathway, including (1) changes in cell cycle dynamics that cause irreversible senescence, reversible quiescence or lengthening of the
cell cycle, (2) decreased expansion of the transiently amplifying progenitor (TAP) pool, (3) increased cell death and/or (4) altered neuronal lineage speciﬁcation.
(B) The above mechanisms of neurogenesis impairment could be due to aging of the adult neural stem cell (aNSC) lineage itself (cell-autonomous), aging of
the local or systemic environment (non-cell-autonomous), or both. In the case of non-cell-autonomous changes, the underlying causes would be a decrease in
neurogenesis-promoting factors or an increase in neurogenesis-inhibiting factors (arrows). The sources of such factors could be the systemic milieu [via blood
or cerebrospinal ﬂuid (CSF)], support cells of the subventricular zone niche (such as ventricle-lining ependymal cells or blood vessel endothelial cells) or cells
of the neurogenic lineage themselves (aNSCs, TAPs or neuroblasts).
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surrounding SVZ niche are likely to be inter-related events, and
it remains to be established whether such changes within the
niche contribute to, or are themselves caused by, age-related
decreases in neurogenesis.
Does irreversible stem cell exhaustion/loss/senescence occur
in the aging SVZ?
This key question remains to be answered due to the lack of consen-
sus amongst published ﬁndings and the current technical hurdles in
reliably identifying aNSCs described earlier. It is noteworthy, how-
ever, that alterations in the proliferation and/or cell cycle properties
of aNSCs and TAPs have been identiﬁed (Tropepe et al., 1997; Ah-
lenius et al., 2009; Bouab et al., 2011; Shook et al., 2012) and that
experiments de-regulating either cell-autonomous or non-cell-autono-
mous control mechanisms have shown that functional exhaustion of
SVZ stem cell activity can in principle occur (Kippin et al., 2005;
Imayoshi et al., 2010). Interestingly, radial glial-like neurogenic pre-
cursors in the dentate gyrus have been found to undergo a terminal
astrocytic differentiation, leading to the proposal of a ‘disposable’
model of neural stem cell (Encinas et al., 2011).
The implications of when, how and why SVZ
neurogenesis declines with age
Evolutionary theories of aging make the distinction between chrono-
logical age (measured in time) and biological age (measured in
terms of cellular function). Until now, studies of age-related declines
in adult neurogenesis have focused on chronological aging, and have
clearly established many of the consequences of the aging process
on adult neurogenesis: reduced cellular proliferation in the niche,
decreased numbers of progenitors and neuroblasts, and reduced
olfactory function. While these studies have left unresolved the issue
of upstream changes in aNSC and progenitor biology, they have
nevertheless established that the when of the biological aging of
adult neurogenesis occurs sometime between early adulthood and
middle-age, and signiﬁcantly before rodents are ‘old’. To uncover
the upstream cellular events and molecular mechanisms (i.e. the how
of declining neurogenesis), the experimental design of future studies
will need to be signiﬁcantly re-oriented towards younger ages, so
that more light is shed on the process of aging rather than its conse-
quences.
Given the functional importance of adult neurogenesis for cog-
nitive plasticity and brain maintenance, the why of age-related
declines in neurogenesis remains unknown. Evolutionarily, because
natural selection is largely geared towards improving reproductive
ﬁtness, one possibility is that there is simply insufﬁcient evolu-
tionary pressure to select for individuals that maintain high levels
of adult neurogenesis after reproductive age; indeed, in the hippo-
campus of various species, proliferation declines rapidly after the
age of ﬁrst reproduction (Kirkwood & Rose, 1991; Amrein et al.,
2011). A second possibility is that the cellular mechanisms
restricting neurogenesis as we get older are actually protective,
preventing tumor development and/or stem cell exhaustion from
occurring at earlier ages. Thus, different therapeutic objectives
may ultimately be desirable depending on one’s biological age:
reducing aNSC activity to the minimal amount necessary at early
ages to preserve the replicative life and genomic integrity of aNS-
Cs, vs. activating aNSCs at later ages to restore a minimal level
of adult neurogenesis in the old brain. The answers to these ques-
tions may have signiﬁcant implications for the design of future
therapeutic strategies.
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CELLULAR ORGANIZATION OF THE CENTRAL CANAL EPENDYMAL
ZONE, A NICHE OF LATENT NEURAL STEM CELLS IN THE ADULT
MAMMALIAN SPINAL CORD
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Abstract—A stem cell’s microenvironment, or “niche,” is a
critical regulator of its behaviour. In the adult mammalian
spinal cord, central canal ependymal cells possess latent
neural stem cell properties, but the ependymal cell niche has
not yet been described. Here, we identify important similari-
ties and differences between the central canal ependymal
zone and the forebrain subventricular zone (SVZ), a well-
characterized niche of neural stem cells. First, direct immu-
nohistochemical comparison of the spinal cord ependymal
zone and the forebrain SVZ revealed distinct patterns of neu-
ral precursor marker expression. In particular, ependymal
cells in the spinal cord were found to be bordered by a
previously uncharacterized sub-ependymal layer, which is
relatively less elaborate than that of the SVZ and comprised
of small numbers of astrocytes, oligodendrocyte progenitors
and neurons. Cell proliferation surrounding the central canal
occurs in close association with blood vessels, but unlike in
the SVZ, involves mainly ependymal rather than sub-ependy-
mal cells. These proliferating ependymal cells typically self-
renew rather than produce transit-amplifying progenitors, as
they generate doublets of progeny that remain within the
ependymal layer and show no evidence of a lineage relation-
ship to sub-ependymal cells. Interestingly, the dorsal pole of
the central canal was found to possess a sub-population of
tanycyte-like cells that express markers of both ependymal
cells and neural precursors, and their presence correlates
with higher numbers of dorsally proliferating ependymal
cells. Together, these data identify key features of the spinal
cord ependymal cell niche, and suggest that dorsal ependy-
mal cells possess the potential for stem cell activity. This
work provides a foundation for future studies aimed at un-
derstanding ependymal cell regulation under normal and
pathological conditions. © 2009 IBRO. Published by Elsevier
Ltd. All rights reserved.
Key words: mouse, sub-ependymal cells, differentiation, pro-
liferation, precursors, tanycytes.
Adult neural stem cells are responsible for maintaining and
repairing central nervous system (CNS) tissues. These
crucial functions are controlled by the stem cell’s “niche,”
that is, its adjacent cells, extracellular matrix molecules,
diffusible factors and circulating signals, which together
regulate stem cell survival, proliferation and differentiation
(Fuchs et al., 2004; Morrison and Spradling, 2008; Walker
et al., 2009). Understanding how neural stem cells and
their niches interact is critical for determining why stem
cells are highly neurogenic in some regions of the adult
nervous system and quiescent in others, for promoting
tissue regeneration following injury and disease, and for
re-establishing appropriate stem cell regulation in cancer
or in aging.
Neural stem cells possess an astrocytic phenotype in
the subventricular zone (SVZ) of the forebrain, which is the
most well-characterized stem cell niche in the adult CNS
(Chojnacki et al., 2009). The SVZ stem cell niche is com-
prised of quiescent ependymal cells, which line the lateral
ventricles, and a heterogenous mixture of sub-ependymal
cells that includes astrocytes, transit-amplifying progeni-
tors, neuroblasts, tanycytes, microglia, and blood vessels
(Doetsch et al., 1997; Shen et al., 2008; Tavazoie et al.,
2008; Pastrana et al., 2009). Sub-ependymal astrocytes
are neural stem cells in the SVZ; they generate transit-
amplifying progenitors, which produce migratory neuro-
blasts that replenish olfactory bulb interneurons (Lois and
Alvarez-Buylla, 1994; Doetsch et al., 1999; Imura et al.,
2003; Morshead et al., 2003). Astrocytic stem cells in the
SVZ retain an apical contact with the lateral ventricle and a
basal process that extends towards local vasculature (Mir-
zadeh et al., 2008; Shen et al., 2008; Tavazoie et al.,
2008). They normally divide slowly, but following experi-
mental depletion of SVZ cells, are capable of reconstituting
the principal SVZ cell populations (Morshead et al., 1994;
Doetsch et al., 1999).
Neural stem cells have also been isolated from the
ependymal zone surrounding the central canal of the spi-
nal cord (Weiss et al., 1996; Johansson et al., 1999; Mar-
tens et al., 2002). In the spinal cord, there is no defined
sub-ependymal layer, there is no neurogenesis, and
ependymal cells rather than astrocytes are the primary
source of in vitro stem cell activity (Meletis et al., 2008).
Little is known about the spinal cord ependymal cell niche,
but cuboidal, tanycytic and radial classes of lumen-con-
tacting, ciliated ependymal cells have been identified
(Bruni and Reddy, 1987; Meletis et al., 2008). The anti-
genic and functional differences between these three
classes of ependymal cells are unclear. However, ependy-
mal cells are rapidly activated following spinal cord injury,
proliferating and undergoing multi-lineage differentiation to
Abbreviations: BrdU, bromodeoxyuridine; CNS, central nervous sys-
tem; d, day(s); DAB, 3,3-diaminobenzidine; DIV, days in vitro; E,
embryonic; EGF, epidermal growth factor; FGF2, fibroblast growth
factor-2; GFAP, glial fibrillary acidic protein; P, postnatal; SVZ, sub-
ventricular zone.
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contribute astrocytes and oligodendrocytes to the injured
tissue. Thus, at least a sub-population of spinal cord
ependymal cells has latent neural stem cell properties
(Johansson et al., 1999; Namiki and Tator, 1999; Meletis et
al., 2008).
In the present study, we investigated whether key fea-
tures of the well-defined forebrain stem cell niche exist
surrounding the central canal. This detailed study of the
spinal cord ependymal zone revealed that important ele-
ments of the SVZ stem cell niche are conserved surround-
ing the central canal, but with a distinct organization. Iden-
tifying the cellular organization of the ependymal cell niche
will facilitate future efforts to understand and modify
ependymal cell regulation under normal and pathological
conditions.
EXPERIMENTAL PROCEDURES
Animals
Experiments were conducted in accordance with the guidelines of
the Canadian Council of Animal Care and were approved by the
institutional Animal Care committee. A total of 70 two-month-old
CD1 mice (Charles River Laboratories, St. Constant, QC, Can-
ada) were used. For bromodeoxyuridine (BrdU) incorporation ex-
periments, mice were administered three 100 !l intraperitoneal
injections of BrdU (Sigma, 1.5 mg/injection) at 3 hour intervals,
and were sacrificed either 1 or 21 days later.
Neurosphere cultures from the adult spinal cord
Mice were given a lethal dose of chloral hydrate (7%) and a 12–16
mm segment from each lumbar spinal cord was dissected into ice
cold HBSS (Wisent). Spinal cords were dissociated to single cells
using papain (Worthington). Cells were re-suspended in 30 ml of
DMEM/F12 (3:1) (Invitrogen) supplemented with 1% Penicillin/
Streptomycin (Wisent), 1 !g/ml Fungizone (Invitrogen), 2% B27
(Invitrogen), 20 ng/ml epidermal growth factor (EGF) (Sigma) and
25 ng/ml fibroblast growth factor-2 (FGF2) (Sigma). The medium
was replenished with EGF and FGF2 every 3–4 days and with
B27 every week. To assess self-renewal and obtain greater num-
bers of neurospheres, primary spheres grown for 14 days were
passaged by centrifugation, the pellet dissociated by trituration,
and the cells re-plated under the same conditions.
To differentiate neurospheres for Western blotting and immu-
nocytochemistry, secondary neurospheres were gently triturated
and plated onto poly-L-lysine-coated dishes (0.02 mg/mL in sterile
water; Sigma) in medium consisting of DMEM/F12 (3:1) (Invitro-
gen) supplemented with 1% Penicillin/Streptomycin (Wisent), 1
!g/ml Fungizone (Invitrogen), 2% B27 (Invitrogen), 1% fetal bo-
vine serum (Wisent), 2 ng/ml EGF (Sigma) and 2 ng/ml FGF2
(Sigma). Differentiated cells were either lysed for Western blotting
or fixed in 4% paraformaldehyde for 15 min for immunocytochem-
istry. Secondary spheres were characterized by plating them as
above and processing them for immunocytochemistry after 4–6
hours.
Western blotting
For biochemical analyses, spinal cord-derived neurospheres were
lysed using Ripa Buffer (1 M Tris pH 8, 5 M NaCl, NP-40 10%,
SDS 10%, Sodium Desoxycholate 10% in dH20) supplemented
with sodium vanadate (25 !l/5 ml Ripa Buffer, Fisher) and pro-
tease inhibitors (Complete Mini, Roche Diagnostics). Protein con-
centrations were determined using the bicinchoninic acid assay
(Pierce). Twenty-five micrograms of protein from each sample
was boiled in sample buffer (0.5 M Tris–HCl pH 6.8, glycerol, SDS
10%, Bromophenol blue, "-mercaptoethanol), separated using
SDS-PAGE (10% acrylamide), and transferred onto a Nitrocellu-
lose membrane (0.45 !m, Bio-Rad). Membranes were immersed
in Ponceau Red (0.2% Ponceau S (Fisher) in 11% trichloroacetic
acid (Fisher)) to visualize the proteins, washed in Tris–buffered
saline containing 0.2% Tween (TBS-T) and blocked in 5% skim
milk powder (Carnation). They were then incubated overnight at
4 °C with primary antibody. The following antibodies were used:
mouse anti-rat "III tubulin (1:1000, Covance), mouse anti-human
CNPase (1:1000, Chemicon), rabbit anti-cow GFAP (1:1000,
Dako), and mouse anti-Xenopus "-actin (1:10 000, Abcam). HRP-
conjugated secondary antibodies, diluted in blocking solution,
were used as follows: anti-mouse IgG (1:5000, Bio-Rad) or anti-
rabbit IgG (1:5000, Chemicon). Secondary antibodies were de-
tected using the ECL chemiluminescence reagent kit (GE Health
Care) and X-Omat Blue film (Kodak). Membranes were subse-
quently stripped with Re-Blot Plus Mild (Millipore), re-blocked and
re-probed as described above.
Immunohistochemistry
Tissue processing and basic immunohistochemical procedures
were performed as detailed in Bednarczyk et al. (Bednarczyk et
al., in press).
The primary antibodies used were mouse anti-human Ki67
(1:200, BD Biosciences), mouse anti-mouse NeuN (1:200, Chemi-
con), chicken anti-Vimentin (1:1000, Chemicon), rabbit anti-
mouse Olig2 (1:500, Chemicon), rabbit anti-rat NG2 (1:200,
Chemicon), mouse anti-rat "III tubulin (1:500, Covance), rabbit
anti-human GAD65 (1:1000, Chemicon), rabbit anti-human Sox2
(1:1000, Chemicon), mouse anti-rat Mash-1 (1:100, BD Bio-
sciences), mouse anti-human CNPase (1:500, Chemicon), rabbit
anti-cow GFAP (1:1000, Dako), mouse anti-pig GFAP (1:1000,
Chemicon), mouse anti-rat Nestin (1:400, BD Biosciences),
chicken anti-Nestin (1:5000, Novus), rabbit anti-cow S100" (1:
1000, Sigma), mouse anti-cow S100, " subunit (1:1000, Sigma),
rat anti-mouse PECAM (1:300, BD Pharmingen) and rat anti-BrdU
(1:200, AbD Serotec).
For bright-field immunohistochemistry, primary antibodies
bound to sections were detected using the species-appropriate
biotinylated secondary antibody (Jackson ImmunoResearch, PA,
USA), the signal was amplified using the avidin–biotin-peroxidase
system (VectaStain ABC Kit, Vector Laboratories), and revealed
using a 3,3-diaminobenzidine (DAB)-containing solution (Bednar-
czyk et al., in press). For fluorescence immunohistochemistry,
primary antibodies were detected using species-appropriate sec-
ondary antibodies that were conjugated to either CY3 (1:400,
Jackson ImmunoResearch), Alexa 488 (1:1000, Invitrogen) or
Alexa 647 (1:1000, Invitrogen). Nuclear counterstaining was per-
formed using either Hoechst 33342 (0.2 !M, Sigma) or TOPRO-3
(1 !M, Invitrogen). For fluorescence double-labelling using anti-
Ki67 and anti-Nestin antibodies, which were both raised in mouse,
we used a sequential immunofluorescence procedure. Briefly, the
same procedure was followed except that after the application of
the Nestin primary antibody and detection using the anti-mouse
CY3 secondary antibody, the sections were re-blocked for 30 min
prior to incubation with the anti-Ki67 antibody. Fluorescence triple-
labelling of BrdU, Ki67 and Vimentin was as described in (Bed-
narczyk et al., in press).
Microscopy was performed using either a motorized Olympus
IX81 microscope equipped with a black and white CCD camera or
a Leica SP1 laser-scanning confocal microscope. To generate
multi-channel images, black and white images were colorized and
merged using Adobe Photoshop. Image manipulations were lim-
ited to Brightness/Contrast, and were performed in a standardized
manner to all images. Images were assembled into figures using
Adobe Illustrator.
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Resin-embedded semi-thin sections
Some sections processed for bright-field immunohistochemistry
were further sectioned to 1 !m thickness to improve resolution of the
signal. Following application of the DAB solution, sections were
rinsed in phosphate buffer, fixed with 1% osmic acid (Electron Mi-
croscopy Science) for 30 min, dehydrated in a graded series of
ethanols and propylene oxide (Fisher) and then embedded in elec-
tron microscopy grade Resin (Durcapan ACM, Sigma). Resin-em-
bedded sections were cut at 1micron thickness on an ultramicrotome
(Ultracut E, Reichert Jung), counterstained with 0.5–1% toluidine
blue and mounted on slides. They were then coverslipped using
Permount, and examined using bright-field illumination.
Quantification of proliferating cells surrounding the
central canal
The distribution of Ki67(!) cells surrounding the central canal was
quantified following DAB-based and fluorescence-based immuno-
histochemistry. Diagrams were prepared in which the ependymal
layer and sub-ependymal region of the central canal were each
divided into dorsal, dorsomedial, ventral and ventromedial zones.
Following DAB-immunohistochemistry, the ependymal layer was
identified morphologically under phase-contrast illumination and
the locations of Ki67(!) cells were recorded from 28–38 coronal
sections from each of five animals. For fluorescence immunohis-
tochemistry, the ependymal layer was identified based on Vimen-
tin expression and the locations of Ki67(!) cells were recorded
from 32–36 coronal sections from each of four additional animals.
Cells were considered to belong to the region where the majority
of the cell was located. For each animal, 100% was set to the total
number of Ki67(!) cells, and the percentage of cells in each of the
eight zones was calculated. Using both methods, summary dia-
grams were built by averaging the percentage of Ki67(!) cells per
zone from all animals.
Quantification of blood vessels surrounding the
central canal
The distribution of blood vessels surrounding the central canal and
their proximity to proliferating ependymal cells was quantified
following triple-label immunofluorescence for Ki67 and Vimentin
and the endothelial marker PECAM. The central canal ependymal
zone was again identified based on Vimentin expression. Dia-
grams were prepared where the central canal ependymal and sub-
ependymal zones had three horizontal lines drawn through them; the
first line was drawn directly through the midline and the other two
were drawn at the dorsal and ventral extremities of the central canal.
The quantification of PECAM (!) blood vessels was achieved by
counting the number of times a blood vessel intersected either the
dorsal, medial or ventral horizontal lines. The total number of blood
vessel intersections with dorsal, medial and ventral lines was com-
piled from 10 coronal sections from each of three animals. Ki67(!)
cells were simultaneously recorded as above.
RESULTS
Isolation and characterization of neurospheres from
the adult mouse lumbar spinal cord
Multipotent neurospheres can be cultured from the adult
mouse spinal cord (Weiss et al., 1996; Meletis et al., 2008).
We were able to generate neurosphere cultures from the
adult mouse lumbar spinal cord (Fig. 1) that expanded
rapidly in vitro (Fig. 1a–d) and expressed typical neural
stem cell markers such as Nestin, Sox2 and CD133 (Fig.
1e–j). Although neurogenesis does not occur in the adult
spinal cord, spinal cord-derived neurospheres differenti-
ated into neurons, astrocytes and oligodendrocytes in vitro
(Fig. 1k–m), including GABAergic neurons (Fig. 1n–p).
These experiments confirmed that multipotent, neurogen-
ically competent neural stem cells can be isolated from the
adult spinal cord. To better understand the in vivo regula-
tion of spinal cord-derived stem cells, we characterized the
ependymal cell niche, which is the origin of multipotent,
self-renewing spinal cord-derived neurospheres (Johans-
son et al., 1999; Martens et al., 2002; Meletis et al., 2008).
SVZ-associated neural precursor markers are
expressed surrounding the central canal
Immunohistochemical comparison of the forebrain SVZ
and spinal cord ependymal zone showed that markers of
SVZ-associated cell lineages are also found surrounding
the central canal (Fig. 2). Ependymal cells of both the
forebrain SVZ and the spinal cord central canal expressed
Vimentin and S100" (Fig. 2a, b). Transit amplifying type C
progenitor cells in the forebrain SVZ are located sub-
ependymally and express NG2 and the nuclear transcrip-
tion factors Olig2 (Fig. 2c, d) and/or Mash1 (not shown)
(Doetsch et al., 1997; Aguirre et al., 2004). In the spinal
cord, small numbers of NG2 and Olig2-expressing cells
were likewise present directly adjacent to the ependymal
cells, as well as scattered throughout the parenchyma (Fig.
2c, d). Mash1, which is associated with neurogenic SVZ
progenitors, was not detected in the spinal cord (data not
shown). Type B astrocytes and astrocytic stem cells in the
forebrain SVZ are located sub-ependymally and express
glial fibrillary acidic protein (GFAP) (Fig. 2e) (Doetsch et
al., 1999). Surrounding the central canal, we observed (i)
frequent GFAP-immunoreactive fibers of sub-ependymal
astrocytes that extended into the ependymal layer and (ii)
rare GFAP-immunoreactive cell bodies within the dorsal
ependymal layer itself that possessed dorsally projecting
processes (Fig. 2e). Ki67-immunoreactive proliferating
cells, which are restricted to the sub-ependymal layer of
the forebrain SVZ, were less common surrounding the
central canal and found within the ependymal layer itself
(Fig. 2f). Both sub-ependymal and ependymal cells in the
forebrain SVZ express Nestin and the transcription factor
Sox2 (Fig. 2g, h). Within the spinal cord, Nestin immuno-
reactivity was not detected in the majority of ependymal
cells, but it was prominently expressed by a sub-population
of cells at the dorsal pole of the ependymal zone (Fig. 2g).
These dorsal Nestin-expressing cells possessed long Nes-
tin-immunoreactive filaments that extended along the dor-
sal midline. Similar fibers were sometimes seen extending
from the ventral pole and occasionally from the lateral
ependymal zone (Fig. 2g), but these displayed far weaker
Nestin immunoreactivity. Sox2, unlike Nestin, was highly
expressed throughout the ependymal zone of the central
canal (Fig. 2h), as well as in some sub-ependymal cells.
Together, this comparison revealed that several mark-
ers of SVZ-associated neural precursor lineages are also
expressed in the ependymal and/or sub-ependymal zones
of the adult spinal cord. To understand the composition of
the ependymal cell niche, we investigated these observa-
tions in greater detail.
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Fig. 1. Isolation and characterization of neurospheres from the adult mouse lumbar spinal cord. Lumbar spinal cords of adult mice were dissected,
dissociated and plated using standard neurosphere forming conditions. Small spheres were visible after 1 week and reached full size after 14 days in vitro
(DIV) (Fig. 1a), at which time they were similar in size and morphology to 7 DIV forebrain neurospheres (not shown). Passaged primary (1°) neurospheres
generated secondary (2°) neurospheres after 7 DIV (Fig. 1b). Quantification of the total number of 1° (c) and 2° (d) neurospheres obtained per mm of spinal
cord showed that up to 30 1° spheres were grown per mm of lumbar spinal cord; upon passaging, these spheres generated up to 1600 2° spheres/mm. Using
the same culture conditions, approximately 800 primary spheres are typically generated from a single adult striatal SVZ (data not shown) Note that the cellular
debris from the spinal cord seen in 1° cultures (a) was removed upon passaging (b). Immunohistochemistry for various stem/progenitor/proliferation markers
on 2° neurospheres (e–j), illustrating that Nestin, CD133, Sox2, Olig2 and Ki67 were abundantly expressed (e–i) while NG2 was not present at detectable
levels (j). 2° neurospheres were differentiated and assessed for multipotentiality byWestern blot analysis and immunocytochemistry using antibodies against
neurons (!III tubulin), astrocytes (GFAP) and oligodendrocytes (CNP) (k–m). Analysis by Western blotting revealed the absence of neuron, astrocyte and
oligodendrocyte markers in undifferentiated 2° spheres and their appearance after as little as 3 days (d) of differentiation (k). After 9 d of differentiation, cells
displaying the appropriate morphologies for all three neural cell types were detectable by immunocytochemistry (l, m). After 18 d of differentiation, a
sub-population of !III tubulin-expressing neurons co-expressed the GABAergic marker GAD65 (arrow, n–p). Differentiated cultures were counterstained with
Hoechst 33342 to identify nuclei (l, n, p). Scale bar in b!120 "m (for a, b), in j!20 "m (for e–j), in p!10 "m (for l–p).
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The central canal possesses a rudimentary
sub-ependymal zone
Unlike the forebrain SVZ, the central canal lacks a distinct
layer of sub-ependymal cells. Given the expression of
neural precursor markers surrounding the central canal,
we used two different approaches to assess the possibility
that small numbers of sub-ependymal cells may neverthe-
less be present. First, we performed immunofluorescence
for the ependymal cell marker Vimentin and counter-
stained with the general nuclear marker TOPRO-3 (Fig.
3a). Using this approach together with confocal micro-
scopy, we identified the nuclei of numerous Vimentin(–)
cells that were tightly apposed to the Vimentin-expressing
ependymal layer. We confirmed this observation on 1 !m
semi-thin sections using DAB-based immunohistochemis-
try for a second ependymal cell marker, S100" and
counter-stained with toluidine blue (Fig. 3b); again, we
observed the nuclei of numerous S100"(!) cells juxta-
Fig. 2. Comparison of neural precursor marker expression within the forebrain subventricular zone (SVZ) and the spinal cord ependymal zone.
Fluorescence immunohistochemistry was performed on 40 !m sections of the forebrain SVZ and spinal cord central canal. Forebrain ependymal cell
markers Vimentin (a) and S100" (b) were expressed by ependymal cells lining the central canal. The forebrain progenitor markers NG2 (c) and Olig2
(d) were not expressed within the ependymal layer of the spinal cord, but were often present adjacent to the ependymal layer (short arrows). GFAP
(e), a marker of forebrain neural stem cells and astrocytes, was expressed by sub-ependymal astrocytes immediately adjacent to the spinal cord
ependymal layer (e, short arrow), and GFAP immunoreactivity was also observed at the dorsal pole of the central canal ependymal layer (e, long
arrow). Ki67 (f), a marker of proliferating cells, was exclusively expressed sub-ependymally in the forebrain but was concentrated within the ependymal
layer surrounding the central canal. Nestin (g), a marker of undifferentiated stem cells and progenitors throughout the forebrain SVZ, was expressed
at the poles of the spinal cord ependymal layer (long arrow) and displayed long, dorsally directed projections. Sox2 (h), a second neural stem cell and
progenitor marker in the forebrain SVZ, was expressed by all the ependymal cells of the central canal as well as by some sub-ependymal cells just
outside of this zone (short arrow). In all panels, white lines illustrate the approximate borders of the ependymal layer. Scale bars"15 !m.
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posed against the S100!(!) ependymal cells. Cells that
were in close contact with the ependymal layer were surpris-
ingly abundant using both these approaches, as we typically
observed about 6 cells/1 "m cross-section through the cen-
tral canal. To determine the antigenic profile of these sub-
ependymal cells we used multi-label immunofluorescence.
These experiments revealed multiple cell types within the
immediate microenvironment of ependymal cells, including
GFAP(!)Sox2(!) astrocytes, Olig2(!) oligodendrocyte pro-
genitors and NeuN(!) neurons (Fig. 3c–e). In addition,
Olig2(!) cells were often observed along the basal pro-
cesses of ependymal cells (Fig. 3f). Thus, the ependymal cell
niche includes several sub-ependymal cell types that closely
border the ependymal layer.
Proliferating ependymal cells are concentrated dorsally
Previous work has used BrdU incorporation into the DNA
of dividing cells to reveal the existence of small numbers of
constitutively proliferating spinal cord ependymal cells
(Horner et al., 2000). To identify and characterize the cells
proliferating surrounding the central canal in greater detail,
we performed immunohistochemistry for Ki67, a marker
expressed by actively proliferating cells at all stages of
their cell cycle (Fig. 4). Proliferating cells were identified
throughout the grey and white matter, as well as surround-
ing the central (Fig. 4a). Between zero and nine Ki67(!)
cells were observed in the ependymal/sub-ependymal lay-
ers per section (Fig. 4b, c).
To assess the distribution of proliferating cells sur-
rounding the central canal, spinal cord cross-sections were
analyzed for Ki67 expression using DAB immunohisto-
chemistry and phase-contrast microscopy (Fig. 4d–g).
Ki67(!) cells were primarily found in the ependymal layer,
however a small number of proliferating cells appeared to
have a sub-ependymal localization (Fig. 4d, e). Quantifi-
cation of the dorso-ventral distribution of Ki67(!) cells
Fig. 3. Detection of sub-ependymal cells in close apposition to the ependymal cell layer of the central canal. Confocal image of immunofluorescence
for the ependymal cell marker Vimentin and the general nuclear marker TOPRO-3 (a). Multiple unlabelled nuclei are found directly adjacent to the
Vimentin(!) ependymal cells (arrows). 1 "m semi-thin section stained for the ependymal cell marker S100! using DAB-immunohistochemistry and
counterstained with toluidine blue (b). The nuclei of several S100!(") cells (arrows) are closely apposed to the S100!(!) ependymal cell layer.
Immunohistochemical characterization of sub-ependymal cells (c–e). Sub-populations of Vimentin(–) sub-ependymal cells were observed that were
either GFAP(!)Sox2(!) (c), Olig2(!) (d) or NeuN(!) (e) (arrows). Olig2(!) cells could also be observed along the radial fibers of Vimentin(!) dorsal
ependymal cells (f) (arrows). Scale bars in a, b, e (for c–e) and f#10 "m.
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revealed that all five animals examined possessed a
greater number of Ki67(!) cells at the dorsal pole com-
pared to the ventral pole, and in four of the five animals this
difference was at least two-three fold (Fig. 4f). Group anal-
ysis revealed a dorsal-to-ventral proliferation gradient in
the ependymal layer with more than three times as many
proliferating cells found within the dorsal ependymal zone
(33.6"2.41%) when compared to the ventral ependymal
zone (10.2"4.04%) (Fig. 4g).
To verify the dorsal concentration of ependymal cell
proliferation, as well as to more reliably distinguish be-
tween ependymal and sub-ependymal cells, we performed
double-label immunofluorescence with Ki67 and Vimentin
and repeated the above analysis using four additional
Fig. 4. Proliferating ependymal cells are concentrated dorsally. Schematic showing the distribution of proliferating cells throughout the grey and white
matter of the spinal cord (a). The locations of Ki67 immunoreactive cells were compiled from 20–25 coronal sections from each of three animals.
Quantification of the number of Ki67(!) ependymal and sub-ependymal cells per sections (b). Between 0 and 9 cells were counted per section. A
representative image of Ki67(!) cells in the ependymal zone is shown in (c). The dorsal-ventral and ependymal/sub-ependymal distributions of
proliferating cells surrounding the central canal were determined using both DAB-immunohistochemistry for Ki67 (d–g) and fluorescence immuno-
histochemistry for Ki67 and Vimentin (h–k). The ependymal (E) and sub-ependymal (SE) regions were each sub-divided into four zones along the
dorso-ventral axis: dorsal, dorsomedial, ventromedial and ventral. Using both DAB and fluorescence immunohistochemical approaches, the majority
of Ki67(!) proliferating cells were found to be located in the ependymal layer (d, h). Ki67(!) nuclei were also infrequently detected in cells located
adjacent to the ependymal layer (e, i). Individualized data of the percentage of Ki67(!) cells found within the dorsal ependymal (DE), dorsomedial
ependymal (DME), ventromedial ependymal (VME), ventral ependymal (VE), and total SE zones using each immunohistochemical method is shown
in (f, j), and summary diagrams of the group percentages of Ki67(!) cells/zone is shown in (g, k). Note that both approaches revealed that higher
numbers of Ki67(!) proliferating ependymal cells are located dorsally. For DAB-immunohistochemistry, data were compiled from 28–38 sections/
animal, 13–32 cells/animal, n#5 animals. For fluorescence immunohistochemistry, data were compiled from 32–36 sections/animal, 51–79 cells/
animal, n#4 animals. Scale bar in c#10 !m and i#15 !m (for d, e, h, i).
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animals (Fig. 4h–k). The vast majority of proliferating cells
were found to be Vimentin(!) ependymal cells (Fig. 4h),
however a small number of Vimentin(–) proliferating cells
were also observed sub-ependymally (Fig. 4i). When the
dorsal-ventral analysis was repeated as above, approxi-
mately 95% of proliferating cells surrounding the central
canal were found to be Vimentin(!) ependymal cells and
5% were Vimentin(–) sub-ependymal cells (Fig. 4j, k). The
number of sub-ependymal cells identified with this ap-
proach may be an underestimation, as cells were only
classified as sub-ependymal when they were clearly not
co-labelled with Vimentin. Using this more stringent clas-
sification strategy, all animals again possessed a greater
number of Ki67(!) cells at the dorsal pole compared to the
ventral pole, with individual dorsal-ventral pole differences
ranging from 1.5 to 10 fold (Fig. 4j). Group data confirmed
a dorsal concentration of Ki67(!) proliferating ependymal
cells, with 30.0"1.67% of proliferating cells within the dor-
sal ependymal zone versus 11.6"2.90% in the ventral
ependymal zone (Fig. 4k).
Together, these results reveal an asymmetric distribu-
tion of ependymal cell proliferation surrounding the central
canal, with higher numbers of proliferating ependymal cells
located at the dorsal pole.
Proliferating central canal ependymal cells undergo
self-renewing divisions in close proximity to local
vasculature
Recent studies indicate that neural precursor proliferation
in both the forebrain SVZ and the hippocampal subgranu-
lar zone occurs in close association with blood vessels
(Palmer et al., 2000; Shen et al., 2008; Tavazoie et al.,
2008). To assess whether proliferating ependymal cells
possess a similar relationship with blood vessels, sections
of the spinal cord were processed for fluorescence immu-
nohistochemistry for Vimentin, Ki67 and platelet endothe-
lial cell adhesion molecule (PECAM), an endothelial cell
marker. This analysis failed to provide evidence for a clear
relationship between blood vessels and ependymal cell
proliferation, as proliferating ependymal cells were often
non-existent when vessels projected into the ependymal
layer itself (Fig. 5a, b). Since the relationship between
neural precursor proliferation and the vasculature in the
SVZ was likewise not evident until examined in the rostro-
caudal longitudinal direction (Shen et al., 2008; Tavazoie
et al., 2008), we also analyzed longitudinal sections of the
spinal cord (Fig. 5c, d). Ki67(!)Vimentin(!) ependymal
cells were found at regular intervals along the rostro-
caudal axis and were visualized almost exclusively in
doublets (Fig. 5c, d), in contrast to what was observed
using coronal sections (Fig. 4b). Moreover, the exami-
nation of these longitudinal sections revealed that dou-
blets of Ki67(!)Vimentin(!) cells surrounding the central
canal were consistently located within approximately 12
microns of the PECAM-immunolabelled blood vessels
(Fig. 5d). While Ki67(!) cells were concentrated dorsally
(Fig. 4), quantification showed no evidence for a differential
distribution of blood vessels between dorsal, medial and ven-
tral regions of the central canal (1.1"0.14, 1.2"0.22, and
1.03"0.24 blood vessel intersections/section, respectively).
Taken together, these data indicate that ependymal cell prox-
imity to blood vessels is necessary but not sufficient to stim-
ulate their proliferation.
While proliferation in the forebrain SVZ is mediated by
rapidly dividing transit-amplifying progenitors, proliferating
ependymal cells did not show evidence of producing such
transit-amplifying progenitors under normal conditions. Di-
viding cells were tagged by administering BrdU to a group
of animals that were sacrificed either 1 or 21 days post-
injection (Fig. 5e–i). As expected from the Ki67 results
(above), virtually all ependymal cells that incorporated
BrdU 1 day earlier were found in doublets (97.5"1.25%)
and still expressed Ki67 (97.6"1.94%). The vast majority
of BrdU-retaining cells remained in doublets even after 21
days (90.2"5.95%). The small fraction of single BrdU-
retaining cells may simply represent doublets that were
divided upon sectioning of the tissue. Of the 21 day BrdU-
retaining cells, only 51.4"3.84% remained proliferative
(i.e. double-labelled with Ki67) (Fig. 5h, i). There were no
cases of BrdU(!) doublets composed of one Ki67(#) cell
and one Ki67(!) cell, and all BrdU(!) doublets were com-
posed of Vimentin(!) ependymal cells. Thus, unlike astro-
cytic forebrain stem cells, dividing spinal cord ependymal
cells do not produce rapidly dividing transit amplifying pro-
genitors under normal conditions. The fact that both
daughter cells remain within the ependyma is suggestive
of symmetrical ependymal cell division, and implies that
the primary function of ependymal cell proliferation under
normal circumstances is ependymal cell maintenance.
Neural precursor markers are expressed at the
dorsal pole of the central canal
In the forebrain SVZ, Nestin and GFAP are markers of
undifferentiated neural precursors and astrocyte-like neu-
ral stem cells, respectively. Given the concentration of
ependymal cell proliferation at the dorsal pole of the central
canal, we studied the Nestin and GFAP immunoreactivity
that was previously observed in this dorsal area (Fig. 2) in
greater detail.
Multiple approaches demonstrated that dorsal ependy-
mal cells preferentially express Nestin. Using DAB-immu-
nohistochemistry, Nestin-immunoreactive fibers could be
observed extending from the dorsal ependymal layer and
spanning the entire distance of the grey matter to the
dorsal columns (Fig. 6a). At higher magnification, similar
fibers displaying much weaker Nestin immunoreactivity
could also be detected extending from the ventral ependy-
mal layer (Fig. 6b). This pattern of Nestin immunoreactivity
was confirmed using two separate antibodies to Nestin
(not shown). On 1 !m semi-thin sections, Nestin immuno-
reactivity was detected in the apical cytoplasm and basal
processes of cells whose nuclei were located within the
dorsal ependymal layer (Fig. 6c). Moreover, when sections
were triple-labelled using immunofluorescence for Nestin
and the ependymal markers Vimentin and Sox2, analysis
by confocal microscopy confirmed that the Nestin(!) dor-
sal cells express ependymal cell markers (Fig. 6d). In order
to determine if the Nestin(!) dorsal ependymal cells con-
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tributed to the dorsal concentration of proliferation that we
previously observed (Fig. 4), we double-labelled sections
for Ki67 and Nestin. Proliferating cells in the dorsal ependy-
mal layer typically expressed Nestin and had a basal process
(Fig. 6e). Thus, dorsal ependymal cells are strongly immuno-
reactive for a marker of undifferentiated neural precursors,
Nestin, and proliferating cells in this dorsal region are part of
the Nestin(!) population.
The same immunohistochemical analyses were car-
ried out to evaluate GFAP immunoreactivity within the
dorsal ependymal layer (Fig. 6f–j). Under epi-fluorescence
illumination, GFAP-immunoreactive processes were com-
monly observed projecting into the ependymal layer (Fig.
2e), however it was not always apparent whether the cell
bodies of origin were ependymal cells or sub-ependymal
astrocytes. When using DAB-immunohistochemistry, GFAP-
immunoreactive cell bodies could be observed within the
ependymal layer itself (Fig. 6g, h). These cells were mainly
located at the dorsal pole of the ependymal zone, and
possessed both a lumen-contacting apical process and a
dorsally-projecting basal process on semi-thin sections (Fig.
6h). Confocal microscopy of triple-labelling with GFAP, Vi-
mentin (which under normal conditions is solely expressed
by ependymal cells, and not by GFAP-expressing astro-
cytes, Fig. 3c) and Sox2 (which is expressed by both
ependymal cells and astrocytes, Fig. 3c) indicated that the
GFAP-expressing cells are antigenically consistent with
being ependymal cells (Fig. 6i). The same findings were
made using two separate GFAP antibodies (not shown).
Quantification of GFAP(!)Vimentin(!) cells revealed an
average of 1.91"0.54 cells/section (n#3 animals, 15 sec-
tions/animal). These cells had a dorsal-to-ventral gradient
with 82.2"19.5% located dorsally, 11.4"13.2% medially,
and 6.38"6.32% ventrally. Interestingly, when we per-
Fig. 5. Ependymal cells divide near the surface of blood vessels and do not produce transit-amplifying progenitors. Triple-label immunofluorescence
for Vimentin, Ki67 and PECAM on coronal (a, b) and longitudinal (c, d) sections through the spinal cord ependymal zone. Ki67(!) proliferating
ependymal cells do not exhibit a consistent relationship with PECAM(!) blood vessels on coronal sections, as they were often absent when vessels
passed through the ependymal layer (a, arrow) and were often present at locations not immediately adjacent to blood vessels (b, arrow). When
examined on longitudinal sections, however, Ki67(!) proliferating cells within the Vimentin(!) ependymal zone were typically found in doublets (c, d
arrows) and were invariably associated with blood vessels (d, arrows). To assess the fate of proliferating ependymal cells, fluorescence immunohis-
tochemistry was performed for BrdU, Ki67 and Vimentin on longitudinal spinal cord sections of mice treated with BrdU either 1 day (d) or 21 d earlier
(e–h). Vimentin immunoreactivity was used to locate the regions containing the ependymal layer. Quantification of the percentage of BrdU-
incorporating cells found in doublets or expressing Ki67 after 1 d (n#3) and 21 d (n#3) (e). Virtually all BrdU(!) cells were found in doublets at both
time points, indicating that transit-amplifying progenitors are not produced (e). Doublets were almost all Ki67(!) at 1 d (e, f, g) but 50% of these
doublets were no longer Ki67(!) after 21 d (e, h, i). Errors bars represent the standard error of the mean (SEM) of these data. Scale bar in b#10 !m
(for a, b), d#35 !m (for c, d) and in i#6 !m (for f–i).
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formed double-labelling for GFAP and Ki67, we did not
observe proliferating GFAP(!) cells within the ependymal
layer (Fig. 6j), indicating either that GFAP(!)Vimentin(!)
cells do not proliferate or that they proliferate only rarely.
However, it is intriguing that the distribution of GFAP(!)
immunoreactive cells directly correlates with the prolifera-
tion gradient previously observed (Fig. 4).
Collectively, the selective expression of Nestin and
GFAP by cells in the dorsal ependymal zone contributes to
an unexpected degree of cellular heterogeneity within the
ependymal cell niche, as summarized in a model in Fig. 7.
DISCUSSION
Unlike the highly neurogenic astrocyte-like stem cells of
the forebrain SVZ, ependymal cells of the spinal cord are
normally relatively quiescent, only displaying stem cell
properties following tissue injury or in culture (Frisen et al.,
1995; Johansson et al., 1999; Martens et al., 2002; Meletis
et al., 2008). In the present study, we analyzed the cellular
organization of the spinal cord ependymal cell niche. We
show that the spinal cord ependymal zone possesses
many key features of the SVZ stem cell niche, however
with a distinct organization. The model of the ependymal
cell niche provided by this work (Fig. 7) will facilitate further
investigation of the cellular and molecular mechanisms
controlling the stem cell properties of spinal cord ependy-
mal cells.
A rudimentary sub-ependymal layer surrounds the
central canal
Although the central canal is known to lack a distinct
sub-ependymal layer, we identified small numbers of sub-
ependymal cells that were situated immediately adjacent
to the ependymal layer and that were antigenically distinct
from ependymal cells. These cells expressed markers of
astrocytes, oligodendrocyte progenitors and neuronal
cells, which are likewise found (in higher numbers) within
the forebrain SVZ. It is important to note that, despite
similarities in the composition of sub-ependymal cell types
in the SVZ and spinal cord, there are fundamental differ-
ences. Within the SVZ, sub-ependymal cells constitute a
direct lineage, from astrocyte-like stem cells to transit-
amplifying progenitors to migratory neuroblasts and glio-
blasts. This highly neurogenic astrocytic stem cell-derived
Fig. 6. Expression of Nestin and GFAP within the dorsal ependymal layer. DAB immunohistochemistry for Nestin (a–c) and GFAP (f–h) on spinal cord
cross-sections. At low magnification, Nestin-expressing cells were apparent within the dorsal ependymal zone and displayed prominent dorsally
projecting fibers. These fibers extended the entire length of the dorsal median grey matter (a, short arrows). At higher magnification, pronounced
Nestin expression was detected within the cells of the dorsal ependymal zone and their dorsally projecting fibers (b, short arrow). Ventrally projecting
fibers that were less Nestin immunoreactive were also visible projecting from the ventral pole (b, long arrow). Toluidine blue counterstaining of 1 !m
semi-thin sections showed Nestin expression within the cytoplasm and dorsally projecting fibers of cells in the dorsal ependymal zone (c, short arrows).
At low magnification, GFAP-expressing astrocytes were scattered throughout the parenchyma but GFAP immunoreactivity could also be observed
within the ependymal zone (f, white arrow). At higher magnifications (g) and on toluidine blue-counterstained semi-thin sections (h), 1–2 GFAP-
immunoreactive cell bodies consistently appeared to be present within the dorsal ependymal layer (short arrows). Note the GFAP immunoreactivity
within the perinuclear cytoplasm (short arrow), the apical cytoplasm that contacts the lumen of the central canal (long arrow), and within dorsally
projecting basal fibers (arrowheads) (h). Triple-label immunofluorescence was performed for the ependymal cell markers Vimentin and Sox2, together
with either Nestin (d) or GFAP (i). Both the Nestin-expressing and GFAP-expressing cells were found to co-express the ependymal cell markers (d,
i, short arrows). Immunofluorescence for Ki67 and either Nestin (e) or GFAP (j), illustrating that Ki67(!) ependymal cells usually co-express Nestin
(e) but not GFAP (j). Scale bar in f"70 !m (for a, f), in g"15 !m (for b, g), in h"10 !m (for c, h), in i"10 !m (for d, i) and in j"10 !m (for e, j).
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lineage results in the formation of a prominent sub-ependy-
mal zone of proliferating cells. Thus, sub-ependymal as-
trocytic stem cells are capable of replenishing all principal
SVZ cell types, including the forebrain ependymal cells
(Morshead et al., 1994; Doetsch et al., 1999; Luo et al.,
2008). There is no evidence for such a lineage relationship
among the cells surrounding the non-neurogenic central
canal, where the vast majority of proliferation occurs
ependymally, there is only a rudimentary sub-ependymal
layer, and sub-ependymal neurons are actually mature
NeuN(!) neurons rather than Doublecortin(!) neuroblasts.
Since previous lineage tracing experiments have shown that
all neurosphere-forming capacity in the adult spinal cord orig-
inates from ependymal cells (Meletis et al., 2008), it is likely
that sub-ependymal astrocytes, oligodendrocyte progenitors
and neurons that directly surround the central canal act as
regulatory influences within the ependymal cell niche.
A dorsal concentration of self-renewing
ependymal cells
We detected a consistent dorsal-to-ventral gradient of pro-
liferating ependymal cells. This gradient may be due to
Fig. 7. Comparison of the key features of the forebrain SVZ stem cell niche and spinal cord ependymal cell niche. In the forebrain (a), the lateral
ventricles (LV) are lined with ciliated ependymal cells (E) that express Vimentin (grey) and Nestin (green). Ki67(!) proliferating cells (red) are solely
sub-ependymal and are invariably found closely apposed to PECAM-expressing blood vessels (Shen et al., 2008; Tavazoie et al., 2008) (BV, dark red).
Within the sub-ependymal zone (SE), there are GFAP-expressing astrocytes (blue), Olig2-expressing progenitors (yellow) and DCX-expressing
neuroblasts (violet) which all co-express Nestin. NeuN-expressing neurons (white) are located beneath the sub-ependymal zone and do not proliferate.
In the spinal cord (b), the central canal is lined with ciliated ependymal cells that likewise express Vimentin. Ki67(!) proliferating cells are primarily
found within the ependymal rather than sub-ependymal zone and are distributed in a dorsal to ventral gradient (red gradient). Rare sub-ependymal
proliferation is also detected (not illustrated). Proliferating cells are found in doublets and are always closely apposed to PECAM-expressing blood
vessels (however, this association is not clearly evident on coronal sections). There are Nestin-expressing and GFAP-expressing Vimentin(!) cells
at the dorsal pole that possess extensive basal projections. Within the sub-ependymal layer, there are GFAP(!) astrocytes, NeuN(!) neurons and
Olig2(!) oligodendrocyte progenitors. Olig2(!) cells are often observed along the basal processes of dorsal ependymal cells.
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intrinsic dorsal-to-ventral differences between ependymal
cells or to a dorsal concentration of mitotic signals. Prolif-
erating ependymal cells were almost always found in dou-
blets when examined along the rostro-caudal axis and they
were closely associated with the vasculature. The close
proximity of Ki67(!) proliferating ependymal cells to blood
vessels has similarities to recent observations in the fore-
brain SVZ (Shen et al., 2008; Tavazoie et al., 2008). Inter-
estingly, in both the SVZ and the spinal cord ependymal
zone, the relationship between proliferation and vascula-
ture was ambiguous when examined on cross-sections,
and only became apparent when longitudinal/sagittal sec-
tions were analyzed. In the case of the central canal, we
did not detect a dorso-ventral difference in blood vessel
density surrounding the central canal, suggesting that
proximity to vasculature is necessary but not sufficient for
ependymal cell proliferation. The close association of pro-
liferating ependymal cells with blood vessels raises the
possibility of ependymal cell regulation by systemically-
mediated hormonal changes and/or pharmacological treat-
ments (Tavazoie et al., 2008).
Our findings indicate that proliferating central canal
ependymal cells normally divide symmetrically rather than
generate transit-amplifying progenitors. Unlike in the fore-
brain SVZ, where astrocytic stem cells generate rapidly
dividing Type C progenitors, central canal ependymal cells
that had incorporated BrdU continued to be found in dou-
blets after 21 days, indicating (i) that they do not produce
a transit-amplifying daughter cell, and (ii) that neither
daughter cell migrates out of the ependymal cell layer.
Thus, under normal conditions, it appears that proliferating
ependymal cells primarily produce ependymal cell progeny
that remain resident in the ependymal layer. Previous stud-
ies suggest that the mode of ependymal cell division is
drastically altered following spinal cord injury. Injury in-
duces a rapid and marked increase in the proportion of
ependymal cells that are proliferating, and ependymally-
derived cells infiltrate the entire injury site, generating at
least astrocytes and oligodendrocytes (Frisen et al., 1995;
Namiki and Tator, 1999; Mothe and Tator, 2005; Meletis et
al., 2008; Cizkova et al., 2009). Elucidation of the molec-
ular signals underlying this symmetric-to-asymmetric tran-
sition in ependymal cell division is an important future
objective.
A sub-population of cells at the dorsal pole of the
central canal co-expresses ependymal and neural
precursor markers
Nestin, a marker of undifferentiated neural cells in both the
developing and adult nervous systems, was found to be
highly expressed in a dorsal population of central canal
ependymal cells. These dorsal ependymal cells possessed
filamentous processes that extended along the dorsal mid-
line to the dorsal column white matter. Weaker Nestin
immunoreactivity was also present at the ventral pole.
Dorsal cells that were proliferating were also found to
co-express Nestin. Thus, Nestin expression may define a
more immature ependymal cell phenotype. Interestingly,
we also identified relatively rare (1–2 cells/section) cells at
the dorsal pole that express GFAP. GFAP is expressed by
astrocytes throughout the nervous system, but also by
primitive neural stem cells in the forebrain SVZ (Doetsch et
al., 1999; Imura et al., 2003; Morshead et al., 2003). In the
present study, we found that the GFAP-expressing cells at
the dorsal pole co-expressed Vimentin, a marker solely
expressed by ependymal cells under normal conditions.
Further work will be required to evaluate the nature of
these cells.
Based on their long, basally projecting fibers, Nestin-
expressing cells correspond to tanycytic or radial ependy-
mal cells. Cells having the distinctive morphology of the
Nestin-expressing cells described here appear to derive
from “ependymoglial cells” that originate early during em-
bryonic spinal cord development. Following closure of the
neural tube and fusion of the dorsal walls of the central
canal, at approximately E15 in the mouse, the neuroepi-
thelial-derived ependymoglial cells persist at the dorsal
and ventral midlines, maintaining long filament-rich fibers
that can still be observed extending all the way to the pia at
E18 (Sturrock, 1981). The dorsal fibers of these cells can
be traced along the dorsal grey matter even into adulthood,
but by P5 their trajectory within the dorsal columns is
obscured by white matter (Sturrock, 1981). The functions
of these cells during development and adulthood have yet
to be identified.
Antigenic differences between cuboidal, tanycytic and
radial classes of ependymal cells have not been previously
described, and the presence of intermediate phenotypes
has led to the suggestion that these classes may actually
represent a spectrum (Meletis et al., 2008). The fact that
the neural precursor markers Nestin and GFAP are ex-
pressed by a sub-population of Vimentin(!) cells raises
the possibility of heterogeneity in ependymal cell functions
in vivo. Although it is established that the neurosphere-
forming capacity in the adult spinal cord is derived from
ependymal cells (Meletis et al., 2008), it is unclear whether
all spinal cord ependymal cells have equivalent stem cell
potential. Previous studies have shown that spinal cord
injury increases the proportion of ependymal cells that are
proliferating (Mothe and Tator, 2005; Meletis et al., 2008),
induces ependymal expression of Nestin and to a lesser
extent GFAP (Meletis et al., 2008), and stimulates an
increase in the number of neurospheres that can be cul-
tured (Xu et al., 2006). We therefore favour the idea that
the Nestin(!) dorsal population of ependymal cells is more
undifferentiated within the normal in vivo context, but that
the wider ependymal cell population is capable of entering
a stem cell-like state under the appropriate circumstances,
that is following in vitro culturing or in vivo injury.
CONCLUSION
Spinal cord ependymal cells have neural stem cell poten-
tial both in vitro and following tissue injury in vivo. Here, we
found that they do not display multilineage potential or the
ability to produce transit amplifying progenitors under nor-
mal conditions. Analysis of the ependymal cell niche re-
vealed a previously unrecognized level of cellular hetero-
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geneity and complexity, and indicated that many of the key
elements of the forebrain stem cell niche are in fact
present. However, these elements are organized in a dis-
tinct fashion. Determining the molecular basis of the cel-
lular interactions occurring within the spinal cord ependy-
mal zone may help us to unlock the stem cell potential of
ependymal cells to promote spinal cord repair.
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